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1 HEPATOPROTECTIVE ACTIVITY OF NANNARI MATHIRAI 
1. INTRODUCTION 
             Siddha system of medicine is a holistic medical system which has been 
developed gradually during the consecutive era. The word Siddha has been derived 
from the word Siddhi which literally means “Attaining perfection in life” or even it 
may be termed as “Heavenly Bliss”(1).Traditional medicine is the sum total of 
knowledge, skills and practices based on theories beliefs and experiences indigenous to 
different cultures that are used to maintain health as well as to prevent, diagnose, 
improve or treat physical and mental illness. “An Ounce of prevention is worth a pound 
of cure”. 
               Siddha is widely practiced in the Tamil speaking areas of South India. Over 
the last several decades, the place for Modern allopathic system of medicine in many 
segments of Health care system are followed by worldwide it is because of its advantage 
of managing medical emergencies. Siddha system of medicine has ability to cure the 
root cause of disease and hence effective in treating severe chronic disease. It is a well-
known fact that, it is safe, time tested, without any drastic adverse effects. Siddha 
pharmacology consist of 32 internal and 32 external medicines. (2) 
               Medicinal plants are naturally gifted with invaluable bioactive compounds 
which form the backbone of traditional medicines. The actions are due to the presence 
of phytochemical components like glycosides, tannins, alcohols, aldehydes, etc (3). 
Those chemical components are not only for the discovery of therapeutic agents but are 
also an asset for the future genera. “Siddha is simply the science of understanding 
your own unique self and being who you are meant to be”. 
               Siddha medicine preparations includes Herbs, Metals, Minerals, Animal by 
products (3). However, no scientific data regarding the identity and effectiveness of these 
herbal products are available. Now this is a time to standardization and prove the 
efficacy of these medicines through universally accepted scientific parameters. 
Whatever the system of medicine we are taking first of all its toxic substances affect the 
liver. So, we must protect the Liver by giving Hepatoprotective drugs. 
               The Greek word for Liver “HEPATO” or “HEPAR”. Liver is the Largest vital 
organ in our body. It weighs about 1400 grams in adults. The Liver’s mass comprises 
One-fourth or One-fifth of a total adult body’s weight and one-eighteenth of the body’s 
INTRODUCTION 
 
2 HEPATOPROTECTIVE ACTIVITY OF NANNARI MATHIRAI 
weight during Infancy. It is the heaviest internal organ and the Largest gland in the 
Human body. It is located in Right upper quadrant of the abdominal cavity, it rests just 
below the diaphragm, to the right of the stomach and overlies the Gallbladder (4). 
               The Liver performs the metabolic homeostasis of the body as well as 
biotransformation, detoxification and excretion of many endogenous and exogenous 
compounds, including Pharmaceutical and environmental chemicals. Therefore, 
maintenance of a healthy liver is essential for the overall well-being of an individual (5). 
The Liver’s highly specialised tissues regulate a wide variety of high-volume 
biochemical reactions, including the synthesis and breakdown of small and complex 
molecules, many of which are necessary for normal vital functions.  
               Liver also involved in the synthesis of fatty acids, lipoproteins, amino acids 
and plasma proteins which is known as albumin, fibrinogen and prothrombin. Liver also 
plays an important role in storage and metabolism of fat-soluble vitamins and irons.  
Water soluble vitamins, vitaminB12 are also stored in liver (6). 
               The liver is a metabolically active organ responsible for many vital life 
functions. The liver is thought to be responsible for up to 500 separate functions, usually 
in combination with other systems and organs (7). It interacts with cardiovascular and 
immune system and it also serves as an excretory organ. 
               Behind the liver there is a small organ called the gallbladder, which function 
is to store bile produced by the liver and empty it into the small intestine, digestion and 
absorption. Bile pigment, cholesterol and drugs are excreted by liver. Liver also regulate 
endocrine functions of hormones. Various hormones like insulin, glucagon, growth 
hormone and GI hormones are degraded by liver. Kuffer cells are most important 
phagocytic cells which is present in liver. These Kuffer cells plays an important role in 
removing unwanted materials from the circulation. Endocytosis is the mechanism by 
which these materials are removed. Liver cells are called Hepatocytes.           
               Hepatocyte plays an important role in the metabolism of drugs and 
xenobiotics. For effective elimination, the drug and the metabolite must be made 
hydrophilic. Reabsorption of these metabolite by renal tubules is dependent on its 
hydrophobicity. Many drugs and metabolites are hydrophobic. The more hydrophobic 
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a substance is, the more likely it will be reabsorbed. The liver converts them into 
hydrophilic compounds so the metabolite will easily remove from the body(6a). 
The liver is the vital organ and supports almost every other organ in the body. 
Because of its strategic location and multidimensional function, the liver is also prone 
to many diseases (8). 
               Liver diseases caused by variety of factors. Such as viruses, alcohol, drugs 
particularly paracetamol and drugs used to treat cancer. Fast food, environmental 
pollutants and sedentary life style also caused liver disease. If the liver become diseased 
its results loss of vital functions like depression of immune system, sluggish digestive 
system, obesity, fatigue which can cause significant damage to the body. The most 
common liver diseases are Hepatitis, Cirrhosis, Alcohol and drug related liver 
diseases,FLD,Liver tumour, Rey’s syndrome (9). In recent years, people widely suffered 
from liver diseases. In India, liver disease is the tenth most common cause of death. 
               According to the latest WHO data published in May 2014, Liver disease 
deaths in India reached 2,16,865 or 2.44% of total deaths. The age adjusted death rate 
is 21.96 per 1,00,000 of populations. Population ranks India#61in the world (10). 
According to WHO, about 46% of global disease and 59% of the mortality is because 
of chronic diseases and almost 35millon people in the world die of chronic liver 
diseases. Liver diseases rate steadily increasing over the years (11). 
               The major sign of liver disease is Jaundice (Hyperbilirubinemia) which is 
known as yellowish discolouration of skin and mucous membrane (12). In Siddha system 
of medicine, “Jaundice” is correlated with “Pitha Kaamaalai” or “Manjal Kaamaalai”. 
As per the text Maanjal Kaamaalai is of 13 types (13). Clinically Jaundice is divided 
into three types. They are Prehepatic, Hepatic and Post hepatic. Many of liver diseases 
are accompanied by Jaundice(12a). A healthy liver is essential for the healthy life. So it 
is important to take care of liver in a healthy way. One of the natural and healthy way 
to take care of liver is Siddha system of medicine. In this medicine various polyherbal 
preparations are available to treat liver diseases. 
               Herbal drugs are significant source of hepatoprotective drugs. Mono and 
polyherbal preparations have been used in various liver disorders. According to one 
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estimate, more than 700 mono and poly-herbal preparations in the form of decoction, 
tincture, tablets and capsules from more than 100 plants are in clinical use(7b). In the 
modern scenario, diseases are becoming drug-resistant and scientists are studying 
possible roles of plant-based drugs for screening lifesaving drugs. Treatment options 
for common liver diseases such as cirrhosis, fatty liver, and chronic hepatitis are 
problematic. The effectiveness of treatments such as interferon, colchicine, 
penicillamine, and corticosteroids are inconsistent at best and the incidence of side 
effects profound. it may also cause various other diseases. So, there is a need for safe 
and potent hepatoprotective drug to treat various liver disease. 
               In recent years synthetic drugs are showing more adverse effect, to overcome 
this problem researchers are trying to avoid this risk of those drugs. Whenever a drug 
is prescribed to a patient, they are facing risk of side effect, so long-term use of these 
drugs patient should be careful. But in herbal medicine the toxicity of herbal drugs is 
less when compared with the synthetic medicines(7c). Due to known side effect, patient 
preferred to take alternative medicine which is natural and healthy way (14). The process 
of healing and regeneration of liver cells are support and promote by herbal preparations 
with less side effects. 
               Several hundred plants have been examined for use in a wide variety of liver 
disorders. Just a handful has been fairly well researched. The latter category of plants 
includes: Silybum marianum (milk thistle), Picrorhiza kurroa (kutkin), Curcuma longa 
(turmeric), Camellia sinensis (green tea), Chelidonium majus (greater celandine), 
Glycyrrhiza glabra (licorice) and Allium sativa (garlic). 
               The Hemidesmus indicus is well known plant because of its medicinal 
property its easily reliable and commonly used plant all over the world. The World 
Health Organization (WHO) estimates that 80% of the world health populations 
presently use herbal medicines for some aspect of primary health care(7d). Although 
various drugs are flooding in the market used as hepatoprotective agent. In that many 
of them having adverse effects. The author is interested to describe about Nannari 
Matirai for hepatoprotective activity(Kaamaalai-Jaundice). I think it will be more 
effective to treat liver disease. 
               Siddha system is a treasure which contains enormous herbal preparations. 
They are highly effective and devoid of adverse effects. For this reason, Siddha system 
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of medicine has been drawing global attention in recent times. Liver disorders are 
increasing day by day. So, there is a need and demand for effective, safe and accurate 
treatment of liver diseases. Therefore, it is not surprising that a considerable interest has 
been developed in search of potent hepatoprotective drug from herbal origin. 
     Based on above facts, one of the Polyherbal preparation mentioned in Siddha 
literature is Nannari Mathirai. I hope this Siddha medicine Nannari Mathirai will be 
effective drug for the cure of liver disease(Jaundice-Kaamaalai). So, I interested to 
validate the Nannari Mathirai, a unique herbal preparation for its hepato-protective 
activity. 
               This Siddha drug “Nannari Mathirai” is used for (Jaundice-Kaamaalai)is 
yet remained unexplored for its exact chemical, pharmacological, toxicological profile 
in terms of scientific research. To fill these scientific lacunae, the present work will be 
undertaken to evaluate the chemical, toxicity profile and pharmacological potentials of 
Nannari Mathirai in various hepatotoxicity models. 
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2.AIM AND OBJECTIVES 
AIM: 
               The present study was focused to validate the Hepatoprotective (Jaundice-
Kaamaalai) of NANNARI MATHIRAI in experimental animals with CCL4, Ethanol 
induced hepatotoxicity and Anti-oxidant activity. 
OBJECTIVE: 
               The scientific study on Nannari Mathirai was carried out in the following 
stages. 
➢ Collection of different texts in Siddha and modern literature relevant to this 
study.      
➢ Description of pharmacognostic features of the plant in this formulation 
including the taxonomic identification, collection, purification of the plant 
etc.  
➢ Preparation of the trail drug Nannari Mathirai as per classical Siddha text.  
➢ Standardisation of the trial drug Nannari Mathirai by means of 
physiochemical analysis, phytochemical analysis.  
➢ Evaluate Bio chemical analysis of the test drug to derive acidic and basic 
radicals. 
➢ To estimate the presence of elements, functional groups and particle size 
through instrumental analysis of the trial drug. Evaluating the microbial 
load and activity of the trail drug. 
➢ Evaluation of the Acute and 28 days epeated oral toxicity study of the test 
drug according to OECD guidelines.  
➢ Evaluation of Pharmacological study of the drug through the following 
activities:  
1) Hepatoprotective activity of CCL4 induced Hepatotoxicity.  
2) Hepatoprotective activity of Ethanol induced Hepatotoxicity. 
3) Anti-oxidant property.                    
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3.1   REVIEW OF LITERATURE 
DRUG REVIEW: 
The trial drug “NANNARI MATHIRAI” was taken from the Siddha 
literature “KANNUSWAMY PARAMBARAI VAITHIYAM” for treating Kaamaalai 
(Jaundice).P.no:141,Edition year:1948. 
 The ingredients of the drugs are. 
1. Nannari (Hemidesmus indicus.) 
2. Seeragam (Cuminum cyminum) 
3. Elam (Elettaria cardamomum) 
4. Perunseeragam (Foeniculum vulgare) 
5. Sevvagathi (Sesbania grandiflora) 
3.1.1. GUNAPADAM ASPECT 
1. NANNARI 
Scientific name: Hemidesmus indicus.  
Synonyms:  
     Angarimooli, Narunetti, Paathaalamooli, Kopaagu, Saaribam, Paarkodi,      
Neerundi, Kaananuchaari, Krishnavalli, Chaariyam.  
Vernacular names:  
Tam  : Nannari  
Eng  : Indian sarasaparilla  
Mal  : Nannari  
Kan  : Sugandha-palada  
Sans  : Sariba  
Hindi  : Magrabu  
Properties and action:  
     Suvai   : Inippu (Sweet)  
            Thanmai          : Cold potency  
     Pirivu   : Inippu (Sweet)        
Action:   
➢ Diaphoretic                    
➢ Alternative  
➢ Tonic  
➢ Demulcent  
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➢ Diuretic  
Parts used: Root   
General characters:  
      சலததோடம் பித்தமதி தோகம் உழலல 
      சலதமறு சீதமின்னோர் தஞ்சூ- டுலகமதிற் 
      சசோன்னமது தமகம் புண் சுரமிலைசெ லோசமோழிக்கும் 
      சமன்மதுர நன்னோரி தைர். 
-        - ததலரெர் குணைோகடம்  
Indications:  
Hemidesmus indicus cures pitha diseases, insect bite, thirst, sinusitis, diabetes  
mellitus, syphilis.  
Important preparations  
❖ Nannari karpam,   
❖ Nannari manappagu.  
Medicinal uses:  
➢ The root is soaked with 30ml of warm water and give it thrice a day cure  
indigestion and impotence.  
➢   Root powder mixed with cow’s milk cures oliguria. It also gives along with  
cumin seeds [15].  
2.SEERAGAM 
Scientific name:Cuminum cyminum  
Synonyms: 
            Asai, Chiri, Upakumbapeesam, Narcheeri, Thutthasambalam, Piraththi-
vika,Pithanasini, Bosanakudori, Meththiyam.  
Vernacular names  
Tam : Asai,Nar cirakam,pittanacini,pocanakutari  
            Eng : Cumin Seed, Cumin  
               Hindi : Jira, Safed jira  
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               Kan : Jirage, Bilejirege  
               Mal      : Jeerakam  
               Mar      : Pandhare jire  
   Sans     : Svetajiraka, Ajaji, iraka. 
            Tel    : Jilakaraka, Tella jilakara.    
Parts used: Seeds  
   Properties:  
               Suvai     : karppu, sweet         
               Thanmai : Coolant  
               Pirivu      : Inippu (Sweet)   
Actions       :   
➢ Astringent,   
➢ Stimulant, 
➢ Stomachic,   
➢ Carminative.  
General character: 
   பித்தசமனு மந்திரிலெப் பினனப் படுத்திெைன் 
   சத்துருலை யுந்துரந்து சோதித்து – மத்தசனனும் 
   ரோசனயு மசைன்று நண்லபப் பலப்படுத்தி 
   தபோசனகு டோரிசசயும் தபோர். 
      ததரன் சைண்போ.(17)  
Indication:  
         It enhances hunger and it induces digestion.  
Important preparation:  
❖ Seeraga karpam.  
❖ Asai chooranam  
❖ Panchadhebageni legiyam  
❖ Mayiliragathi chooranam 
❖ Asaithylam 
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Medicinal uses:  
➢ It improves Gut motility and helps in digestion. It is used to increase urine 
flow to relieve bloating.  
➢ It helps in preventing boils, rashes, pimples and excess toxic content.           
➢ Cumin also increases the release of bile from the liver. Bile helps digest fats 
and certain nutrients in our gut.   Add cumin seeds in 1400ml of heated gingely oil, 
and then cool it. This oil when taken for head bath cures headache, eye diseases, 
giddiness and vomiting. 
➢ Cumin seeds are also one of the ingredients of Panchadeepakini Legiyam(18) 
3.ELAM 
Scientific name: Elettaria cardamomum – 
Synonyms         : Onchi, Gorangum, Thudi.  
Vernacular names:  
Tamil    : Elam  
English   : Cardamom  
Tel    : Elakulu  
Mal    : Elattari  
Kan    : Elakki  
Sansk    : Ela  
Hin    : Elachi 
   Partsused       : Seeds      
   Properties:  
Suvai    : Kaarppu (Pungent)  
Thanmai : Veppam (Hot potency) 
Pirivu    : Karppu (Pungent)  
    Actions:  
➢ Carminative  
➢ Stomachic      
➢ Expectorant      
➢ Tonic.  
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General characters:  
        சதோண்லட ைோய்கவுள் தோலுகு தங்களில் 
    ததோன்றும் தநோெதி சோரம்பன் தமகத்தோல் 
    உண்லட தபோசலழுங் கட்டி கிரிச்சரம் 
    உழலல ைோந்தி சிலந்தி ைிஷஞ்சுரம் 
    பண்லட சைக்லக ைிதோகதநோய் கோசோமும் 
    போழுஞ் தசோமப் பிணிைிந்து நட்டமும் 
    அண்லட ெலீளைன் பித்தம் இலைக்சகல்லோம் 
    ஆல மோங்கமழ் ஏல மருந்ததத 
- பதோர்த்த குண சிந்தோமணி.(19)                         
Indications:  
              It cures cough, diarrhoea, haemorrhoids, dyspepsia, vomiting, anal fissure.  
Medicinal uses:  
➢ Powdered form of seeds of cardamom, dried ginger, cloves, cumin 
seeds cure stomach ache, ulcer.  
➢ Roasted seeds of cardamom, omam and cumin seeds then they are 
powdered and given to cure indigestion (20).                              
4. PERUNSEERAGAM 
Scientific name      : Foeniculum vulgare  
Other name  : Sombu, Venseeragam 
Vernacular names:  
 Tamil  : Sombu    
Eng          : Fennel  
Tel  : Peddajilakarra  
Mal            : Perunjirakam  
Hind            : Saumph  
            Kan                : Badhesoppu  
Parts used: Flower, Seeds, Root.  
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Properties and action : 
            Suvai  :  Aromatic  
            Thanmai  : Veppam (Hot potency) 
Pirivu        : Karppu (Pungent)   
Actions:    
➢ Carminative   
➢ Stomachic.  
General characters:  
                    தெோனிதநோய் குன்மம் உரூட்லசமந் தம்சபோருமல் 
   தபனமுறு கோசம் பலீிகமிலரப் – பசீனௌலர 
   தசர்க்கின்ற ைோதமுதபோஞ் சீர்சபரிெ சீரகத்தோல் 
   மூக்குதநோ ெில்லல சமோழி 
- அகத்திெர் குணைோகடம்.                                           
Indications:  
            Cures Uterine disorders, Abdominal pain, Fever, Indigestion, Dyspepsia, 
Cough, Liver diseases, Tonsillitis, Rhinitis.   
Medicinal uses:  
➢ Sombutheenir: 1 part of Anise seed is mixed with 20 parts of water and 
allowed to the process of distillation.  
➢ Dose:15ml to 20 ml.  
➢ Anise seed is slightly fried and powdered. About 2gms of this powder 
along with sugar cures uterine disorders, Abdominal pain.  
➢ Distilled water taken from anise seeds flower, when given for children cures    
indigestion, Worms and loose stools(18a).  
➢ Fennel seeds oil is used to relive cold, bronchitis and as a massage oil to cure 
joint pains. The decoction of seed is used to increase breast milk secretion in 
nursing mothers 
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5. SEVVAGATHI 
           Scientificname : Sesbania grandiflora     
           Synonmys: 
Accham, Muni, Kareram.  
      Vernacular names:  
Tamil : Agathi  
Eng : Sesban   
Tel : Avise  
Mal : Agatti  
 Pers : Agti  
 Kan : Agashi  
Parts used: Leaves, Flower, Bark, Root.  
Properties:  
               Suvai                 : Bitter  
               Thanmai           : Coolent  
            Pirivu                : Karppu (Pungent)  
Actions:      
➢ Antidote  
➢ Refirgerant  
➢ Laxative  
➢ Vermifuge.  
General characters:  
              நோடிரற் பனிப்பனீும் நோசிக் கலறக்கதழ்லை 
            தெோடித் துலடத்துள் சளோளிெோற்றும் – போசடத் 
            தைரகத்தி னுந்துணங்லகத் தண்டோ மெிதல 
            துைரகத்திப் பூக்கோண் டுதி. 
                           -   அகத்திெர் குணைோகடம்.           
Indications:  
            It controls nasal bleeding and it excretes excessive heat from our body.   
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Medicinal uses:  
➢ It can be used in detoxification of the body, if there is chronic toxicity due to 
improper dietary patterns over a period of time.  
➢ The leaves prove to be helpful in worm infestations and bleeding 
disorders (21).  
3.2.1     BOTANICAL ASPECT 
1. HEMIDESMUS INDICUS 
Scientific classification:  
Kingdom : Plantae  
Division : Magnoliophyta  
Class       : Magnoliopsida  
  Order        : Gentianales  
  Family      : Apocyanaceae  
  Genus       : Hemidesmus  
  Species     : indicus    
The plant description: 
It is semi erect and sometimes prostrate shrub with woody aromatic roots. 
The slender, numerous stems is terrate with thick nodes. The leaves are variable, 
opposite and short petioled. They are oblong, elliptic to linear lanceolate. The 
flowers are green on the outside and purplish inside. The stem and branches of the 
plant twine anticlockwise and the roots have a camphor like smell. Flowers may be 
greenish yellow to greenish purple on the outside and yellow to light purple on the 
inside. It has fused corolla that numbers twice that of the calyx.  
Pistil is bicarpellary with free ovaries many ovuled and having distrint styles. 
Distribution:  
The species is distributed throughout the tropical and subtropical parts 
of India, especially in upper Gangetic plains, Bengal, Madhya Pradesh and 
South India.  
Part used: Leaves, Flower, Bark, Seed, Roots.  
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Chemical constituents:  
The root contains hexatriacontane, lupeol, octacosanoate, α-amyrin, β-
amyrin, acetate, sitosterol, coumarino-lignoid-hemidesminine, hemidesmin 1 and 
hemidesmin 2, six pentacyclic triterpenes including two oleaneces and three ursenes.  
Properties and uses:  
➢ Root bark of this plant known as “Indian sarsaparilla” are prescribed 
in dyspepsia, loss of appetite, nutritional disorders, fever, skin 
diseases and ulceration especially those of syphilitic origin, 
constitutional syphilitis, chronic rheumatism and leucorrhoea.  
➢ Hot infusion of root bark with milk and sugar is used as tonic especially 
for children in chronic cough and diarrhoea. (22) 
2.  CUMINUM CYMINUM 
Scientific Classification:  
Kingdom : Plantae   
Class       : Asterids  
Order      : Apiales  
Family    : Apiaceae  
Genus      : Cuminum  
Species : cyminum(23)  
The Plant Description: 
    A slender, annual, glabrous herb, leaves twice or thrice 3-partite, ultimate  
segments filiform, Flowers in compound umbels bracteole, bracts linear rigid. 
Calyx teeth small, subulate, unequal shaped. Fruit cylindric shape, tip 
narrowed, seeds somewhat dorsally compressed. 
Distribution:  
Extensively cultivated as a cold-season crop on the plains and as 
summer crop on the hills in Northern India, Himalayas, Punjab, Baluchistan, 
Kashmir, Kumarun, Garhwal and Chamb. The plant also imported from Persia 
and Asia minor.  
Part used           : Seeds  
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Macroscopic Characters:  
    Fruit, a cremocarp, often separated in to mericarps, brown with light 
coloured ridges, ellipsoidal, elongated, about 4 to 6 mm, high and 2 mm,wide.  
Chemical Constituents  
Cuminaldehyde, Cuminin,1,3 - β - menthadien -7-al, 1,4- β - menthadien -7-
al, β-cymene, terpinene, β-pinene,7-1(O-β-D-galalacturonide)-4,5dihydroxy, 
glycosides, luteolin and apigenin. Fatty oil, resin, mucilage, a valuable essential oil 
thymine contains cuminol or cumic aldehyde 56 p.c, a mixture of hydro carbons, 
cyme or cymol, terpene etc (22a). 
Medicinal uses  
➢ Seeragam, Chukku, Elam and Nellimulli powder 1-part sugar ½ part mixed 
with and used for reduce pitham.  
➢ Cumin seeds soaked in karisalai leaf juice then make it dried powder mixed 
with sugar and chukka powder used for the treatment of jaundice and vatha 
Disease(24a).   
3. ELETTARIA CARDAMOMUM 
Scientific Classification:  
Kingdom : Plantae  
Class  : Monochlamydeae   
Order  : Zingiberales  
Family  : Zingiberaceae  
Genus  : Elettaria  
Species : cardamomum  
 The Plant Description:  
A tall herbaceous perennial, with branching subterranean roots, stock, from 
which arise a number of upright leafy shoot. It is 5-18 ft. height and bearing alternate, 
elliptical or lanceolate sheathing leaves. Flowers are borne in panicles and arising 
from the base of vegetative shoots.  
Fruits are trilocular capsules, fusiform to ovoid in shape and pale green in 
yellow in colour, its containing 15-20 seeds. Cardamom seeds have pleasant aroma 
and pungent taste. 
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Distribution: 
 It is a native of the evergreen forest of south India, growing wild in the 
Western Ghats. 
Parts used: Seeds.  
Chemical Constituents:  
The seeds contain Volatile oil, Cineol, Terpineol, Terpinene, Limonene and 
Sabinene.   
Medicinal Uses  
➢ Powdered form of seeds of cardamom, dried ginger, cloves, cumin seeds 
cures stomach ache, ulcer.  
➢ Roast seeds of cardamom, omam and cumin seeds then they are 
powdered and given to cure indigestion (25).  
4. FOENICULUM VULGARE 
Scientific classification:  
 Kingdom : Plantae  
 Division : Angiosperms  
 Class  : Dicotyledons   
 Order  : Umbellale  
    Family  : Apiaceae  
 Genus  : Foeniculum  
 Species  : vulgare. (26)  
The Plant descripition:  
            A stout, erect, glabrous aromatic herb upto 1.8m in height, leaves 3-
4 times pinnate with very narrow linear or subulate segments. Flowers are 
small. Fruits are oblong, ellipsoid or cylindrical, straight or slightly curved 
greenish or yellowish brown.  
Distribution:  
            Cultivated throughout India.  
Parts used:  
            Flowers, Seed,Fruits.    
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Chemical constituents:  
Ascorbic acid, riboflavin, a, ß and     tocopherol, ß tocotrienol, choline, 
trigonelline,p-cymene, anethole, anisaldehyde, camphene, estragole, fenchone, 
fenchene, foeniculin, methylchavichol, chlorogenic, hydroxyl benzoic and 
hydroxyl cinnamic acids(27).   
Medicinal uses:  
➢ The fruits are sweet, acrid, bitter, emollient and refrigent.  
➢ They are used as anthelmintic, aromatic, carminative, emmanogogue, stimulant 
and stomachic.  
➢ It is beneficial in diseases related to chest and kidney.  
➢ Juice is used to improve eyesight, hot infusion given in amenorrhoea.  
➢ Oil from seeds is anodyne, diuretic, stimulant and vermicide.   
                            5. SESBANIA GRANDIFLORA  
Scientific classification:   
Kingdom       : Plantae  
Division        : Angiosperms  
Class             : Dicotyledons  
Order            : Fabales  
Family          : Fabaceae              
Genus           : Sesbania  
Species         : grandiflora  
The Plant descripition : 
 It is a fast-growing tree, the leaves are regular and rounded and the flowers 
white, Red or pink. The fruits look like flat, long, thin green, beans. Leaves are 15-
30 cm long with leaflets in 10-20 pairs or more and an odd one. Flowers are oblong, 
1.5-10 cm long in lax, with two to four flower racemes. 
Distribution:  
            South east Asia to Northern Australia, India, Sri lanka.  
Parts used: Leaves, Flower, Bark, Root.   
 
 
REVIEW OF LITERATURE 
 
19 HEPATOPROTECTIVE ACTIVITY OF NANNARI MATHRAI 
 
Chemical constituents:  
Three isoflavanoids, isovestitol, medicarpin, sativaan along with another 
known compound, betulinic acid were isolated from the root of sesbania 
grandiflora.The structures of the isolated compoundswere characterised by means of 
spectroscopic techniques.(UV,IR,MS).Pharmaceuticals.2012 Aug;5(8):882-889.  
Medicinal uses:  
➢ The juice from the flowers is used to treat headache, headache, head 
congestion, or snuffy nose. As a snuff, the juice is supposed to clear 
the nasal sinuses. The root is used for inflammation.  
➢ The bark is used in infusions for small pox. The powdered bark is used for 
ulcers of the mouth and alimentary canal.  
3.2 DISEASE REVIEW 
       3.2.1 SIDDHA ASPECT DISEASE REVIEW: 
                                       ( KAAMAALAI ) JAUNDICE  
Other names:   
In Siddha literature Kaamaalai also known as Manjal kaamaalai, Pitha 
kaamaalai, Kamala, Kamila.  
Kaamaalai is one among those diseases which occur due to derangement of 
pitha uyir thathu. In this disease eyes, tongue, urine and the whole body will get 
yellowish discolouration.  
Aetiology:  
 Yugi vaidhya chinthamani states that jaundice will occur when one 
consumes more food which stimulates pitha thathu, drinking unhygienic and impure 
water, seasonal changes and also indulges in excessive sexual activity under the 
conditions of severe anaemia are the causes of this disease.  
Premonitory symptoms:  
In this disease, excessive salivation, nausea, bitterness of tongue, 
anorexia, indigestion, dryness of the body and shrinking of skin like a frog. 
After that, eyes, nail beds, face and skin and also urine become yellow in color. 
“பருகதை உள்ளங்கோ லுள்ளங் லககள் 
பகர்முகங்ண் ணுடம்புமிக ைைளுப்பு கோணுங் 
  கருகதை கோல்லகக தெோய்ச்ச லோகுங் 
கனமோக நடுக்கிதெ இலளப்புண் டோக்குஞ் 
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சுருகதை மலந்தோனும் ைறண்டு கட்டுந் 
தூெமுக மஞ்சளிட நிறம தோகும் 
சைருகதை ைகீ்கமோய்க் கலளப்புண்டோகும் 
மிகக்கோது மந்தந்ததலல கனப்புண்தடோகும்." 
-யூகிமுனி  
Again, in this disease, palm, sole, face, eyes and the body will become pale; 
there would be severe fatigue in the extremities, shivering of the body, frequent 
dyspnoea, constipated and hardened feces, and yellowish discolouration of face, 
oedema, lassitude, deafness and heaviness of head [28].  
Classification of the disease:  
 In Siddha literatures, it is classified in to 13 varieties. They are as follows;  
➢ Vatha kaamaalai 
➢ Pittha kaamaalai 
➢ Kaba kaamaalai 
➢ Vatha kaba kaamaalai 
➢ Pittha kaba kaamaalai 
➢ Mukkutra kaamaalai 
➢ Manjal kaamaalai 
➢ Uthu kaamaalai   
➢ Varal kaamaalai 
➢ Azhagu kaamaalai 
➢ Sengamala kaamaalai 
➢ Kumba kaamaalai 
➢ Gunma kaamaalai 
Among the 13 varieties of jaundice, seven types are curable and eight types 
are incurable. Curable types include   
 1.Udhu kaamaalai,  
 2.Varal kaamaalai,  
 3.Manjal kaamaalai,   
 4.Pitha kaamaalai,  
 5.Kabha kaamaalai,   
6.Vatha kabha kaamaalai,  
                       7.Pitha kabha kaamaalai.   
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The other varieties are not easily curable.  
Treatment:  
          Intake of variable food and other deeds stimulates pittha thathu, pitha 
increases in its strength, joins kaba and becomes pitha kaba factor. This factor spoils 
the spreading vayu (paravu kal- Vyanan) and prevents it from doing its normal work 
and thus it spoils the strength of blood. Because of this, liver gets affected and also 
the bile unable to flow in its normal route as there is an obstruction.  
          Hence the bile mixes with the blood and jaundice occurs. The vatha factor 
gets affected and the disease occurs due to pitha vatha factor. Apart from this, the 
other vayu (gases) also get spoiled.  
Hence the duty of the doctor is to set right the altered pitha kabam and pitha 
vatham, in order to make the bile flow in its normal route and to increase the strength 
of blood by suitable treatment. The altered spreading vayu (gas) and other vayu 
(gases) should be brought to normal and made to do the normal regular work. Then 
medicines for the disease should be given.  
To induce vomiting:  
Since vomiting is a symptom in this disease, it should not be induced though 
it is advocated in Siddha literatures.  
To induce diarrhoea:  
To stimulate normal and easy bowel movements, the following substances 
which have laxative action can be given:  
➢ Phyllanthus emblica (Indian gooseberry)  
➢ Terminalia chebula (Kadukkai) 
➢ Anthemides flower (Simai samanthi flower) 
➢ Buds of rose (Roja) 
➢ Grapes (Kodi munthrigai) 
➢ Picorrhiza kurroa (Kadukurohini) 
➢ Bark, leaves and flower of purging cassia (Sarakkondrai) 
➢ Root of Indian jalap (Sivathai) 
➢ Flower of neem (Veppam pu) 
➢ Tinospora cordifolia (Senthil) 
A decoction of the above substances may be made and given for jaundice for    
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laxative purpose[28a].   
Other medicines for vomiting and diarrhoea:  
1.Malakudara oil:  
The medicinal malakkudara oil in a dose of one teaspoonful with a small 
quantity of milk can be given at bed time. The next day morning faeces will be passed 
out easily.  
2.Malakudara mezhugu: 
Malalakudara wax (mezhugu) of the size of a fever nut (kazhal kay-Caelpinia 
bonduc) can be given at bet time. Easy motion will occur in the morning.  
3.Thithippu bedi mezhugu or legiyam:  
        Sweet diarrhoea wax (thithippu bedhi mezhugu) or sweet diarrhoea leghiyam 
(thithippu bedhi leghiyam) should be taken at bed time as a size of Indian gooseberry. 
Easy to motion will occur in the morning. It may be given in suitable doses in the 
morning and evening.  
4.Sanjivi tablets: 
If the motion is not passed out properly by the above methods, 2 Sanjivi tablets 
given along with hot water can be given for children. Motion will be passed easily.  
For adults, one among the following may be given in a dose of 2 tablets with 
hot water in the morning alone. Faeces will be passed easily. The medicines are 
vajjirakandi tablet, attabairava tablet, suka viresana tablet, jivarathina tablet, 
virechana bhupathy and lavangathy tablet. When sanjivi tablet along with leaf juice 
of Euphorbia nivula (ilaikkalli) is given, vomiting and diarrhoea will be induced. 
Vomiting for two or three times will occur. Diarrohoea will also occur. Along with 
vomit or faeces, the bile fluid will also come out.  
5.Marukkarai kaai:   
The unripened fruit of Randia dumetorum (marukkarai kaai) in its tender 
reddish form may be taken. It may be soaked in lime juice and leaf juice of Euphorbia 
nivula(ilaikkalli) for two days in each. Then it can be taken out and dried.  
                 This can be ground and made into powder. ½ pinches can be given in the        
morning alone. Diarrhoea and vomiting will occur [29].  
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Medicines for Jaundice (Siddha Aspect):  
1.Karisalai chooranam (Powder of Eclipta alba):  
➢ Powder of dry leaves of Eclipta alba (Karisalai) 35 gm 
➢ Powder of epicarp of Terminalia chebula (Kadukkay) 15gm 
➢ Powder of pepper (Milagu) 10 gm 
➢ Powder of the root of Lowsonia alba – henna plant (Maruthonri) 10 gm. 
 Mix the all the above ingredients and ground it in the mortar to make it as a 
fine powder. Take 2gm of the above, add 200mg of rusted iron Chenduram and take 
2 times a day with buttermilk. Within 5 to 10 days, jaundice will get cured.  
2.Karisalai matthirai (Tablet of Eclipta alba):  
❖ Eclipta alba - one hand full 
❖ Black cumin 
❖ Long pepper 
❖ Pepper (Piper nigrum) 
❖ Garlic (Allium sativam) 
  Take each ingredient ¼ palam(8.5 gm) , Ground them all in the mortar and 
make tablets in the size of Solanum torvum (Sundai), dry them in shade and put them 
in a widemouthed bottle; pour good quality gingily oil and close it with a lid and put 
it in sunlight. Take each tablet twice a day. Jaundice along with oedema will get 
cured. Tamarind and salt should be avoided (30).  
3.Jaundice powder (another process):  
❖ Charred turmeric – one part 
❖ Cubeb – fried, pounded and powdered – one part 
❖ Cumin seeds – fried, pounded and powdered – one part 
❖ Cane sugar powder – 4 parts 
❖ Calx of gypsum – 1 part 
Mix all the above five ingredients and make it as a powder. Jaundice will be 
cured when this powder is taken in doses of 10 to 15 Kundri two to three times a day 
when with cow’s milk or goat’s milk or honey or in orange juice. It can also use as 
adjuvant to any other calyx or Chenduram or any other medicines prescribed for 
jaundice. By this, anaemia, oedema and liver diseases will get cured [31].  
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 4.Kizha nelli ney (Ghee of Phyllanthus amarus):  
❖ Juice of Phyllanthus amarus 1.35 liter (one measure) 
❖ Cow’s ghee1.35 liter (one measure) 
❖ Cubeb (Valmilagu) 
❖ Nutmeg (Myristica fragrances) (Jathikkay) 
❖ Cardamom (Eletaria cardamom) (Elam) 
Each 17.5 gm (1/2 palam) is taken. All of them may be ground in a 
mortar with milk. Then this may be heated and processed for oil (Thylam) and 
filtered. 16 ml (the standard volume of a small spoon (Uchikarandi) may be 
consumed in the morning and evening.  
Jaundice will be cured. Salt-free diet is essential[31a].  
5.Karisalainey (Ghee of Eclipta Alba)            
❖ Juiceof Eclipta 1.35 litre (1Measure), 
❖ Cow’s ghee 1.35 litre (one measure), 
❖ Thirikaduku (dry ginger, pepper, long pepper) 35 gm (one palam), 
❖ Hyoscyamus niger(Kurosani omam) 8.5 gm (1/4 palam), 
❖ Cubeb (Valmilagu) 17.5 gm (½ palam). 
Ghee may be prepared as per the literature. Mix the above two and take in 
doses of ¼ to ½ teaspoon two or three times a day with cow’s milk or its buttermilk 
or goat’s milk or its buttermilk.  
  It can be given with honey also or it can be taken separately. It can be used 
as an adjuvant for any other Calyx or Chenduram. It will give an excellent cure for 
spleen and liver enlargement also[31b].  
6.Ponnangani (Ghee of Alternanthera sessilis for jaundice):  
The root of Alternanthera sessilis may be collected and macerated on a stone  
slab. It is taken in elumichai alavu and be soaked into 4 liters of cow’s milk and is 
allowed to mix with it. The next day, the butter from it may be taken out and 
consumed. Jaundice will be cured.  
7.Arunelli (Phyllanthus distichus for jaundice):  
              Phyllanthus distiches in the size of the fruit of Alexandrian laurel (punnai 
kay) may be taken and macerated on a stone slab. This may be given along with ¼ 
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of a measure of sour buttermilk for 3 days in the morning. Jaundice will be cured. 
Rice with goat’s milk can be taken. Salt should be avoided.  
8.Nandiyavattai (Powder of East Indian rose for jaundice):  
 Pericarp of the root of multiple-layered East Indian rose, pericarp of the root 
of Indian jalap which is cooked in milk, the outer part of Terminalia chebula – equal 
quantities of these 3 things may be dried and pounded in a stone mortar and the 
powder may be filtered by a muslin cloth. If this powder in a three-finger pinch is 
consumed with hot water, jaundice, predominant Pittha condition, and oedema can 
be cured.  
9.Kaiyanthakarai karkam (Green paste of Eclipta alba):  
              Tender leaves of Eclipta alba, tender leaves of Coldenia procumbens 
(Seruppadai), turmeric and pepper- equal quantities of the above 4 substances may 
be taken and macerated on a stone slab.  
A lime- sized paste may be consumed along with goat’s urine. Jaundice and  
oedematous jaundice will be cured.  
10.Pirandai (Cissus quadrangularis medicine for jaundice):  
Tender leaves of Cissus quandrangularis, Pepper,Acorus calamus, dry 
ginger equal quantities of these ingredients may be taken and macerated on a stone 
slab. An areca nut sized ball of this paste may be covered in rice bran and consumed.  
11.Aridradhi churnam parpam (Medicine of turmeric, etc. and calx for 
jaundice):  
  Turmeric (Manjal), pericarp of Terminalia chebula (Kadukkay thol), pericarp 
of Terminalia belerica (Thandrikay thol) and pericarp of Indian gooseberry (Nelli 
mullai), Pircorzhiazha kurroa (Kadugurohini), rock salt (Induppu) equal quatities of 
the above substances may be taken, dried and pounded in a stone mortar. One 
Verukadi (cat’s foot print) quantity mixed with water may be consumed. Jaundice 
will be cured.  
   Leaves of Pavonia zeylanica (Chitramutti), bark of Cassia fistula (Konrai), 
Syzygium cumini (Naval), coriander leaves, purified iron powder, leaves of 
Indigofera tinctoria(Avuri) – equal quantities of the above substances may be taken 
and Calx of the above may be prepared. The Calx may be put in a mortar and ground 
with lime juice. The paste in the size of the Solanum torvum(Sundaikkay) may be 
consumed. Jaundice will be cured.  
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12.Amanakkilai marundhu (Leaves of castor plant for jaundice):  
Tender leaves of castor plant (Aamanakku kozhundhu), tender leaves of 
Trianthema protulacasturm (Saranai kozhundhu), dry ginger and white onion- 
equal quantities of the above things may be taken and macerated on a stone slab. 
The paste may be mixed with buffalo curd and consumed. Jaundice will be cured.  
 
 13.Arappodi marunthu (Medicine of iron filings for jaundice):  
 Iron filings may be put soaked in the bark juice of Terminalia arjuna 
(maruthu) and allowed to absorb the juice. Then the iron filings may be taken out 
and dried in the sun. Then it is powdered. Take 40 Terminalia chebula fruits. 
Remove the seeds. Fry the epicarp portion in a vessel and make it charred, and then 
it is powdered. Equal quantities of this powder along with the iron powder may be 
consumed. Ascitis, anaemia and jaundice will be cured.  
 14.Puvarasu kozhundhu ilai kudineer (Decoction of tender leaves of Thespesia 
populnea for jaundice):  
  Put the iron pot on a stove. 8 gm of pepper may be put into the pot and fried. 
Make a powder of it keeping it in the pot itself. Then pour ½ measures of tender  
coconut water into the pot over the pepper. Let it be boiled in the pot. One handful 
of    tender leaves of Thespesia populnea may be taken and squeezed to get juice. 
The juice may be poured into the pot when it starts boiling and the squeezed leaves 
may also be put in to the pot itself. Within a few minutes, the water portion in the 
pot will be reduced to 1/8 of a measure.  
Take the pot away from the stove and make it cool. Filter the decoction. The  
decoction is to be consumed when it is slightly hot. If it is prepared and consumed 
for three times, jaundice will get cured immediately.  
Saltiest and pungent diet should not be taken at the time of drinking this 
decoction for the whole day. Sweet substances are also to be reduced. Before 
consuming this medicine, the required food can be eaten [32].  
The procedure for consuming this medicine:  
If the first dose of medicine is taken at 6pm of the day. The second dose is to 
be taken at 6 am of the next day. The third dose is to be taken at 6pm on the second 
day. For the whole day, salt-free rice porridge alone should be taken.  
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The next day morning a little of cow’s butter may be put on the head and 
after half an hour, bath should be taken in cold water.  
Then the needed food can be taken. Those who suffer from this disease for a 
longer duration can consume 3 doses of this medicine with a break of one day. For 
children, dosage should be adjusted suitably according to their age, body type and 
strength [33].  
 
 15.Decoction for jaundice:  
Flower of Madhuca longifolia (Iluppai), Tinospera cordifolia (Sinthil), neem 
petioles, petioles of Adathoda vasica, clearing nut, Vettiver ziznaioides- take equal 
quantities of the above and prepare a decoction. The decoction may be taken along 
with sugar, ghee and honey. Jaundice will get cured.  
70 gm of Sivanatha powder along with cold water or honey or with the three 
fruit (three myrobalans-kadu, tanri and nelli) decoction may be consumed. Jaundice 
will get cured.  
Diet for jaundice:  
➢ Salt should be restricted according to the strength of the patient. Porridge 
without salt and tamarind is good. Twice boiled rice can be given.  
➢ As stated in above, when the bile flow is obstructed in the bile duct, fat will 
not be digested as bile is not available for digestion. Ghee, butter, oil and 
all other fatty substances should be avoided until the disease is cured 
completely.  
➢ Tender vegetables which are not fried with mustard and gingelly oil, green, 
fruits, butter milk and goat’s milk can be taken in. Ginger paste can be 
added to diet to induce appetite. To the diet, cane juice, lime juice and 
ginger can be added.  
➢ Smoking, tobacco chewing, and alcohol–like substances should be fully 
avoided. Rest is essential until the disease is completely cured [34].  
Some of the medicinal plants to treat Liver diseases:  
Foeniculum vulgare:  
Hepatoprotective activity of Foeniculum vulgare (Family of Umbelliferae) 
essential oil was studied using a carbon tetrachloride induced liver fibrosis model in 
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rats. The hepatotoxicity produced by chronic carbon tetrachloride administration was 
found to be inhibited by Foeniculum vulgare essential oil with evidence of decreased 
levels of serum aspartate aminotransferase, alanine aminotransferase, alkaline 
phosphatase and bilirubin.  
Indigofera tinctoria: 
A bioactive fraction, indigtone (12.5100mg/kg p.o) characterized as trans-
tetracos15enoic acid (TCA), obtained by fractionation of a petroleum ether extract 
of the aerial parts of Indigofera tinctoria (Family of Fabaceae), showed significant 
dose dependent hepatoprotective activity against paracetamol (200mg/kg i.p) and 
CCl4 (0.5ml/kg p.o mixed with liquid paraffin 1:1) induced liver injury in rats and 
mice. Pre-treatment reduced Hexobarbitone induced sleep time, and zoxazolamine 
induced paralysis time. Pre and post treatment reduced levels of transaminases, 
bilirubin, TG, LPO and restored the depleted GSH in serum.  
Rubia cordifolia: 
Rubiadin isolated from Rubia cordifolia Linn, (Family of Rubiaceae) at a 
dose of 50, 100 and 200 mg/kg was administered orally once daily for 14 days in 
rats. The substantially elevated serum enzymatic activities of serum GOT, GPT, ALP 
and GGT; decreased activities of glutathione S transferase and glutathione reductase 
were restored towards normalization in dose dependent manner which were induce 
by CCl4 treatment in rats. It also significantly prevents the elevation of hepatic MDA 
formation and depletion of reduced GSH content in the liver.  
 Solanum nigrum: 
The effects of Solanum nigrum (Family of Solanaceae) extract (SNE) was 
evaluated on thioacetamide (TAA) induced liver fibrosis in mice. Mice in the three 
TAA groups were treated daily with distilled water and SNE (0.2 or 1.0 g/kg) via 
gastrogavage throughout the experimental period. SNE reduced the hepatic 
hydroxyproline and αsmooth muscle actin protein levels in TAA treated mice. SNE 
inhibited TAA induced collagen (α1) (I), transforming growth factor-β1 (TGF-β1) 
and mRNA levels in the liver. Histological examination also confirmed that SNE 
reduced the degree of fibrosis caused by TAA treatment. Oral administration of SNE 
significantly reduces TAA induced hepatic fibrosis in mice, probably through the 
reduction of TGF-β1 secretion.  
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Terminalia catappa: 
Punicalagin and Punicalin isolated from the leaves of Terminalia catappa L. 
(Family of Combretaceae) reduced hepatitis by reducing levels of AST and ALT 
which increased by APAP administration in rats [35].  
3.2.2. MODERN ASPECT OF DISEASE REVIEW: 
Liver Diseases:  
Definition 
            Liver diseases is any disturbances of liver functions that causes illness. The 
liver is responsible for many critical functions within the body and should it become 
diseased or injured, the loss of those functions can cause significant damage to the 
body.  
Liver diseases also referred as hepatic disease. Liver diseases are a broad 
term recounting any number of diseases affecting the liver. Many are escorted by 
jaundice caused by increased levels of bilirubin in the system. 
 Liver disease may be classified as: -  
❖ Hepatitis, inflammation of the liver, instigated mainly by various viruses but 
also by some poisons, autoimmunity or hereditary conditions.  
❖ Cirrhosis is the foundation of fibrous tissue in the liver, replacing dead liver 
cells. The death of the liver cells can be affected by viral hepatitis, alcoholism 
or contact with other liver toxic chemicals.  
❖ Haemochromatosis, a hereditary disease causing the accretion of iron in the 
body, eventually leading to liver damage [36].  
❖ Cancer of the liver (Primary hepatocellular carcinoma or Cholangio 
carcinoma and metastatic cancers, usually from other Parts of the 
gastrointestinal tract).  
❖ Wilson's disease, a hereditary disease which reasons the body to retain 
copper. Primary sclerosing cholangitis, an inflammatory disease of the bile 
duct, likely autoimmune in nature.  
❖ Primary billiary cirrohisis, autoimmune disease of slight bile ducts.  
❖ Budd-Chiari syndrome, complication of the hepatic vein.  
❖ Gilbert's syndrome, a genetic syndrome of bilirubin metabolism, found in 
about 5% of the population.  
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❖ Glycogen storage disease type II, the build-up of glycogen causes liberal 
muscle weakness (Myopathy) throughout the body and touches various body 
tissues, particularly the heart, skeletal muscles, liver and nervous system [37].  
Causes for Liver diseases:  
Liver disease can be caused by a variety of factors. Causes include:  
Congenital birth defects, or abnormalities of the liver present at birth 
metabolic disorders, or defects in basic body processes Viral or bacterial infections, 
Alcohol or poisoning by toxins, Certain medications that is toxic to the liver. 
Nutritional deficiencies, Trauma, or injury[37]  
Symptom of liver diseases includes:  
❖ Symptoms may begin slowly and slowly get worse. They may also begin 
suddenly and be severe from the start.  Early symptoms may be mild and 
include:  
❖ Breath with a musty or sweet odor, Change in sleep patterns, Changes in 
thinking,Confusion that is mild, Forgetfulness, Mental fogginess, 
Personality or mood changes, Poor concentration, Poor judgment, 
Worsening of handwriting or loss of other small hand movements.  
More severe symptoms may include:  
❖ Abnormal movements or shaking of hands or arms, Agitation, excitement, 
or seizures (occur rarely), Disorientation, Drowsiness or confusion, 
Strange behavior or severe personality changes, Slurred speech, Slowed 
or sluggish movement, people with hepatic encephalopathy can become 
unconscious, unresponsive, and possibly enter a coma.  
❖ A rare but severe form of the liver infection called acute fulminant 
hepatitis causes liver failure. Symptoms of liver failure include:  
❖ An enlarged and tender liver, Enlarged spleen, Susceptibility to bleeding, 
Encephalopathy which is a disorder that affects how the brain functions, 
Changes in mental status or level of consciousness, Ascites which is an 
accumulation of fluid inside the abdomen, Edema or swelling under the 
skin, Aplastic anemia a condition in which the bone marrow cannot make 
blood cells[38a].   
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 Hepatitis:  
It is the infection and damage of liver particularly involving the hepatocytes. 
It is usually due to various infective and toxic substances. The condition can be self-
limiting, healing on its own, or can progress to scarring of the liver. A group of 
viruses had known as the hepatitis viruses’ origin most cases of liver damage 
worldwide. Hepatitis can also be due to toxins (notably alcohol), other infections or 
from autoimmune process[37a].  
Viral Hepatitis:  
❖ Viral hepatitis is the cause of most cases of acute hepatitis. Types include 
Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis B with D, Hepatitis E, 
Hepatitis F virus (existence unknown), and Hepatitis G or GBV-C.  
❖ Hepatitis A or infectious jaundice is affected by a picornavirus transmitted 
by the fecaloral route. It causes an acute form of hepatitis and does not have 
a chronic stage. 
❖ Hepatitis B is caused by a hepadnavirus, which can cause 500,000 to 
1,200,000 deaths per year worldwide due to the complications of chronic 
hepatitis, cirrhosis, and hepatocellular carcinoma. Hepatitis C (originally 
"non-A non-B hepatitis") is caused by a virus with an RNA genome that is a 
member of the Flaviviridae family. 
❖ Hepatitis C may lead to a chronic form of hepatitis, culminating in cirrhosis. 
❖ Hepatitis D is caused by hepatitis delta agent, which is alike to a viroid as it 
can only propagate in the presence of the Hepatitis B virus. 
❖    Hepatitis E produces symptoms similar to hepatitis A.  
❖ Hepatitis F virus is a hypothetical virus linked to hepatitis. Several hepatitis 
F virus candidates emerged in the 1990s; none of these reports have been 
substantiated. 
❖ Another potential viral cause of hepatitis, initially identified as hepatitis G 
virus is probably spread by blood and sexual contact [43]. There is very little 
evidence that this virus causes hepatitis, as it does not appear to replicate 
primarily in the liver.It is now classified as GB virus C. 
In addition to the hepatitis viruses, other viruses can also cause hepatitis, 
including cytomegalovirus, Epstein-Barr virus, yellow fever, etc. Non-viral infection 
like Toxoplasma, Leptospira and Q fever also causes hepatitis [38]. 
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Fatty Liver:  
❖ Fatty liver, also known as fatty liver disease (FLD), Steatorrhoeic 
hepatosis or Steatosis hepatitis, is a reversible condition where outsized 
vacuoles of triglyceride collect in liver cells via the process of Steatosis. 
Normal liver may cover as much as 5% of its weight as fat. Lipiotic liver 
may contain as much as 50% of its weight as fat, most of being 
triglycerides.  
❖ Severe fatty liver is sometimes accompanied by inflammation, a situation 
that is mentioned to as Steatohepatitis. The progression to cirrhosis may 
be influenced by the amount of fat and degree of Steatohepatitis and by a 
variety of other informing factors.  
Cirrhosis:  
Cirrhosis can be defined as a chronic disease condition giving morphological 
alteration of the lobular structure characterized by destruction and regeneration of 
the parenchyma cells and increased connective tissue. Major morphological changes 
induce granular or nodular appearance and are characterized by the presence of 
septate or collagen throughout the liver [39].  
 Infective Agents:  
These are mainly viruses like, Type A and Type B, Non – A, Non – B, Delta 
agent, virus of yellow fever, Epstin – Barr virus, cytomegalovirus, virus of Herpes 
simplex, Rubella, Marburg agent and others like Leptospira icterohaemorrhagiae, 
Leptospira canicola, Taxoplasma gondii, Borrelia recurrentis, etc  
Toxic Agents:  
   Chlorpromazine and other Phenothiazine derivatives, Monoamine oxidase 
inhibitors (MAO-inhibitors), Erythromycin, Tetracycline, INH, Rifampicin, 
Methyldopa, Chlorpropamide, Phenylbu-tazone, Indomethacin, Paracetamol, 
Thiouracil, Acetaminophen, Halothen, Alcohol, Carbon tetrachloride, etc [40].  
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     Tab 1. List of Hepatotoxic therapeutic agents and chemicals:  
      Therapeutic agents  Chemicals  
Allopurinol  Methotrexate  Alcohol  
Amiodarone  Nicotinic acid  Arsenic  
Azathioprine  Nitrofurantoin  Carbon tetrachloride  
Carbamazepine  Paracetamol  Chloroform  
Chlorpromazine  Phenelzine  Copper  
Chloroform  Phenytoin    
Ciglitazone  Pravastation    
Cimetidine  Quinidine    
Dantrolene  Rifampicin    
Erythromycin  Salicylates    
Galactosamine  Simvastatin    
Halothane  Sodium valproate    
Iproniazid  Sulphonamides    
Isoniazid  Tetracyclines    
Ketoconazole  Ethanol    
 
Liver Cancer:  
The liver is inclined to cancer induction by a variety of human made and 
naturally occurring chemicals. Chemical substances include, aflatoxin B, cycasin, 
and safrole etc among human made substance are DDT, carbon tetrachloride, 
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chloroform, thioacetamide. Studies in experimental animals designate quite clearly 
that development of cancer of the liver is associated with the number of obvious non-
malignant lesions appearing prior to the occurrence of neoplastic malignancy.  
Diagnosis:  
❖ Many further tests may also be used to support the diagnosis. These 
include blood test such as, Liver function tests, which are blood tests that 
check a wide variety of liver enzymes and by products.  
❖ A complete blood count (CBC), which looks at the type and number of 
blood cells in the body.  
❖ Abdominal X-rays.  
❖ Ultrasounds, to show size of abdominal organs and the presence of 
masses.  
❖ An upper GI study, which can detect abnormalities in the esophagus 
caused by liver disease.  
❖ Liver scans with radio tagged substances to show changes in the liver 
structure.ERCP, or endoscopic retrograde cholangiopancreatography. A 
thin tube called an endoscope is used to view various structures in and 
around the liver.  
❖ Abdominal CT scan or abdominal MRI, which provide more information 
about the liver structure and function.  
Diagnosis of Drug-Related Hepatotoxicity:  
There is no single test, including liver biopsy that can be used to diagnose 
drug-related Hepatotoxicity. Other causes of liver injury must first be considered 
with the use of a combination of serologic tests, imaging studies, and clues from the 
patient history. CT denotes computed tomography, MRI magnetic resonance 
imaging, MRCP magnetic resonance cholangiopancreatography, ERCP endoscopic 
retro grade cholangiopancreatography, AST aspartate aminotransferase, ALT 
alanine aminotransferase, TIBC totaliron-binding capacity, and A1AT alpha1-
antitrypsin[38b].  
Hepatotoxicity:  
Hepatotoxicity implies chemical-driven liver damage. The liver plays a 
Central role in transforming and clearing chemicals and is disposed to the toxicity 
from these agents. Certain medicinal agents when taken in overdoses and sometimes 
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even when introduced within therapeutic ranges may injure the organ. Other 
chemical agents such as those used in laboratories and industries, and natural 
chemicals (e.g. microcystins) can also induce hepatotoxicity.  
Chemicals that cause liver injury are called hepatotoxins. The human body 
identifies almost all drugs as foreign substances (i.e. Xenobiotics) and subjects them 
to various chemical processes, (i.e. metabolism) to make them suitable for 
elimination. This involves chemical transformations like reduction in fat solubility 
and alteration in biological activity.  
Although almost all tissue in the body have some ability to metabolize 
chemicals, smooth endoplasmic reticulum in liver is the principal "metabolic 
clearing house" for both endogenous chemicals (e.g., cholesterol, steroid hormones, 
fatty acids, and proteins), and exogenous substances (e.g. drugs). The central role 
played by liver in the clearance and transformation of chemicals also kinds it 
susceptible to drug induced injury.  
The mechanism of hepatotoxicity in liver can be labelled by two methods:  
Direct: - This group comprises the products (or their metabolic products) that 
produce direct injury to the plasma membrane, endoplasmic reticulum and other 
organelles of the hepatocytes. Direct hepatotoxicity may be exemplified as non-
selective destruction of the structural basis of hepatocyte metabolism.  
Some of the direct hepatotoxins comprise carbon tetra chloride, chloroform, 
tetrachloroethane, iodoform and elemental phosphorus.  
Indirect: -These are more selective, and are antimetabolic and related compounds 
that produce hepatic hurt by interference with specific metabolic pathway.  
❖ The hepatic damage produced by indirect hepatotoxins may be mainly 
cytotoxicity expressed as necrosis or mainly cholestatic expressed as arrested 
bile flow with or without bile duct injury.  
❖ A group of enzymes located in the endoplasmic reticulum, recognized as 
cytochrome P-450, is the most important family of metabolizing enzymes in 
the liver. Cytochrome P-450 is the terminal oxidase component of an electron 
transport chain.  
❖ It is not a single enzyme, but rather covers of a family of closely related 50 
isoforms, six of them metabolize 90% of drugs [41]. There is a remarkable 
diversity of individual P-450 gene products and this heterogeneity allows the 
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liver to perform oxidation on a vast array of chemicals (including almost all 
drugs). Due to its unique metabolism and close relationship with the 
gastrointestinal tract, the liver is subject to injury from drugs and other 
substances. About 75% of blood coming to the liver arrives directly from 
gastrointestinal organs and then spleen via portal veins which carry drugs and 
xenobiotics in concentrated form. Several mechanisms are accountable for 
either inducing hepatic injury or worsening the damage process.  
❖ Many chemicals damage mitochondria, an intracellular organelle that 
produces energy. Its dysfunction releases extreme number of oxidants which 
in turn injures hepatic cells. Activation of some enzymes in the cytochrome 
P-450 system such as CYP2E1 also chief to oxidative stress injury to 
hepatocyte and bile duct cells lead to accumulation of bile acid inside liver 
[42].  
❖ This promotes further liver damage. Non-parenchymal cells such as Kupffer 
cells, fat storing stellate cells and leukocytes (i.e. neutrophil and monocyte) 
also have role in the mechanism [43].  
❖ More than 900 drugs have been concerned in causing liver injury, and it is 
the most common reason for a drug to be withdrawn from the market. Drug 
persuaded liver injury is responsible for 5% of hospital admissions and 50% 
of all acute liver failures [44].  
❖ The liver produces large quantities of oxygen free radicals in the course of 
detoxifying xenobiotic and toxic substances.  
❖ Reactive oxygen species (ROS) has been exposed to be linked to liver 
diseases, such as hepatitis, cirrhosis, portal hypertension, viral contagions 
and other liver pathological conditions [45]. They play an important role in the 
inflammation process after intoxication by ethanol, carbon tetrachloride or 
carrageenan.  
❖ These radicals and the reactive species resultant from them react with cell 
membrane, induce lipid peroxidation and are responsible for various 
deleterious belongings in cells and tissues where they are generated. ROS 
induce alterations and loss of structural/functional architecture in the cell, 
leading directly to cytotoxicity and/or indirectly to genotoxicity, with 
numerous serious anomalies favouring disharmony and diseases [46].  
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❖ Hepatic injury caused by chemicals, drugs, and virus is a well-known 
toxicological problem to be occupied care of by various therapeutic 
measures.  
3.3PHARMACEUTICAL REVIEW: 
MATHIRAI:  
             Some of the raw drugs are ground well by adding juices of leaves, 
ginger, breast-milk,lemon juice, or some decoctions and made into small pills 
according to its dose and dried.(47)  
  The ingredients should be first purified and powdered into a fine 
powder and then macerated with the prescribed juices or liquid one after the 
other in their order. Each time it must be grinded till it becomes waxy in 
consistency does not adhere to the fingers or mortar and pestle; lastly it must 
be made into pills as prescribed and dried in shade.  
Other names: Kuligai,Urandai,Vadagam. 
Equipment required:  
1. Mortar and pestle  
2. Trays and dishes for handling powders and pastes of the drugs and for making 
the pills or tablets.  
3. Vessels and spoons for preparation of and the handling of decoctions and 
juices.  
Purification of drugs in Siddha system (suddhi seithal) : 
❖ The process of detoxification or purification of the drug is called 
‘suddhiseithal’ in Siddha medical terminology.  
❖ Nature has created innumerable plant, herbs, metals, poisonous substances, 
minerals, salts and other organic substances. The Siddha had selected such 
of those things which can render relief to innumerable ailments of mankind 
suffered. Any matter in nature has to be utilized for medicine purposes the 
properties which may cause bad effects should be neutralized or eliminated. 
That’s why every raw drug used in Siddha medicine is purified before 
preparing it as a medicine.  
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Purification : 
❖ The exact part of the herb which has been prescribed should alone be taken 
for medicine. There should not be other impurities like mud, sand or any 
such thing. If it is green leaf, dried or decomposed leaves or insects should 
be eliminated. Care should be taken in identifying the herbs properly.  
❖ As a general rule, when anything is subjected to be processed by using heat, 
soaking either alone or with some other substance, some chemical reaction 
may take place.  In these process impurities, toxins would be eliminated and 
the substances become purified. Hence some of the poisonous herbs which 
are purified by using heat.  
Importance of purification : 
❖ The drugs when subjected to heat like roasting or soaked in liquids 
undergo some chemical reactions. Such as oxidation of toxic substances to non-toxic 
substances, elimination of certain poisonous chemicals to non- poisonous 
substances. In these ways not only the toxicity, impurities or removed but also 
enhance the potency of the drugs.   
Rules of tablet preparation: 
❖ All the metals, minerals and poisonous organic drugs should be 
purified as per the rules of Siddha system of medicines.  
❖ Before preparing mathirai, the raw drugs required are powdered separately 
and then mixed to attain homogeneity, then grinded together until it reaches 
waxy in consistency.  
❖ The fine paste which does not stick to the mortar should be considered as 
the right consistency for rolling pills. The compounded drugs should be 
ground in a mortar for the prescribed period, with the addition of prescribed 
juices and decoctions.  
❖ If any of the preparation of pills, if mercury and sulfur are the key 
ingredients then the mercury should be grinded first and sulfur is added to 
it and grinded and further continued.  
❖ In case of inclusion of hard raw drugs, they should be grinded first; the 
reason behind this if hard substances are added to smooth substances, they 
will not be grinded finely.   
REVIEW OF LITERATURE 
 
39 HEPATOPROTECTIVE ACTIVITY OF NANNARI MATHRAI 
 
❖ Croton seeds if included can be grinded at the last: because croton on 
grinding releases oil; if added early the effect of medicine will be 
suppressed, so it should be added finally.  
❖ Aromatic substances like camphor, lac, musk, are added just before 24 
minutes the paste reaches waxy consistency.  
❖ The paste should not adhere to the mortar nor does it adhere to the pestle. 
The individual drugs should be separately weighed after being powdered 
and then taken in the ratio prescribed in the preparation.  
Preparation of Mathirai in Manufacturing Units : 
❖ In manufacturing unit, Chooranam is compressed into tablets. Binders like 
Gum acacia, lubricants like liquid paraffin and disintegrators like Talcum 
powder are used for preparing tablets. Chooranam is first prepared 
according to the above procedures. Then the ingredients are mixed with in 
the form of granules before compressing as tablets. 
❖ They must be mixed with some adhesive substances or binders such as 
gum acacia. To prevent the sticking of the tablets to the punches and dyes 
a lubricant like liquid paraffin is added. If the tablet is to dissolve quickly, 
a disintegrator like talcum powder is added (48) 
❖ The pills should be always dried in a warm, dry shady Place and never 
kept in the sun, because volatile matters in the pills are easily lost and 
Phyto chemical break down of active principle are faster in sunlight of the 
tropics.  
Storage:  
❖ Almost all the maathirai is contain highly active ingredients (or) 
poisonous drugs, (or) metallic compounds etc., hence they should be 
stored in well stoppered glass vials, with relevant labels and 
instructions.  
❖ The adjuvants recommended for each medicine are beneficial in giving 
good treatment results. 
❖ If the maathirais lose their natural shape, color, smell, taste etc., it is 
not advisable to consume them. If properly stored, they can be used for 
for one year. (49) 
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 Shelf life of medicines : 
Medicines can be classified into internal and external medicines. They are 
each in 32 types. Mathirai comes under the category of internal medicines. The 
shelf life of medicines indicates the potency of medicines. The medicines even 
though seems to be fresh is not efficacious after sometime. So, the medicines should 
not use after certain period.  
 The shelf life of mathirai,  
As per Siddha literature Agamarunthu padal in Gunapadam 
Thathu-seevam text  
 உயர்சூர ணம்பிட்டு வடகம் வவண் வணய்நான்கி 
         னுயிர்மூன்று திங்கவெண்வணய் 
விரலிடுமு யர்ந்தமாத்  திரரகடுகு பக்குவம் 
         ......................................................................... 
 வகாள்ொறு  மமாராண்டு..........................................  
      - குணபாடம் தாது சீவம் வகுப்பு 
              From above the quote the shelf life of Mathirai is 1 yr. But according to 
Ayush   guidelines the shelf life is 2 yr.   
 Traditional tests for Mathirai:   
 Characters: 
➢ Non sticky on rolling  
➢ No cracks over the surface after drying  
➢ Shall be rolled uniformly over the plane surface.   
Based on these characters the drug is assessed as the appropriate one for 
medication.  
             Tab 2: Testing parameters for Mathirai-AYUSH guidelines : 
S.No  Tests  
  1  Description, Colour, Odour  
  2  Weight Variation  
  3  Disintegration Time (Not more than 15 minutes)  
  4  Identification TLC/ HPTLC/GLC  
  5  Assay  
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  6  Test for heavy/toxic metals  
Mercury  
Arsenic  
Cadmium  
Lead  
 7  Microbial Contamination  
Total Bacterial count  
Total Fungal count  
 8  Test for specific pathogen  
E. coli  
Salmonella species  
Pseudomonas aeruginosa  
Streptococcus aureus  
9  Test for aflatoxins B1, B2, G1, G2  
Modern Aspect of the formulation:  
Tablet (Pill)-Mathirai  
A tablet is a pharmaceutical dosage form, it otherwise called as caplet. 
Medicinal tablets are called as "pills". Originally "pills" referred specifically to a soft 
mass rolled into a ball shape, rather than a compressed powder. (50)   
As per Indian Pharmacopeia 2007 defined the Tablets are solid dosage forms 
each containing a unit dose of one or more medicaments. They are anticipated for 
oral route. A tablet consists an active medicament with excipents which are in 
powder form are compressed or pressed into a solid dosage form. About two third 
drugs prescribed are in solid dosage form and tablets include half of them.  
Classification:  
 As per IP2007 tablets are majorly classified into following categories (Indian 
pharmacopoeia 2007)  
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1. Uncoated Tablets:   
This type of tablets contains single layer or more than one-layer tablet 
consisting of active ingredient with the excipents, no additional cover is applied on 
to it after the compression.  
2. Coated Tablets:  
  Coated types of tablets have an additional coating layer on it after the tablet 
was compressed, the coating layer of tablets formed with sugar, gums, resins, 
inactive or insoluble fillers, plasticisers, polyhydric alcohols, waxes.  
3.Dispersible Tablets:   
  These are the film coated or uncoated tablets because a uniform dispersion 
when suspended in water. 
4.Effervescent Tablets:   
  These type of tablets which are uncoated and are planned to be dissolved and 
produce an dispersion before they are administered the dissolution is achieved by the 
reaction between an organic acid and bicarbonate which produce CO2, thus produced 
CO2 will disintegrate the tablet so which dissolves in the solution to produce an 
suspension which was rapidly absorbed. 
 5.Modified-release Tablets:   
  These types of tablets are the coated or uncoated tablets which are designed 
in such a way that the rate or location of the active ingredient released is modified. 
It includes enteric coated tablets, prolong release tablet or delay release tablet.   
A) Enteric-coated Tablets:   
These are also called as gastro resistant tablets as they resistant to the gastric 
juices; these are formulated by coating the tablet with anionic polymer of 
methylacrylic acid and their esters or by coating with cellulose acetyl pthylate.  
  E.g: erythromycin, NSAIDS  
B) Prolonged- release Tablets:   
These types are otherwise called as sustain release tablets or extended release 
tablets was formulated in such a way that the active ingredient is released for a 
prolong duration of time and is available in systemic circulation after administration.  
C) Delayed-release Tablets:   
This dosage form was planned to release the drug after some time delay or 
after the tablet has passed one part of the GIT into another. All enteric coated tablets 
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are type of delayed action tablet but all delayed action of tablets was not enteric or 
not intended to produce enteric action.  
6.Soluble Tablets:  
These are coated or uncoated tablets which are planned to dissolve in water 
before they are administered.  
7.Tablets for Use in the Mouth:  
These are the tablet formulations which are planned to be show local action 
in the buccal cavity. These include buccal tablet, Sublingual Tablets and Troche or 
lozenges. Buccal tablets are placed in between the cheek and gingival. Sublingual 
tablets are placed below the tongue E.g: glyceryl trinitrate.  
8.Tablets for other routes of administration:   
These include implantable tablets and vaginal tablet. These are inserted in to 
the rectum or vagina for their local or systemic action.  
Tablet Ingredients:  
A tablet consists of active medicament with excipents which are in powder 
form are compressed or pressed into a solid dosage form. In addition to active 
ingredients, tablet contains a number of inert materials known as additives or 
excipents. (51)  
• Diluent   
• Binders and adhesive   
• Disintegrents   
• Lubricants and glidants   
• Colouring agents   
• Flavouring agents   
• Sweetening agents   
  1. Diluents:     
Diluents are fillers are used to make bulk of the tablet when the drug dosage 
itself was inadequate to produce the bulk these are used. Secondary reason is to 
provide better tablet properties such as improve cohesion, to permit use of direct 
compression manufacturing or to promote flow.  
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 2.Binders and Adhesives:  
  These materials are added either dry or wet form granules or to form 
cohesive compacts for directly compressed tablet. Ex: Acacia, tragacanth- 
Solution for 10-25% Concentration.  
3.Disintegrents:   
It added to the tablet formulations to facilitate its breaking or disintegration, 
when it contacts in water in the GIT.  Example: Starch- 5-20% of tablet weight. 
Super Disintegrents: Swells up to ten-fold within 30 seconds when contact water. 
Example: Crosscarmellose- crosslinked cellulose.  
4.Lubricant and Glidants:   
Lubricants are planned to prevent adhesion of the tablet materials to the 
surface of dies and punches, reduce inter particle friction and may improve the rate 
of flow of the tablet granulation Example: Lubricants- Stearic acid, stearic acid salt 
- Stearic acid.  
5.Coloring agent:   
The use of colors and dyes in a tablet has three purposes:   
▪ Masking off colour drugs   
▪ Product Identification   
▪ Production of more elegant product   
  All coloring agents must be approved and certified by FDA.  
6.Flavoring agents:  
For chewable tablet- flavor oil are used   
7.Sweetening agents:  
 For chewable tablets: Sugar, mannitol. Saccharine (artificial):500 times 
sweeter than sucrose.  
Advantages:  
• These are very easy and handy to use.  
• As these are unit dosage form fixed dose was administered.  
• Modified drug release rate and duration of tablets be able to increase their 
therapeutic effect and increase the patient compliance by reducing the 
frequency of drug administration.  
• These are cost-effective dosage forms when compared to other dosage forms  
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• The physical, microbial and chemical stability of tablet are superior to other 
dosage forms.  
Disadvantages:  
• The systemic availability of the drug depends on many physiological factors  
• The onset of action was lesser when compared to Intra Venous route. (except 
sublingual tablets)  
• Geriatric and children of small age cannot swallow the tablets easily. 
3.4. PHARMACOLOGICAL REVIEW 
 CCl4 induced toxicity:  
Carbon tetrachloride has been widely used to study liver damage used by free 
radicals. CCl4 toxicity is initiated by the bioactivation of CCl4 to CCl3 
(tricloromethyl free radicals) by the enzymes CYP2E1, CYP2B1, CYP2B2, CYP3A 
chiefly by CYP2E1. The formed CCl3 rapidly reacts with molecular oxygen to form 
CCl3O2 (peroxytricloromethyl free radicals). Both CCl3 and CCl3O2 are highly 
reactive, they covalently bind to macromolecules such as proteins, lipids and nucleic 
acids and react with polyunsaturated fatty acids and form a series of self-propagating 
chain reactions known as “propagation of lipid peroxidation” which may lead to 
damage of endoplasmic reticulum and cell membrane which may lead to necrosis.  
Paracetamol induced liver toxicity:  
Paracetamol is a non-steroidal anti-inflammatory drug which is available as 
OTC (over the counter) drug. The caution of this acetaminophen (Paracetamol) is its 
active metabolite is injury to liver (i.e) leads to liver damage. Normal dose of the 
drug- 4000mg per day (Maximum) (Franciscus A;2012) 2000-3000mg per day is 
mostly recommended. The active metabolite of acetaminophen is N-acetyl p-
benzoquinoneimine(NAPQI)This NAPQI is toxic to the liver cells. Mostly the 90% 
of acetaminophen is metabolized by glucuronide and sulfate conjucation and then 
excreted in the urine. 5-10% is metabolized by cytochrome P450, mainly by 
CYP2E1 which produces NAPQI.  
Alcohol induced toxicity: 
Alcohol is metabolized by liver. This process produces a number of 
potentially dangerous byproduct. Alcohol is converted to acetaldehyde by the 
enzyme Alcohol dehydrogenase (ADH). The formed acetaldehyde is highly 
toxic. Normally the enzyme Aldehyde dehydrogenase (ALDH) rapidly 
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oxidizes acetaldehyde to acetate. Both these enzymes ADH and ALDH are 
also involved in metabolism of vitamin A. Apart from ADH, the enzyme 
CYP2E1 (microsomal ethanol oxidizing system; MEOS) is also involved in 
metabolizing alcohol. MEOS plays a major role when blood ethanol levels are 
high. CYP2E1 produces a toxic byproduct N-acetyl-p- benzo-quinone imine 
(NAPQI) which is responsible for damaging the hepatic protein[38c]. 
Models of Liver Fibrosis:  
Several approaches to induce fibrosis in animals are designated and 
these models can be divided according to their stimulus from inciting injury. 
Liver fibrosis models are connected with (1) Toxic damage (hepatocytes: CCl4 
dimethylnitrosamine (DMN), galactosamine; bile duct epithehal cells:  
thioacetamide (TAA), Immunological-induced damage (heterogonous serum 
and experimental schistosomiasis), Biliary damage (common bile duct ligation 
(BDL) or occlusion), Alcohol-induced damage (baboon ethanol diet or 
Tsukamoto / French model in rats). Nowadays, fibrosis-related models are 
established that have their origin in fatty liver disease, Fatty liver disease, in 
particular the 'malignant' inflammatory form nonalcoholic steatohepatitis 
(NASH), can increase to liver fibrosis and cirrhosis.  
It is strongly associated with obesity and diabetes, two modern health 
problems in Western countries. Of the existing animal models for fatty liver 
disease, as reviewed by the genetic leptondeficient (ob/ob) or lepton- resistant 
(db/db) mice [52].  
The dietary methionine/ choline-deficient models are cast-off in the 
majority of published research. Progressive fibrosis was reported only in 
themethionine/choline-deficient models in 100% of the mice.  
BDL and CCl4 are the most widely used rodent models
 [53] in liver 
fibrosis research to assess the effectively of experimental drugs on the 
pathogenesis, since these models represent features of human pathogenesis. 
Therefore, these models are the best categorized with respect to histological, 
biochemical, cell and molecular changes connected with the development of 
fibrosis.  
In the past years, there is a tendency in fibrosis - related research to shift 
from rat to mice models, and most of the models originally described ferrates 
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are now applied in mice. Moreover, new testing models arise due to the 
development of transgenic or knock-out mice models, which were developed 
to elucidate the pathogenesis and common pathways in liver fibrosis. Examples 
of knockouts with spontaneous formation of liver fibrosis are mdr2-/- mice  
1hx2-/- mice, and the mice models for NASH mentioned above [54].  
Acute and Chronic Models with Carbon Tetrachloride (CCl4)  
CCl4 intoxication results in hepatocyte necrosis and apoptosis with 
damage predominantly in zone III (around central vein) of the liver. The 
mechanism behind this hepatocyte damage is the activation of CCl4 by 
cytochrome P450, which results in the formation of trichioromethyl radical in 
these cells and this free radical initiate lipid peroxidation [55].  
The damage to hepatocytes by CCl4 is replicated by high plasma alanine 
transaminase (ALT) and aspartate transminase (AST) levels after CCl4 
administration, CCl4 causes also fatty changes in the hepatocytes. This initial 
damage is followed by hepatic stellate cell activation and tissue fibrosis.  
The CCl4 model is related with tremendous inflammation, a feature that is 
also often seen in livers of patients with liver fibrosis. Disadvantages of this model 
are the variations obtained in disease induction in the animals and the relatively 
high rate of mortality alter CCl4 administration > 20%.  
In animal models CCl4 treatment is used to get different stages of the 
fibrotic process, ranging from early damage and HSC activation until advanced 
cirrhosis. The fibrotic stage obtained in the rodents depends on the number of 
injections of CCl4 that are administered.  
The models for CCI4 that are used in liver fibrosis research, are Acute 
damage (72 hours after a single injection of CCI4) with HSC activation  
            Early and establish fibrosis (4-6 week of twice weekly CCl4 dosing),  
            Early cirrhosis (8 week of twice weekly CCl4 dosing)  
  Advanced micronodular cirrhosis (12 week of twice weekly CCl4 dosing). In 
addition, for each of these models, Spontaneous recovery from fibrosis can be 
studied after cessation of dosing of CCl4.This latter model is a valuable model to 
determine drug induced acceleration of recovery from established fibrosis after 
removal of the inciting stimulus.  
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This is similar to treatment situations in patients with liver fibrosis in case 
their inciting stimulus can be eradicated for instance after alcohol abstinence or after 
antiviral therapy beside hepatitis virus infections.  
CCl4 is administered to the animals via intraperitoneal, subcutaneous or oral 
administration or by inhalation. For intraperitoneal injections, CCl4 is diluted in olive 
oil and given in dosages of 0.5 - 1.0 ml / kg to rats and mice. Often supplementation 
of phenobarbital in drinking water (resulting in induction of hepatocyte cytochrome 
P450) is used to get more reproducible fibrosis improvement and to accelerate the 
speed of fibrosis development. Usually, phenobarbital concentrations of 0.3 - 0.4 g/I 
in drinking water are used and started I week before the initial exposure to CCl4.  
In case of inhalation of CCl4 the animals are placed in an inhalation chamber 
twice a week with a progressively increasing exposure time (1.5 min). Also, with 
this procedure, supplementary phenobarbital in drinking water is added. To reduce 
early toxicity and mortality, some research groups vary with the dose of CCL4 in 
time. In these cases, gradually growing dosages in the first weeks are administered 
to the rats.  
Bile Duct Ligation (BDL):  
The second well-studied experimental animal model of liver fibrosis is the 
bile duct ligation model. This model corresponds with the human pathology of 
biliary cirrhosis, such as extrahepatic biliary atresia and primary sclersoing 
cholangitis. Ligation of the bile duct causes acute epithelial impairment and the 
detergent action of the subsequently released bile salts in the liver is likely associated 
with the solubilization of plasma membranes and hepatocyte cell death.  
This latter is envisaged by elevated ALT and AST levels in plasma, in 
particular proximately after ligation (first week). Characteristics of obstruction of the 
bile are the appearance of bile products, such as bilirubin into the blood circulation, 
which causes jaundice in these animals [56].  
The initial damage is followed by a massive expansion of the bile duct 
epithelial cells and periductal my fibroblasts, which can be referred to as portal 
expansion (stage 1) in total this results in marked liver enlargement, which can be 
up to twice the weight as compared to normal.  
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Then, bile duct epithelial cells and my fibroblasts in the portal tract are 
increasingly expanding which results in a gradual remodelling of the liver 
architecture by linking adjacent portal tracts (biliary cirrhosis stage IV).  
To ligate the bile duct, the abdomen of the rat is opened under general 
anesthesia (preferably N2O/O2/halothane inhalation to agree quick recovery from 
narcosis) to identify the common bile duct. The bile duct turns from the helium of 
the liver, where the hepatic ducts meet, through the pancreas, into the lower end of 
the duodenum. Of note, threat has no gall bladder in contrast to other rodents.  
Three ligatures are located and tied around the bile duct; two closes to the 
liver and one close to the duodenum. The first ligatures will prevent formation of a 
reservoir of bile outside the liver. After tight closure, the bile duct is cut between the 
second and third ligation in order to prevent restoration of the bile flow by bile duct 
formation around the ligature. Subsequently, the abdomen is closed over and 
analgesics can be given to the rats.  
We use a local anaesthetic compound (Marcaine which contains 
bupivacaine), but also systemic acting analgesics are sometimes administered (e.g. 
Temgesic (containing buprenorphine). For mice, the procedure is a little bit more 
complicated because a mouse possesses a gall bladder, and consideration should be 
[paid to tightly ligate the whole duct, in general more than three ligatures are needed, 
to prevent rupture of the bladder and subsequent problems.  
Already in the first days after ligation, proliferation of bile duct epithelial 
cells, activation and proliferation of HSC and my fibroblasts, and deposition of extra 
cellular matrix can be detected microscopically starting in the portal areas of the liver 
(zone 3). After one week, a fibrous expansion of the portal areas is visible and after 
about 10-14 days, portal- portal bridging is visible.  
Three to four weeks after ligation, these rates develop advanced cirrhosis 
characterized by extensive proliferation of the bile ducts, around which the activated 
and transformed HSC are detectable (Markers: a - smooth muscle action and PDGF 
beta receptor) and around which the interstitial collagens (types I and III) are 
deposited.  
A major advantage of the BDL model is the relatively fast development of 
fibrosis (within 3 weeks) in rats. Furthermore, the model is quite reproducible, and 
the mortality due to the ligation procedure in rats is low (<10%). Disadvantages of 
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the BDL models are the limited inflammation associated with this type of fibrosis 
development and the excessive expansion of bile duct epithelial cells.  
Another drawback with regard to drug screening is that the BDL-induced disease 
is difficult to reverse with experimental drugs, and a reason for this may be because 
the initiating stimulus (ligation of the bile duct) remains present during treatment 
periods and causes continuous damage as subsequent fibrosis that troubles the 
potential treatment effects.  
Dimethylnitrosamine (DMN):  
DMN induces liver damage leading to fibrosis and cirrhosis. Characteristic for 
this model is that ongoing administration of this toxic compound finally leads to the 
development of hepatocellular carcinoma in rodents.  
DMN induces liver injury by starting damage to the hepatocyte. It is 
metabolized primarily in hepatocytes by Cytochrome P450 (isotype 2E1) to more 
toxic compounds with formation of reactive oxygen species in hepatocytes and sub-
sequent this will lead to lipid peroxidation. In difference to the hepatotoxin CC14, 
DMN administration does not cause fatty changes, steatosis in the hepatocytes [53]. To 
induce the fibrosis, DMN (10 microliter/kg body wt., i.p) is given 3 days a week for 
3 weeks to rats.  
After administration of DMN, hemorrhagic necrosis is evident in centrolobular 
part (zone III) of the liver. Incomplete septa appear after 7 days and micronodular 
cirrhosis is developed after 3 weeks of treatment with DMN. Increased numbers of 
HSC and my fibroblasts are found in the formed septa. Influx of inflammatory cells, 
mainly lymphocytes, is noted early in DMN- induced liver injury. Advantages of this 
model are that the disease induction is quite reproducible in the animals, and this 
model is associated with a prominent inflammatory reaction. Furthermore, this model 
can be used to study the transition from cirrhosis to hepatocellular carcinoma, and the 
effect of drugs on this process.  
HSC in Culture (In Vitro System):  
HSC are key players in fibrosis and these cells predominantly orchestrate 
the development of the disease. To evaluate the ant fibrotic efficacy of 
experimental drugs, these primary cultured cells are useful in assessing specific 
effects on HSC activities. In particular, the primary isolated HSC are valuable in 
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drug research, because in vitro they spontaneously transform into my fibroblasts, 
and this transformation process is related with cellular activation proliferation and 
matrix production resembling cellular activities that also happen in vivo.  
This transformation does not occur in the various HSC cell lines that are also 
used in literature. Proximately after isolation they signify a inactive stage, e.g. as 
present in the normal healthy liver, with vitamin A droplets as their main 
characteristic. During culture on plastic for about 10-14 days a cell with fibroblast - 
like features is attained. This transformed cell displays different cellular activities as 
compared to the original isolated one.  
The procedure to isolate HSC is well described by various fibrosis research 
groups Briefly, HSC are isolated from livers of normal rats weighing at least 500g 
in order to achieve a good separation from the other hepatic cells.  
The liver is digested with pronase, collagenase and DNase by in situ 
perfusion. Pronase is essential in the isolation, yet it affects the viability of other 
hepatic cells (i.e. hepatocytes) and therefore this procedure can only be used isolate 
HSC from the liver.  
After several centrifuge steps, the cells suspension is subjected to a Nycodenz 
gradient to gather the HSC on top of the Nycodenz layer. The separation is based on 
the low density of the HSC as compared to other liver cells, as a consequence of their 
high cellular lipid content.Instead of Nycodenz, also other compounds are used e.g 
Stractan, Metrizamide, or Percoll, to separate the HSC from the other cells by density 
gradients.  
The yield of HSC after collagenase / pronase digestion and Nycodenz 
separation is about 20-40 x 10E6 cells per rat liver. The yield of HSC attained from 
a mouse liver is much smaller and to isolate and purify proper amounts of HSC, 
about 5 mice have to be used at the same time in one total isolation (Geerts, personal 
communication)  
The purity after isolation can be established by phase contrast microscopy or 
by staining of the cells with markers for hepatic cell types. The isolated cells are 
cultured in DMEM containing 10% FCS 100 U/ml penicillin, and 100 ug/ml 
streptomycin. After 10-14 days in culture, the cells exhibition an activated phenotype 
as assessed by light microscopy and acquires the presence of alpha-smooth muscle 
action.  
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Additionally, it is also conceivable to isolate HSC from human livers. Often 
(parts of) human livers are used that are unbecoming for transplantation are derived 
from tumor-free parts of the human liver and separated after partial hepatectomy.  
Roughly, two methods are used to isolate human stellate cells out-growth of 
the cells by culturing small pieces of the livers in medium and a combined digestion 
with collagenase / pronase, after which HSC were separated from other liver non - 
parenchymal cells by centrifugation over density gradients similar to threat 
procedure. Of note, the first method will yield a combination of various (myo) 
fibroblastic cells including HSC and myofibroblasts.  
These cells are afterward cultured in DMEM< supplemented with 5% Fetal 
Calf Serum and 5% G Human Serum. The fibroblastic nature of the cells can be 
microscopically evaluated, and tested for the expression of a smooth muscle action.  
Liver Slice System:  
A second in vitro test system which was recently developed to assess effects 
of antifibrotic drugs is the liver slice preparation. Drug studies with tissue slices 
(8mm diameter, 250 un thickness that is about 10-12 cell-layers thick) comprising 
stellate cells in their natural environment that uphold there in vivo cellular functional 
and anatomic relationships, may provide additional information about the 
hepatocellular specificity of the experimental drug and their effects on all hepatic 
cells.  
Hepatoprotective and antioxidant effects of tender coconut water (TCW) 
were examined in carbon tetrachloride (CCl4)-intoxicated female rats.  
Liver damage was showed by the increased levels of serum glutamate 
oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT) 
and decreased levels of serum proteins and by histopathological studies in CCl4 
intoxicated rats.  
Augmented lipid peroxidation was presented by elevated levels of 
thiobarbituric acid reactive substance (TBARS) viz, malondialdehyde (MDA), 
hydroperoxides (HP) and conjugated dienes (CD), and also by significant reduction 
in antioxidant enzymes activities, such as superoxide dismutase (SOD), catalase 
(CAT) and also reduced glutathione (GSH) content in liver.  
Darkening of urine on the other hand, CCl4 intoxicated rats treated with TCW 
retained almost normal levels of these constituents. Decreased activities of 
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antioxidant enzymes in CCl4 intoxicated rats and their reversal of antioxidant 
enzyme activities in TCW treated rats, shows the effectiveness of TCW in combating 
CCl4 induced oxidative stress.  
Hepatoprotective outcome of TCW is also evidenced from the 
histopathological studies of liver, which did not show any fatty infiltration or 
necrosis, as observed in CCl4 intoxicated rats
 [57].  
Exams and Tests Physical Examination:  
1. Nutritional assessment 
2. Yellowing of the sclera is usually the first detectable sign of jaundice. 
3. Darkening of urine 
4. Skin examination for icterus 
5. Stigmata of chronic liver disease 
6. Abdominal examination 
7. Inflammed and tender liver 
8. Fluid in the abdomen (ascites) that can become infested 
9. Blood tests 
10. These may initially include 
11. Complete blood count – TC, DC, ESR, Cholesterol 
12. Liver function test 
13. In women, a pregnancy test may be obtained. 
14. Urine analysis: Urine analysis for bile salts and bile pigments. 
 Laboratory Tests: 
1. Abdominal ultrasound 
2. Autoimmune blood markers 
3. Hepatitis virus serologists 
4. Liver function tests 
5. Liver biopsy to check for liver destruction 
6. Paracentesis if fluid is in abdomen Tests for Liver Function. 
Bilirubin:  
Bilirubin is one of the most important factors indicative of hepatitis. It is a 
red-yellow pigment that is normally metabolized in the liver and then defecated in 
the urine.  
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In patients with hepatitis, the liver cannot process bilirubin, and blood levels 
of this substance rise. High levels of bilirubin cause the yellowish skin tone known 
as jaundice.  
Liver Enzymes (Aminotransferases):  
Enzymes known as aminotransferases, including aspartate (AST) and alanine 
(ALT), are free when the liver is damaged. Measurements of these enzymes, 
particularly ALT, are the least expensive and most non-invasive tests for determining 
sternness of the underlying liver disease and monitoring treatment effectiveness. 
Enzyme levels vary, however, and are not always an accurate indicator of disease 
activity.  
Alkaline Phosphatase (ALP):  
High ALP levels can indicate bile duct blockage.  
GGT (gamma glut amyl transpeptidase):  
GGT is often elevated in those who use alcohol or other liver-toxic 
substances to excess.  
Serum Albumin:  
Serum albumin measures protein in the blood (low levels indicate poor liver 
function). Total protein, Serum total protein, protein in the blood (low levels indicate 
poor liver function).  
Prothrombin Time (PT):  
The PT test measures in seconds the time it takes for blood clots to form (the 
longer it takes the greater the risk for bleeding [58].  
3.5 LATERAL   RESEARCH 
HEMIDESMUS INDICUS :  
Anti-microbial activity:  
       The Antimicrobial activity of H.indicus was evaluated against pathogenic 
bacteria Stahylocococcus aures, Pseudomonas and Klebsiella in an in vitro 
condition.The aqueous extract inhibits the growth of bacteria with minimal 
inhibitory concentration ranging from 0.04 mg to 0.08mg.Thus it has significant 
antibacterial activity against Pathogenic bacteria.(61)  
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 In vitro antioxidant and antithrombotic activity: 
  The methanolic extract of H.indicus roots was found to inhibit lipid 
peroxidation and and scavenge hydroxyl and superoxide radicals in vitro. The 
amount required for 50% inhibition of lipid peroxide formation was 217.5μg/ml. 
The extract also inhibited ADP-induced platelet aggregation in vitro [59].  
 Wound healing activity:  
  Coarsely powdered shade dried roots of H.indicus was compactly packed in 
a Soxhlet extractor with methanol as a solvent and it was heated (60-80ºC) for 24 h 
and the final product obtained was dried. The ointment made from the methanolic 
extract of H.indicus displayed significant wound healing activity.(60)  
CUMINUM CYMINUM  
 Hepato protective activity:                 
            Protective effect of Cuminum cyminum on Profenofos induced Liver toxicity. 
Cumin seeds have anti- carcinogenic properties. In one study, it was observed that 
cumin prevents the development of stomach or liver tumours in laboratory 
animals.This cancer protective effect may be due to cumin’s potent free radicle 
scavenging abilities and its effect to enhance liver detoxification enzymes.(62) 
Hypolipidemic activity and Anti-diabetic activity:  
  Oral administration of 0.25g Kg diabetic rats resulted in significant reduction 
in blood glucose and an increase in total haemoglobin and glycosylated 
haemoglobin. It also prevented a decrease in body weight. C.cyminum treatment also 
resulted in significant reduction in plasma and tissue cholesterol, free fatty acids and 
triglycerides. (63) 
Anti-bacterial activity:  
Essential oil of Cuminum cyminum contains p-mentha-1, cuminaldehyde, 
terpene, pinene which shows a Anti-bacterial activity against clavibacter, 
curtobacterium, rhodococcus, erucinia, xanthomonas, agro bacterium which are 
responsible for plant or cultivated disease world-wide. (64)   
Nephroprotective activity:  
The cumin seeds extract and the coriander leaf extract incobination shows 
nephroprotective activity in profenofos induced neprotoxicity in swiss albino 
mice. The biochemical assessment shows the nephroprotective activity of cumin 
and coriander. In comparison to control group mice group creatinine, urea, uric 
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acid was increased in profenofos treated group and profenofos control group. But 
in cumin, and coriander treated group it shows declination in the level of 
creatinine & urea level. (65) 
 ELETTARIA CARDAMOMUM:  
 Gastroprotective activity of Cardamom:  
A crude methanolic extract, essential oil, Petroleum ether soluble and 
insoluable fractions of methanolic extract were studied in rats at doses of 100-500, 
12.5-50, 12.5-150 and 450 mg/kg, respectively for their ability to inhibit the gastric 
lesions induced by aspirin, ethanol and pylorous ligature. (66)  
Anti-ulcerogenic activity of Elettaria cardamomum    
The gastro protective action of petroleum ether soluble fractions and essential 
oils of E.cardamomum is due to increase in gastric motility and it has inhibitory 
effect in over production of some products of 5-lipoxygenase pathway.(67)   
Anti-convulsant activity:  
          The methanolic extract of E.cardamomum against chemically 
(pentylentetrazole) and electrically (maximal electric shock) induced seizures in 
mice.Various pharmacological activities Anti -inflammatory, Analgesic, Anti -
oxidant, Anti- microbial effects.(68)    
Antimicrobial activity:  
The n-hexane seed of the cardamom seed was found to exhibit rather broad 
antimicrobial activity against S.mutans, Propinobacterium acenes,Pityrosporum 
ovale, Trichophyton mentagrophytes.Isao Kubo, Masaki Himejima, Antimicrobial 
activity of flavor compenents of Cardamom Elettaria cardmomum.(69)    
FOENICULUM VULGARE: 
 Antioxidant activity: 
  Antioxidant activity of ethanol and water extracts of FS was determined by 
the thiocyanate method, the extraction yields and gallic acid equivalents.The 
inhibition of lipid peroxidation in percent of water and ethanol extracts of FS, a-
tocopherol, BHA and BHT. Ethanol and water extracts of FS exhibited effective 
antioxidant activity at all concentrations. The effects of various amounts of water 
and ethanol extracts of FS (50–250 mg) on peroxidation of linoleic acid emulsion. 
Determination of in vitro antioxidant activity of fennel (Foeniculum vulgare) seed 
extracts. (70) 
REVIEW OF LITERATURE 
 
57 HEPATOPROTECTIVE ACTIVITY OF NANNARI MATHRAI 
 
Anti-bacterial activity: 
Fennel is used to treat many bacterial, fungal, viral, and mycobacterial 
infectious diseases (31). Fennel has antibacterial activity due to compounds such as, 
linoleic acid, undecanal, 1, 3-benzenediol, oleic acid and 2,4-undecadienal. Fennel 
has 5-hydroxy-furanocoumarin which has important role antibacterial activity of this 
plant.  
Antifungal activity: 
Antifungal activity of fennel essence on Sclerotinia sclerotiorum was 
investigated. The antifungal effect of this plant against Sclerotinia sclerotiorum 
observed based on survival of the microorganisms (70a).  
A study demonstrated that nitric oxide production in peritoneal macrophages 
which were treated with fennel extract at a concentration of 10 mg/ml significantly 
increased. Also, the production of reactive oxygen species compared to the control 
group increased. 
Gastro-protective activity: 
It has been shown that fennel plant has significant protective effect on 
gastrointestinal disorders. It was shown that the use of fennel oil emulsions 
eliminated colic in 65% of treated infants which was considerably better than the 
control group. (71)  
SESBANIA GRANDIFLORA  
Hepatoprotective activity: 
The hepatoprotective activity of ethanolic and aqueous extractof sesbania 
grandiflora (Linn) flower in ccl4 induced hepatotoxicity models in rats was 
investigated. The ethanolic and aqueous extract of sesbania grandiflora (Linn) 
flower was screened for hepatoprotective activity in ccl4 induced rats for its dose 
200mg/kg bw. The ethanolic and aqueous extract of s.grandiflora (Linn) flower 
significantly (p<0.001) decreased the biochemical parameters (SGOT, SGPT, 
ALP,TP, and TB). Silymarin (25mg/kg), a known hepatoprotective drug used for 
comparison exhibited significant activity p<0.001). The extract did not shown any 
mortality upto a dose of 2000g/kg body weight. These findings suggested that the 
ethanolic and aqueous extract of sesbania grandiflora (Linn) flower 500mg/kg was 
effective in bringing out functional improvement of hepatocytes. The healing effect 
of this extract was also confirmed by histological observations. 
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         The ethanolic extract at doses of 250 and 500mg/kg,p.o and aqueous extractat 
doses500mg/kg, p.o of sesbania grandiflora (Linn) flower had significant effect on 
the liver of ccl4 induced hepatotoxicity animal model.(72a) 
Antioxidant and cardioprotective effect: 
Sesbania grandiflora was evaluated for the cardio protective effects against 
cigarette smoke-induced oxidative damage in rats. Adults male wistar-kyoto rats 
were exposed to cigarette smoke for a period of 90 days and consequently treated 
with s.grandiflora aqueous suspension (SGAS, 1000mg/kg body weight per day 
orally)for a period of 3 weeks. The results suggested that chronic cigarette smoke 
exposure increases the oxidative stress, thereby disquieting the cardiac defence 
system and s grandiflora protects the heart from the oxidative damage through its 
antioxidant potential. (72b) 
Antiurolithiatic activity: 
             The leaf juice of s.grandiflora was evaluated for median lethal dose, gross 
behavioural changes,antiurolithiatic and antioxidant activities. The antiurolithiatic 
activity wasevaluated by a calculi-producing diet model, using gentamicin 
(subcutaneously) and 5%ammonium oxalate in rat feed to induce calcium oxalate-
type stones. The leaf juice of s.gradiflora was safe orally and exhibited no gross 
behavioural changes except for an increase in urination. The leaf juice of 
s.grandiflora showed significant antiurolithiatic     activity against calcium oxalate-
type stones and also exhibited antioxidant properties.(72c) 
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4. MATERIALS AND METHODS 
DRUG SELECTION: 
 This present study, the Herbal formulation “NANNARI MATHIRAI” (73) was 
taken as the compound drug preparation for Kaamaalai (Jauncide)mentioned in the 
classical Siddha literature “Kannuswamy parambarai vaithiyam” written by 
Kannuswamy pillai, published by Thirumagal Vilasa acchagam, Chennai, pg.no:141, 
Edition year:1948. 
INGREDIENTS: 
                              Table 3: Ingredients of Nannari mathirai: 
NAME OF DRUGS BOTANICAL NAME QUANTITY 
Nannari Hemidesmus indicus 1 Thola (12 grams) 
Seeragam Cuminum cyminum 1 Thola (12 grams) 
Elam Elettaria cardamomum 1 Thola (12 grams) 
Perunseeragam Foeniculum vulgare 2 Thola (24 grams) 
Sevvagathi Sesbania grandiflora Requid quantity 
Collection of the Plant materials: 
All the raw materials were bought from the Ramasamy Mudhaliyar Store, Parry’s 
corner, Chennai. 
Identification and Authentication of the drug: 
The raw materials were identified and authenticated by the experts of 
Gunapadam, Government Siddha Medical College, Arumbakkam, Chennai- 106. The 
specimen sample of each raw material has been kept in the PG Gunapadam department 
individually for future reference. 
Purification of the drugs: 
 Purification process was done as per classical Siddha literature [74]. 
                                               Table 4: Purification of drugs: 
 
 
 
  Raw Drug           Method of Purification 
Nannari The root was cleaned with a white cloth. Finally, washed and dried. 
Elam Roasted in the Pan and outer skin are removed. 
Seeragam Cleaned well without any dust impurities and slightly roasted in pan. 
Perunjeeragam Cleaned well without any dust impurities and slightly roasted in pan. 
Sevvagathi The Fresh flowers is washed in the running water. 
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4.1. PREPARATION OF THE TRAIL DRUG NANNARI MATHIRAI: 
Procedure: 
All the ingredients such as Root bark of Nannari, Seeragam, Elam, were 
purified and dried in the shade until complete evaporation of the moisture content 
and Required quantity of fresh Sevvagathi flower juice was taken. Except 
Sevvagathi flower juice all other ingredients are taken and powered separately. 
Then all the powder was mixed together. 
Finally, the mixture was ground well which favours the homogenous 
preparation. Then the mixture of the powder was sieved through the thin clean white 
cloth. After that by adding required quantity of Nannari root bark juice and 
Sevvagathi juice then ground it well and make it as a karkam. Finally make it as a 
Pill for 130mg.Finally, the end product was obtained, which was kept in an air tight 
container and labeled as “Nannari Mathirai” (NM). 
Storage of the Drug: 
The prepared test drug was stored in a clean, air tight glass container.The 
 contents were inspected frequently to avoid moisture and insects. 
Administration of the Drug: 
Form of the medicine  : Mathirai 
Route of administration : Enteral 
Dose    : 130mg.1 tab twice a day 
Adjuvant   : Water. 
Indication   : Kaamaalai (Jaundice). 
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                            Fig 1: INGREDIENTS OF NANNARI MATHIRAI: 
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FIG 2. PREPARATION OF NANNARI MATHIRAI 
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4.2. STANDARDIZATION OF THE DRUG: 
Standardization of the drug brings the validation to be used as a medicine by 
subjecting the drug to many analyses and determining its quality and effectiveness. 
Standardization includes many studies such as its organoleptic properties, physical 
characteristics and phytochemical properties and also to assess the active principles 
and elements present in the drug. 
Method of standardization: 
Techniques Involved in Standardization of Compound Drugs: 
❖   Macroscopic Methods 
❖   Microscopic Methods 
❖   Physical Methods 
❖   Chemical Methods 
❖   Biological Methods 
4.2.1. ORGANOLEPTIC CHARACTER:(75) 
The organoleptic characters of the sample were evaluated which include 
evaluation of the formulation by its colour, odour, taste, texture etc. Ten tablets were 
taken into watch glasses and positioned against white back ground in white tube light. 
Its colour was observed by naked eye and results are noted. 
Colour: 
A sample of Mathirai were taken in watch glasses and placed against white back 
ground in white tube light. The Mathirai were observed for its color by naked eye. 
Odour: 
Ten numbers of tablets were smelled individually.Mathirai were smelled, the 
time intermission between two smelling was kept 2 minutes to nullify the effect of 
previous smelling. 
Taste: 
A sample of about Mathirai was tasted and the taste was reported. 
Size: 
            The diameter of ten tablets was measured by Vernier caliper. The mean value 
of diameter was noted. 
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4.2.2 PHYSIOCHEMICAL ANALYSIS OF NANNARI MATHIRAI 
Physicochemical‐ studies of the trial drug have been done according to WHO 
guidelines. Physico chemical studies like total ash, water soluble ash, acid Insoluble 
ash, water and alcohol soluble extract, loss on drying at 105°C and pH were done at, 
Dr. MGR University, Chennai. (76) 
1.Solubility Test: 
A pinch of sample (NM) was taken in a dry test tube and to it 2 ml of the solvent 
was added and shaken well for about a minute and the results are observed. The test 
was done for solvents like distilled water, Ethanol, Chloroform and the results are 
observed individually. 
 2.pH value: 
  Potentiometrically, pH value is determined by a glass electrode and a suitable 
pH meter. The pH of the Nannari mathirai was written in results column 
3. Loss on Drying: 
An accurately weighed 1g of Nannari mathirai was taken in a tarred glass 
bottle. The crude drug was heated at 1050C for 6 hours in an oven till a constant weight. 
The Percentage moisture content of the sample was calculated with reference to the 
shade dried material. 
4. Determination of total ash: 
Weighed accurately 2g of Nannari mathirai was added in crucible at a 
temperature 6000C in a muffle furnace till carbon free ash was obtained. It was 
calculated with reference to the air-dried drug.  
5.Determination of acid insoluble ash: 
Ash above obtained, was boiled for 5min with 25ml of 1M Hydrochloric acid 
and filtered using an ash less filter paper. Insoluble matter retained on filter paper was 
washed with hot water and filter paper was burnt to a constant weight in a muffle 
furnace. The percentage of acid insoluble as was calculated with reference to the air-
dried drug. 
 6.Determination of water-soluble ash: 
Total ash 1g was boiled for 5min with 25ml water and insoluble matter 
collected on an ash less filter paper was washed with hot water and ignited for 15min 
at a temperature not exceeding 4500C in a muffle furnace. The amount of soluble 
ash is determined by drying the filtrate.  
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 7.Determination of water-soluble Extractive: 
 5gm of air-dried drug, coarsely powered Nannari mathirai was macerated 
with 100ml of distilled water in a closed flask for twenty-four hours, shaking 
frequently. The Solution was filtered and 25 ml of filtrated was evaporated in a 
tarred flat bottom shallow dish, further dried at 1000 C and weighted. The percentage 
of water-soluble extractive was calculated with reference to the air-dried drugs.   
 8.Determination of alcohol soluble extractive: 
1 gm. of air-dried drugs, coarsely powdered Nannari mathirai was 
macerated with 20 ml. alcohol in closed flask for 24 hrs. With frequent shaking. It 
was filtered rapidly taking precaution against loss of alcohol. 10ml of filtrate was 
then evaporated in a tarred flat bottom shallow dish, dried at 1000C and weighted. 
The percentage of alcohol soluble extractive was calculated with reference to air 
dried drug. 
Tablet Disintegration test  
Each Nannari mathirai was placed in each of the six tubes of the basket 
present in the disintegration apparatus. The apparatus was operated by using water 
as the immersion fluid maintained at 35-39 °C. At the end of 30 min, the basket is 
lifted from the fluid and the state of the tablet is observed. The disintegration time 
of Nannari mathirai was recorded (78).  
All the results were noted and tabulated in Table No.5  
Weight variation test  
It was carried out to make sure that, each number of tablets contains the 
proper amount of drug. The test was carried out by weighing the 20 tablets 
individually using analytical balance, then the average weight was calculated and 
comparing the individual tablet weights to the average (79).  
The percentage of weight variation is calculated by using this formula.  
% of wt. variation = Individual wt. – Average wt. x 100  
                                             Average wt. 
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                                  Table No. 5. Weight variation limits of Tablets (IP) 
Average weight of tablets  
 
Maximum percentage of 
weight difference allowed  
80 mg or less ±10.0  
Between 80 mg and 250 mg  ±7.5  
250 mg and more  ±5.0  
4.2.3 PHYTOCHEMICAL SCREENING: 
The preliminary phytochemical screening test was carried out for each extract 
of Nannari mathirai as per the standard procedure (77). 
1. Detection of alkaloids: 
Extracts were dissolved individually in dilute Hydrochloric acid and filtered. 
a) Mayer’s Test: Filtrates were treated with Mayer’s reagent (Potassium 
Mercuric Iodide). Formation of a yellow colored precipitate indicates the presence of 
alkaloids. 
 2. Detection of carbohydrates: 
Extracts were dissolved individually in 5 ml distilled water and filtered. The filtrates 
were used to test for the presence of carbohydrates. 
a) Molisch’s Test: To 2 ml of plant sample extract, two drops of alcoholic 
solution of α- naphthol are added. The mixture is shaken well and few drops of 
concentrated sulphuric acid is added slowly along the sides of test tube. A violet ring 
indicates the presence of carbohydrates. 
3. Detection of glycosides:  
Extracts were hydrolyzed with dil. HCl, and then subjected to test for glycosides. 
a) Modified Borntrager’s Test: Extracts were treated with Ferric Chloride 
solution and immersed in boiling water for about 5 minutes. The mixture was cooled 
and extracted with equal volumes of benzene. The benzene layer was separated and 
treated with ammonia solution. Formation of rose-pink color in the ammonical layer 
indicates the presence of anthranol glycosides. 
4. Detection of saponins: 
a) Foam Test: 0.5 gm of extract was shaken with 2 ml of water. If foam 
produced persists for ten minutes it indicates the presence of saponins. 
 
 
MATERIALS AND METHODS      
 
 
68 HEPATO PROTECTIVE ACTIVITY OF NANNARI MATHIRAI 
 
5. Detection of phenols Ferric Chloride Test: 
Extracts were treated with 3-4 drops of ferric chloride solution. Formation  
of bluish black color indicates the presence of phenols. 
6. Detection of tannins Gelatin Test: 
The extract is dissolved in 5 ml of distilled water and 2 ml of 1% solution of 
Gelatin containing 10% NaCl is added to it. White precipitate indicates the presence 
of phenolic compounds. 
7. Detection of Flavonoids: 
a) Alkaline Reagent Test: Extracts were treated with few drops of 
sodiummhydroxide solution. Formation of intense yellow color, which becomes 
colorless on addition of dilute acid, indicates the presence of flavonoids. 
8. Detection of proteins: 
a) Xanthoprotein Test: The extracts were treated with few drops of conc. 
Nitric acid. Formation of yellow color indicates the presence of proteins. 
9. Detection of aminoacids: 
a) Ninhydrin Test:To the extract, 0.25% w/v ninhydrin reagent was added 
and boiled for few minutes. Formation of blue color indicates the presence of amino 
acid. 
10. Detection of diterpenes Copper Acetate Test: 
Extracts were dissolved in water and treated with 3-4 drops of copper acetate 
solution. Formation of emerald green color indicates the presence of diterpenes. 
11. Gum and Mucilage: 
To 1ml of extract add 2.5ml of absolute alcohol and stirring constantly. Then 
the precipitate was dried in air and examine for its swelling properties. Swelling was 
observed that will indicate presence of gum and mucilage. 
12. Test for Quinones 
Extract was treated with sodium hydroxide blue or red precipitate indicates 
the presence of Quinones. 
13. Test for Fixed oils and Fats: 
a. Spot test: A small quantity of extract is pressed between two filter papers. 
Oil stain on the paper indicates the presence of fixed oils. 
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4.2.4.BIO-CHEMICAL ANALYSIS (80): 
Methodology for chemical analysis 
The bio-chemical analysis was done to identify the acid and basic radicals 
present in the sample. 
Preparation of extract: 
5g of NM was taken in a 250 ml clean beaker and 50 ml of distilled water 
was added, boiled well and allowed to cool and filtered in a 100 ml volumetric flask 
and made up to 100 ml with distilled water. 
Preliminary Basic and Acidic radical studies: 
                              Table 6: Test for basic radicals of Nannari mathirai 
PROCEDURE  OBSERVATION INFERENCE 
Test for Potassium: 
A pinch of sample is treated with 2ml of 
sodium nitrate solution and then treated 
with 2ml of cobalt nitrate in 30% of 
glacial acetic acid. 
Formation of Yellow 
Colour 
precipitate 
Presence of 
Potassium 
Test for Calcium: 
Taken2 ml of extract in a clean Test 
tube.Then acetic acid and otassium 
chromate solution were added. 
No Yellow 
precipitate 
Presence of 
Calcium 
Test for Magnesium: 
2ml of extract was taken in a clean test 
tube, few drops of Magnason reagent was 
added in drops. 
Appearance of Brown 
colour 
 
 
Presence of 
Ammonium 
 
 
 
Test for Sodium:2 pinches of NM were 
mixed with HCl and made it into paste. 
And introduced into the blue flame of 
Bunsen burner. 
Appearance of intense 
Yellow 
colour 
Presence of 
Sodium 
MATERIALS AND METHODS      
 
 
70 HEPATO PROTECTIVE ACTIVITY OF NANNARI MATHIRAI 
 
Test for Iron (Ferrous): 
2ml of extract was taken in a clean dried 
test tube and conc. HNO3 and ammonium 
thiocyanate were added. 
Appearance of Blood 
red colour 
Presence of 
Ferrous 
iron 
 
 
Test for Zinc: 
2 ml of the extract was taken in a test 
tube and Potassium ferro cyanide 
solution was added. 
Formation of White 
colour 
precipitate 
Presence of 
Zinc 
Test for Aluminium: 
To the 2m1of the extract was taken in a 
test tube sodium hydroxide drops were 
added to it. 
White precipitate 
Obtained 
Presence of 
Alumini
um 
Test for Lead: 
2 ml of extract was taken in a test tube 
and added with 2ml of potassium iodide 
solution 
Formation of yellow 
colour 
precipitate 
Presence of 
Lead 
Test for Copper: 
To a small portion of a extract 
dilutehydrochloric acid was added and 
then hydrogen sulphide gas is passed 
through the solution. 
Formation 
Black 
Precipitate 
Presence of 
Copper 
Test for Mercury:2m1 of the extract 
was taken in a test tube and treated with 
2ml of sodium hydroxide solution. 
Formation of Yellow 
Precipitate 
Presence of 
Mercury 
Test for Arsenic: 
2m1 of the extract was taken in a test 
tube and treated with 2ml of sodium 
hydroxide solution. 
Formation of 
brownish 
red 
Precipitate 
Presence of 
Arsenic 
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Table.No:7. Test for acidic radical for Nannari mathirai 
PROCEDURE OBSERVATION INFERANCE 
Test for Sulphate: 
2 ml of the extract was taken in 
clean, dry test tube and 5 % 
barium chloride solution was 
added to it. 
Formation of white 
Precipitate 
Presence of 
Sulphate 
Test for Chloride: 
The extract was taken in a test 
tube and then treated with Silver 
nitrate solution. 
Formation of White 
colour 
precipitate 
Presence of 
Chloride 
Test for Phosphate: 
The extract was taken in a test 
tube and treated with ammonium 
molybdate and conc. HNO3. 
Formation of Yellow 
colour 
precipitate 
Presence of 
Phosphate 
Test for Carbonate: 
The substance was taken in a 
clean dry test tube and then 
treated with Conc. HCl. 
Formation of 
Effervescence 
Presence of 
Carbonate 
Test for fluoride &oxalate: 
2ml of extract was taken in a test 
tube and added with 2ml of dil. 
acetic acid, 2ml calcium chloride 
solution and then heated. 
Formation of cloudy 
Appearance 
Presence of 
Fluoride & 
Oxalate 
Test for Nitrate: 
1gm of the NM was heated with 
copper turnings and conc H2SO4 
and observed the test tube 
vertically down. 
Characteristic 
changes 
Presence of 
Nitrate. 
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  4.2.5 ANTIMICROBIAL ACTIVITY (81) 
AGAR- WELL DIFFUSION METHOD 
Principle 
The antimicrobials present in the samples are allowed to diffuse out into 
the medium and interact in a plate freshly seeded with the test organisms. The 
resulting zones of inhibition will be uniformly circular as there will be a confluent 
lawn of growth. The diameter of zone of inhibition can be measured in 
millimeters. 
Materials required 
1.Muller Hinton Agar Medium (1 L) 
The medium was prepared by dissolving 33.8 g of the commercially 
available Muller Hinton Agar Medium (MHI Agar Media) in 1000ml of distilled 
water. The dissolved medium was autoclaved at 15 lbs pressure at 121°C for 15 
minutes. The autoclaved medium was mixed well and poured onto 100mm 
petriplates (25-30ml/plate) while still molten. 
2. Nutrient broth (1L) 
One litre of nutrient broth was prepared by dissolving 13 g of commercially 
available nutrient medium (HI Media) in 1000ml distilled water and boiled to 
dissolve the medium completely. The medium was dispensed as desired and 
sterilized by autoclaving at 15 lbs pressure (121ºC) for 15 minutes. 
3. Streptomycin (standard antibacterial agent, concentration: 10mg / ml) 
4. Culture of test organisms; growth of culture adjusted according to McFarland 
Standard, 0.5% 
1. E. coli (ATCC 25922) 
2. Staphylococcus aureus (ATCC 25923) 
3. Pseudomonas aeroginosa (ATCC 27853)  
4. Klebsiella pneumoniae (ATCC 13883) 
Procedure 
Petriplates containing 20ml Muller Hinton Agar Medium were seeded with 
bacterial culture of E. coli, Pseudomonas aeroginosa, Klebsiella pneumoniae and 
Staphylococcus aureus (growth of culture adjusted according to McFarland Standard, 
0.5%). Wells of approximately 10mm was bored using a well cutter and different 
concentrations of sample such as 250μg/mL, 500μg/mL and 1000μg/mL were added. 
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The plates were then incubated at 37°C for 24 hours. The antibacterial activity was 
assayed by measuring the diameter of the inhibition zone formed around the well 
(NCCLS, 1993). Streptomycin was used as a positive control. 
                                                 ANTIFUNGAL ACTIVITY 
AGAR- WELL DIFFUSION METHOD  
Principle 
  In order to access the biological significance and ability of the sample, the 
antifungal activity was determined by Agar well diffusion method. The antifungals 
present in the samples are allowed to diffuse out into the medium and interact in a 
plate freshly seeded with the test organisms. The resulting zones of inhibition will be 
uniformly circular as there will be a confluent lawn of growth. The diameter of zone 
of inhibition can be measured in millimeters. 
Materials required 
1.Potato Dextrose Agar Medium (1 L) 
The medium was prepared by dissolving 39 g of the commercially available 
Potato Dextrose Agar Medium (HiMedia) in 1000ml of distilled water. The 
dissolved medium was autoclaved at 15 lbs pressure at 121°C for 15 minutes. The 
autoclaved medium was mixed well and poured onto 100mm petriplates (25-
30ml/plate) while still molten. 
3. Clotrimazole (standard antifungal agent, concentration: 10mg / ml) 
4. Culture of test organisms; growth of culture adjusted according to McFarland 
Standard, 0.5% 
• Aspergillus niger (ATCC 16404)  
Procedure 
Potato Dextrose agar plates were prepared and overnight grown species of 
fungus, Aspergillus niger were swabbed. Wells of approximately 10mm was bored 
using a well cutter and samples of different concentrations such as 250μg/mL, 
500μg/mL and 1000μg/mL were added. The zone of inhibition was measured after 
overnight incubation at room temperature and compared with that of standard 
antimycotic (Clotrimazole) (NCCLS, 1993). 
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4.2.6 INSTRUMENTAL ANALYSIS 
SOPHISTICATED INSTRUMENTAL ANALYSIS:  
HPLC - High Performance Liquid Chromatography (HPLC)(82): 
HPLC is a technique in analytical chemistry which is used to separate the 
components in a mixture, to identify each component, and to quantify each 
component. It relies on pumps to pass a pressurized liquid solvent containing the 
sample mixture through a column filled with a solid adsorbent material. Each 
component in the sample interacts slightly differently with the adsorbent material, 
causing different flow rates for the different components and leading to the 
separation of the components as they flow out of the column. In this study, the 
detection and quantitation were carried out using 515 HPLC pumps and 2489 
UV/Visible detectors of Waters Company while the software used was Empower. 
Two methods using different mobile phases were used for chromatographic 
separation of the research drugs – Method I (binary gradient method of Acetonitrile 
& 0.1% Phosphoric acid in Water) and Method II (binary gradient method of 
Methanol 1:25 Acetic acid in Water). Results obtained during Method I have been 
discussed since better separation of compounds was observed during this analysis. 
The chromatographic conditions for Method I are as given below: 
Column  : Symmetry C18, 5 µm, 4.6x250 mm 
Run Time  : 30 minutes 
Injection Volume : 20 µl 
Wavelength (Dual) : 272 nm & 360 nm 
Solvent A  : Acetonitrile 
Solvent B  : 0.1% Phosphoric acid in water 
Flow rate  : 1.0 ml/min. 
Pump Mode  : Gradient 
 
FT IR - Fourier Transform Infra-red Spectroscopy [83] 
FTIR (Fourier Transform Infra-red Spectroscopy) is a sensitive technique 
particularly for identifying organic chemicals in a whole range of applications 
although it can also characterise some inorganics. Examples include paints, 
adhesives, resins, polymers, coatings and drugs. FTIR is an effective analytical 
instrument for detecting functional groups. 
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                                       Fig no:3 FTIR INSTRUMENT 
                
        
 
 
 
 
 
 
 
 
 
       
                                        Fig no:3.1 FTIR MECHANISM  
Principle:  
Spectrophotometric tests are commonly used in the Identification of 
chemical substances and quantification of polymorphic forms. The test procedures 
are applicable to substances that absorb IR radiation. The IR absorption spectrum of 
a substance compared with that obtained concomitantly for the corresponding 
reference standard / reference substance provide conclusive evidence of the identity 
of the substance being tested.  
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 Recording Infrared spectrum of a solid as a disc (as per USP ‹197K›):  
➢ Triturate about 1 to 2 mg of the substance to be examined with 300 to 400 
mg, unless otherwise specified, of finely powdered and dried potassium bromide. If 
the substance is a hydrochloride it is preferable to use potassium chloride.  
➢ Carefully grind the mixture and spread it uniformly in a suitable die.  
➢ Submit it to the pressure of about 800 mPa (8 tons/ cm2).  
➢ Examine the disc visually and if any lack of uniform transparency is 
observed, reject the disc and prepare again.  
➢ Record the spectrum between 4000 to 650 cm-1 unless otherwise specified 
in individual standard test procedure.  
➢ When sample and standard are measured for concordance, the 
transmittance obtained at the start of the scan range, should not deviate by more 
than 10% between them (For eg. If the standard shows a transmittance of 75%, 
the sample transmittance can be between 65% and 85%). 
APPLICATIONS: 
➢ Quantative scans 
➢ Qualitative scan solids, liquids, gasses 
➢ Organic samples, inorganic samples 
➢ Unknown identification  
➢ Impurities screening 
➢ Formulation 
➢ Pharmaceuticals  
FT-IR was the most advanced and the major advantage was its 
➢ Speed 
➢ Sensitivity 
➢ Mechanical Simplicity 
➢ InternallyCalibrated 
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ICPOES (INDUCTIVELY COUPLED PLASMA OPTIC  
EMISSION   SPECTROMETRY) 
 
 
 
 
 
 
 
 
 
 
 
 
Fig: 4.1 ICP-OES INSTRUMENT 
 
 
 
 
 
 
 
 
 
 
 
                                                   
                                          Fig:4.2 ICP-OES MECHANISM 
Manufacturer: Perkin Elmer 
Model:  Optima 5300 DV ICP-OES Inductively Coupled Plasma 
Spectrometer (ICP). 
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Principle: 
An aqueous sample was converted to aerosols via a nebulizer. The aerosols 
are transported to the inductively coupled plasma which was a high temperature zone 
(8,000– 10,000ºC). The analysts are heated (excited) to different (atomic and/or ionic) 
states and produce characteristic optical emissions (lights). These releases are separated 
based on their respective wavelengths and their strengths are measured (spectrometry). 
The intensities are proportional to the concentrations of analyses in the aqueous sample. 
The quantification was an external multipoint linear standardization by comparing the 
emission intensity of an unknown sample with that of a standard sample. Multi-element 
calibration standard solutions are prepared from single- and multi element primary 
standard solutions. With respect to other kinds of analysis where chemical speciation 
was relevant (such as the concentration of ferrous iron or ferric iron), only total essential 
concentration was analysed by ICP-OES. (84) 
Mechanism:  
In plasma emwassion spectroscopy (OES), a VKM solution was presented 
into the core of inductively coupled argon plasma (ICP), which generates temperature 
of approximately 8000°C. At this temperature all elements become thermally excited 
and emit light at their characteristic wavelengths. This light was collected by the 
spectrometer and passes through a diffraction grating that serves to resolve the light 
into a spectrum of its essential wavelengths. Within the spectrometer, this deflected 
light was then collected by wavelength and amplified to yield an strength of  
measurement that can be converted to an elemental concentration by comparison with 
standardization values.(93)The Inductively coupled plasma optical emission 
spectrometric (ICP-OES) analysis was done in SAIF, IIT MADRAS, and Chennai-36 
using Perkin Elmer Optima 5300 DV. 
Application: 
The analysis of major and minor elements in solution NM. 
Objectives: 
❖ Determine elemental concentrations of different metals. 
❖ Learn principles and operation of the ICP-OES instrument 
❖ Develop and put on a method for the ICP-OES sample analysis 
❖ Enhance the instrumental conditions for the analysis of different elements probes the 
outer electronic structure of atoms 
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SEM - SCANNING ELECTRON MICROSCOPE [85] 
DEFINITION 
Scanning Electron Microscopy (SEM), also known as SEM analysis or SEM 
microscopy, is used very effectively in microanalysis and failure analysis of solid 
inorganic materials. Scanning electron microscopy is performed at high magnifications, 
generates high-resolution images and precisely measures very small features and 
objects. 
SEM ANALYSIS APPLICATIONS 
The signals generated during SEM analysis produce a two-dimensional image 
and reveal information about the sample including: 
External morphology (texture), Chemical composition (when used with EDS) 
and Orientation of materials making up the sample. 
The EDS component of the system is applied in conjunction with SEM 
analysis to: 
➢ Determine elements in or on the surface of the sample for qualitative 
information 
➢ Measure elemental composition for semi-quantitative results 
➢ Identify foreign substances that are not organic in nature and coatings on metal 
➢ SEM Analysis with EDS – qualitative and semi-quantitative results 
➢ Magnification – from 5x to 300,000x 
➢ Sample Size – up to 200 mm (7.87 in.) in diameter and 80 mm (3.14 in.) in 
height 
➢ Materials analysed – solid inorganic materials including metals and minerals. 
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Fig no: 5.1 SEM INSTRUMENT 
                                            
 
 
 
 
 
 
 
 
 
 
                                     
 
 
 
                                           
                                          Fig no: 5.2 SEM MECHANISMS 
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THE SEM ANALYSIS PROCESS 
Scanning Electron Microscopy uses a focused beam of high-energy electrons 
to generate a variety of signals at the surface of solid specimens. In most SEM 
microscopy applications, data is collected over a selected area of the surface of the 
sample and a two-dimensional image is generated that displays spatial variations in 
properties including chemical characterization, texture and orientation of materials.      
The SEM is also capable of performing analyses of selected point locations on 
the sample. This approach is especially useful in qualitatively or semi-quantitatively 
determining chemical compositions, crystalline structure and crystal orientations. 
The EDS detector separates the characteristic X-rays of different elements into 
an energy spectrum and EDS system software is used to analyse the energy spectrum 
in order to determine the abundance of specific elements. A typical EDS spectrum is 
portrayed as a plot of X-ray counts vs. energy (in keV). Energy peaks correspond to 
the various elements in the sample.  
Energy Dispersive X-ray Spectroscopy can be used to find the chemical 
composition of materials down to a spot size of a few microns and to create element 
composition maps over a much broader raster area. Together, these capabilities 
provide fundamental compositional information for a wide variety of materials, 
including polymers. 
 In scanning electron microscope high-energy electron beam was focused 
through a probe towards PP. Variety of signals was produced on interaction with the 
surface of the sample. This results in the emission of electrons or photons and it was 
collected by an appropriate detector. 
The types of signal produced by a scanning electron microscope include:  
➢ Secondary electrons 
➢ Back scattered electrons 
➢ Characteristic x-rays light 
➢ Specimen current 
➢ Transmitted electrons. 
This gives the information about the sample and it includes external morphology, 
texture, its crystalline structure, chemical composition and it displays the shape of the 
sample. 
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XRD - X-ray Powder Diffraction (XRD) [86] 
X-ray powder diffraction (XRD) is a rapid analytical technique primarily 
used for phase identification of a crystalline material the analysed material is finely 
ground, homogenized, and average bulk composition is determined. (e.g. 
Determination of unknown solids is important to studies in geology, environmental 
science, material science and biology. 
. 
 
 
 
 
 
 
 
                
 
 
                               
                               Fig no: 6.1 XRD - X-ray Powder Diffraction 
                                 
 
 
 
 
                                      
 
 
 
 
 
 
                                           
Fig no: 6.2 XRD Mechanism 
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Applications:  
➢ Characterization of crystalline materials   
➢ Identification of fine-grained minerals such as clays and mixed layer clays 
that are difficult to determine optically  
➢ Determination of unit cell dimensions.  
With specialized techniques, XRD can be used to:  
➢ Determine crystal structures using Rietveld refinement  
➢ Determine of modal amounts of minerals (quantitative analysis)  
➢ Characterize thin films samples by:  
➢ Determining lattice mismatch between film and substrate and to inferring 
stress and strain.  
➢ Determining dislocation density and quality of the film by rocking curve 
measurements.  
➢ Measuring super lattices in multilayered epitaxial structures  
➢ Determining the thickness, roughness and density of the film using 
glancing incidence X-ray reflectivity measurements  
➢ Make textural measurements, such as the orientation of grains, in a 
polycrystalline sample. 
Strengths and Limitations of X-ray Powder Diffraction:   
Strengths:  
➢ Powerful and rapid (< 20 min) technique for identification of an unknown 
mineral. 
➢ In most cases, it provides an unambiguous mineral determination  
➢ Minimal sample preparation is required  
➢ XRD units are widely available  
➢ Data interpretation is relatively straight forward.  
Limitations:  
➢ Homogeneous and single-phase material is best for identification of 
unknown  
➢ Must have access to a standard reference file of inorganic compounds   
➢ Requires tenths of a gram of material which must be ground into a powder  
➢ For mixed materials, detection limit is ~ 2% of sample  
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➢ For unit cell determinations, indexing of patterns for non-isometric 
crystal systems is complicated.  
Sample Collection and Preparation:  
Determination of an unknown requires: the material, an instrument for 
grinding, and a sample holder.  
➢ Obtain a few tenths of a gram (or more) of the material, as pure as possible  
➢ Grind the sample to a fine powder, typically in a fluid to minimize 
inducing extra strain (surface energy) that can offset peak positions, and 
to randomize orientation. Powder less than ~10 ȝm (or 200-mesh) in size 
is preferred.  
➢ Place into a sample holder or onto the sample surface. 
4.3. TOXICOLOGICAL STUDIES: 
4.3.1 ACUTE ORAL TOXICITY – OECD GUIDELINES - 423  
INTRODUCTION:  
The acute toxic class method is a stepwise procedure with the use of 3 
animals of a single sex per step. Depending on the mortality and/or the moribund 
status of the animals, on average 2-4 steps may be necessary to allow judgment 
on the acute toxicity of the test substance. Morbid animals or animals obviously 
in pain or showing signs of severe and enduring distress shall be humanely killed, 
and are considered in the interpretation of the test results in the same way as 
animals that died on test. The method allows for the determination of an LD50 
value only when at least two doses result in mortality higher than 0% and lower 
than 100%.  
Acute toxicity study was carried out as per OECD guideline (Organization  
for Economic Co - operation and Development, Guideline-423. (87)  
The experimental protocol was approved by the institutional ethical 
committee (IAEC) under CPCSEA (approval IAEC no: 
06/321/PO/Re/S/01/CPCSEA dated12/10/2018 
Animal: Healthy wistar albino female rat weighing 200–220 gm  
Studied carried out at three female rats under fasting condition, signs of 
toxicity were observed for every one hour for first 24 hours and every day for about 
14 days from the beginning of the study.  
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PRINCIPLE:  
It is the principle of the test that based on a stepwise procedure with the use 
of a minimum number of animals per step, sufficient information is obtained on the 
acute toxicity of the test substance to enable its classification. The substance is 
administered orally to a group of experimental animals at one of the defined doses. 
The substance is tested using a stepwise procedure, each step using three animals of 
a single sex. Absence or presence of compound-related mortality of the animals dosed 
at one step will determine the next step, i.e.; − no further testing is needed − dosing 
of three additional animals with the same dose − dosing of three additional animals at 
the next higher or the next lower dose level. The method will enable a judgment with 
respect to classifying the test substance to one of a series of toxicity classes.  
METHODOLOGY  
Selection of animal species:  
The preferred rodent species is rat, although other rodent species may be used. 
Healthy young adult animals of commonly used laboratory strain Swiss albino are 
used. Females should be nulliparous and non-pregnant. Each animal at the 
commencement of its dosing should be between 8 and 12 weeks old and its weight 
should fall in an interval within±20 % of the mean weight of the animals. 
 Housing and feeding conditions:  
The temperature in the experimental animal room should be 22ºC (+3ºC). 
Although the relative humidity should be at least 30% and preferably not exceed 
70% other than during room cleaning the aim should be 50-60%. Lighting should 
be artificial, the sequence being 12 hrs light, 12 hrs dark. For feeding, conventional 
laboratory diets may be used with an unlimited supply of drinking water. Animals 
may be grouped and tagged by dose, but the number of animals per cage must not 
interfere with clear observations of each animal. 
Test Animals and Test Conditions: 
Sexually mature Female Wistar albino rats (200-220gm) were obtained from 
TANUVAS, Madhavaram, Chennai. All the animals were kept under standard 
environmental condition (22 ± 3°C). The animals had free access to water and 
standard pellet diet (Sai meera foods, Bangalore). 
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Preparation of animals:  
The animals are randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization 
to the laboratory conditions. 
 Experiment Procedure: 
Administration of doses 
“Nannari mathirai” prepared as per the classical Siddha literature was 
suspended in 2% CMC with uniform mixing and was administered to the groups of 
Wistar albino rats. 
It was given in a single oral dose by gavage using a feeding needle. Animals 
were fasted prior to dosing. Following the period of fasting, the animals were 
weighed and then the test substance was administered. After the substance has been 
administered, food was withheld for a further 3-4 hours. The principle of laboratory 
animal care was followed. 
Observations were made and recorded systematically and continuously observed as per 
the guideline after substance administration. 
The visual observations included skin changes, mobility, and aggressiveness, 
sensitivity to sound and pain, as well as respiratory movements. They were deprived of 
food, but not water 16–18 hours prior to the administration of the test suspension. 
Finally, the number of survivors was noted after 24 hours and these animals were 
then maintained for a further 14 days and observations made daily. The toxicological 
effect was assessed on the basis of mortality. 
Number of animals and dose levels 
Since this test drug has been under practice for long time and likely to be 
non-toxic, a limit test at one dose level of 2000 mg/kg body weight will be carried out 
with 6 animals (3 animals per step). 
Duration of Study: 48 hours 
Evaluation: 14 Days 
Limit test 
The limit test was primarily used in situations where the experimenter has 
information indicating that the test material is likely to be nontoxic, i.e., having toxicity 
only above regulatory limit doses. A limit test at one dose level of 2000 mg/kg body 
weight was carried out with three animals per step. The test substance-related mortality 
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was not produced in animals, so further testing at the next lower level need not be 
carried out. 
Observations 
The animals were observed individually after dosing at least once during 
the first 30mins and periodically during the first 24 hours. 
 Special attention: First 1-4 hours after administration of drug. 
 It was observed daily thereafter for a total of 14 days, except when they 
needed to be removed from the study and killed humanely for animal welfare reasons or 
are found dead. 
 a. Mortality 
Animals will be observed intensively at 0.5, 2.0, 4.0, 6.0, 12.0, 24.0 and 48.0 hour 
following drug administration on day 1 of the experiment and daily twice thereafter for 14 
days. 
b. Body weight 
Body weights will be recorded at day: ‐1, day 1, 2, 7 and 14 of the study 
c. Cage-side observation 
These include changes in skin and fur, eyes and mucous membranes and also 
respiratory, circulatory, autonomic and central nervous systems, somatomotor activity 
and behaviour patterns. Attention should be directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma. 
d. Gross necropsy 
All animals (including those which die during the test period are removed from 
the study) will be subjected to gross necropsy. Gross necropsy includes examination of 
the external surface of the body, all orifices, cranial, thoracic and abdominal cavities and 
their contents, brain, eye, thymus, lungs, heart, spleen, liver, kidneys, adrenals, testes and 
uterus of all animals 
Histopathology 
Microscopic examination will be carried out in organs to show the evidence of 
any toxicity in gross pathology. 
Data and reporting 
All the data were summarised in tabular form showing the animals used, number 
of animals displaying signs of toxicity, the number animals found dead during the test or 
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killed for humane reasons, a description and the time course of toxic effects andreversibility, 
and necroscopic findings. 
Test substance and Vehicle 
In order to ensure the uniformity in drug distribution in the medium the 
suspension was made by mixing “Nannari mathirai” with 2% CMC solution and it 
was found suitable for dose accuracy. 
 Justification for choice of vehicle 
The vehicle selected as per the standard guideline is pharmacologically inert 
and easy to employ for new drug development and evaluation technique [88] 
 
4.3.2 REPEATED DOSE 28-DAY ORAL TOXICITY STUDY OF 
NANNARI MATHIRAI (OECD GUIDELINE - 407) 
Test Substance  : NANNARI MATHIRAI (NM)  
Animal Source  : TANUVAS,Madhavaram, Chennai.  
Animals   : Wister Albino Rats (Male -40, and Female-40)  
Age    : 6-8 weeks  
Body Weight   : 150-220gm.  
Acclimatization  : Seven days prior to dosing.  
Veterinary examination : Prior and at the end of the acclimatization period.  
Identification of animals : By cage number, animal number and individual  
marking by using picric acid.  
Diet    : Pellet feed supplied by Sai meera foods Pvt Ltd, Bangalore  
Water    : Aqua guard portable water in polypropylene bottles.  
Housing & Environment : The animals were housed in Polypropylene cages provided  
with bedding of husk.  
Housing temperature : between 22ºC + 3ºC.  
Relative humidity  : between 30% and 70%,  
Air changes   : 10 to 15 per hour  
Dark and light cycle  : 12:12 hours.  
Duration of the study : 28 Days 
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Justification for Dose Selection:  
As per OECD guideline three dose levels were selected for the study. 
They are low dose (X), high dose (2X). X is calculated from the acute toxicity 
dose(2000mg) and the body surface area of the rat. i.e X dose is 200 mg/animal, 
2X dose is 400 mg/animal. The results of acute toxicity studies in Wistar albino 
rats indicated that “Nannari mathirai” was non-toxic and no behavioral changes 
was observed up to the dose level of 2000 mg/kg body weight. On the basis of 
body surface area ratio between rat and human, the doses selected for the study 
were100mg/kg (Low dose), 200 mg/kg (Mid dose) and 400 mg/kg (High dose) 
body weight. The oral route was selected for use because oral route is considered 
to be a proposed therapeutic route. 
Preparation and administration of dose 
“Nannari mathirai” at three doses respectively was suspended in 2 ml 
of 2% CMC (Carboxymethyl cellulose) in distilled water. It was administered 
to animals at the dose levels of 100 mg/kg, 200 mg/kg and 400 mg/kg. The test 
substance suspensions were freshly prepared every day for 28 days. The control 
animals were administered vehicle (Water) only. Administration was by oral 
(gavage), once daily for 28 consecutive days. 
METHODOLOGY: 
Randomization, Numbering and Grouping of Animals: 
80 Wistar Albino Rats (40M + 40F) were selected and divided into 4 
groups. Each group consist of 20 animals (Male -10, and Female-10). First 
group treated as a control and other three group were treated with test drug (low, 
mid and high) for 28 days. Animals were allowed acclimatization period of 7 
days to laboratory conditions prior to the initiation of treatment. Each animal 
was marked with picric acid. The females were nulliparous and non-pregnant.  
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                                                       Table 8 
Groups No of Rats 
Group I Vehicle control 20(10male, 10female) 
Group II NM - low dose (100mg) 20(10male, 10female) 
Group III NM -Mid dose (200 mg) 20(10male, 10female) 
Group IV NM- High dose (400 mg) 20 (10male,10female) 
Observations:  
Experimental animals were kept under observation throughout the course 
of Study for the following: 
 Body Weight 
Weight of each rat was recorded on day 1,15,28 at biweekly intervals 
throughout the course of study.   
Food and water Consumption:  
Food and water consumed per animal was calculated for control and the 
treated dose groups. 
Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, 
intensity and duration of these symptoms, if any, were recorded. 
 Functional Observations:  
At the end of the 4th week exposure, sensory reactivity to graded stimuli 
of different types (auditory, visual and proprioceptive stimuli), motor 
reactivity and grip strength were assessed. 
Mortality:  
All animals were observed twice daily for mortality during entire course of 
study.  
Laboratory Investigations:  
Following laboratory investigations were carried out on day 28 in animals 
fasted over-night. Blood samples were collected from orbital sinus using sodium 
heparin (200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for 
Hematology as anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 
10 minutes. On 28th day of the experiment, 24hours urine samples were collected 
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by placing the animals in the metabolic cage with free access to tap water but no 
feed was given. 
The urine was free from fecal contamination. Toluene was used as a 
preservative while collecting the sample. The sediments present in the urine were 
removed by centrifugation and the collected urine was used for biochemical 
estimations. 
On 29th day, the animals were fasted for approximately 18 hours, then 
slightly anesthetized with ether and blood samples were collected from the retro-
orbital plexus into two tubes: one with EDTA for immediate analysis of 
haematological parameters, the other without any anticoagulant and was 
centrifuged at 4000 rpm at 4 °C for 10 minutes to obtain the serum. Serum was 
stored at 20 °C until analyzed for biochemical parameters. 
Haematological Investigations: 
 Blood samples of control and experimental rats was analyzed for 
haemoglobin content, total red blood corpuscles (RBC), white blood corpuscles 
(WBC) count and packed cell volume (PCV). 
Biochemical Investigations: 
Serum was used for the estimation of biochemical parameters. Samples 
of control and experimental rats were analyzed for protein, bilirubin, urea, BUN, 
creatinine, triglyceride, cholesterol and glucose levels was carried using standard 
methods. 
Activities of glutamate oxaloacetate transaminase/ Aspartate 
aminotransferase (GOT/AST), glutamate pyruvate transaminase/ Alanine amino 
transferase (GPT/ALT) and alkaline phosphatase were estimated as per the 
colorimetric procedure. 
Urine analysis: 
Urine samples were collected on end of treatment for estimation of 
normal parameters. The estimations were performed using appropriate 
methodology. 
 Necropsy:  
All the animals were sacrificed by excessive anesthesia on day 29. 
Necropsy of all animals was carried out and the weights of the organs including 
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liver, kidneys, spleen, brain, heart, and lungs were recorded. The relative organ 
weight of each animal was then calculated as follows; 
                                                                     Absolute organ weight (g) 
Relative organ weight = __________________________________________ ×100 
                                                     Body weight of animal on sacrifice day (g) 
Histopathology:  
Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose 
group than the low, then the mid dose group will also be examined. Organs 
will be collected from all animals and preserved in 10% buffered neutral 
formalin for 24 h and washed in running water for 24 h. The organ sliced 5 or 
6μm sections and were dehydrated in an auto technicon and then cleared in 
benzene to remove absolute alcohol. Embedding was done by passing the 
cleared samples through three cups containing molten paraffin at 50°C and 
then in a cubical block of paraffin made by the “L” moulds. It was followed 
by microtome and the slides were stained with Haematoxylin-eosin.  
Statistical analysis: 
Findings such as clinical signs of intoxication, body weight changes, 
food consumption, hematology and blood chemistry were subjected to One-
way ANOVA followed by Dunnet test using a statistics software Graph pad 
version 7. 
4.4. PHARMACOLOGICAL STUDIES: 
4.4.1 HEPATOPROTECTIVE STUDY OF NANNARI MATHIRAI IN  
CCL4 INDUCED HEPATOTOXICITY IN WISTAR ALBINO RAT MODEL: 
Experimental design:  
Animals were divided into 5 groups of 6 rats each. Group I animals served 
as control and received liquid paraffin (LP) subcutaneously at the dose of 3 ml/kg 
body weight of each animal. Group II animals received CCl4+ LP (for 14 days) at 
the dose 1 ml CCl4/kg body weight, in a suspension of double the volume of LP 
(which served as vehicle) subcutaneously at lower abdomen 1 on every 14 days of 
the treatment 2. Group III and IV animals received subcutaneous administration of 
CCl4+ LP. They also received test drugs orally at the dose of 100, 200 mg/kg body 
weight respectively as a suspension of water. Group VI received in addition to CCl4 
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suspension, silymarin (100 mg/kg body weight) daily. Silymarin was used as a 
standard reference drug 3.  
The animals were kept starved overnight on 14th day of experiment. On the 
next day the animals were sacrificed by decapitation, and the blood was collected 
by cutting the jugular vein. The liver and kidney in each case were dissected out, 
blotted of blood, washed in saline and stored in a freezer. Liver were used for various 
biochemical estimations. 
 Biochemical parameters studied 
The activities of serum glutamate pyruvate transaminase, and serum glutamate 
oxaloacetate transaminase was estimated using standard methods. Estimation of serum 
ALP, serum bilirubin and electrolytes were also carried out to assess the acute hepatic 
damage caused by CCL4. 
Statistical analysis 
The data obtained from the study were subjected to statistical analysis by one 
way ANOVA followed by Dunnet„t‟ test, and results were expressed in terms of 
Mean±SEM values. Statistical analysis was performed using INSTAT- V3 Software 
programme [89]. 
 4.4.2. HEPATOPROTECTIVE ACTIVITY OF “NANNARI MATHIRAI” 
AGAINST ETHANOL INDUCED HEPATOTOXICITY IN WISTAR ALBINO 
 RAT MODEL: 
Experimental design: 
The animals were divided into five groups, six animals in each group. 
Animals in Group 1 were treated with Vehicle only twice a day P.O for 25 days served 
as Normal Control Group.Group 2 animals were treated with 40% ethanol 3.76 gm/kg 
twice a day P.O for 25 days which served as Positive Control Group. 
Others animals were pre-treated twice daily with NM 100 and NM 200 mg & 
Silymarin 100 mg/kg P.O for 25 days, 1 hour before Ethanol administration. At the 
termination day, animals were anaesthetized using anesthetic ether and blood collected 
from retro orbital puncture. The level of AST, ALT, TP and ALP and BN were 
estimated as per the standard procedures described by manufacturer using serum kit. 
Biochemical parameters studied: 
The activities of serum glutamate pyruvate transaminase, and serum glutamate 
oxaloacetate transaminase was estimated using standard methods.  Estimation of 
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serum ALP, serum bilirubin and electrolytes were also carried out to assess the acute 
hepatic damage caused by Ethanol. 
Statistical analysis: 
The data obtained from the study were subjected to statistical analysis by one 
way ANOVA followed by Dunnett t-test, and results were expressed in terms of 
Mean±SEM values. Statistical analysis was performed using INSTAT- V3 Software 
programme [90].
4.4.3 ANTIOXIDANT ACTIVITY OF NANNARI MATHIRAI [91] 
DPPH radical scavenging assay (2, 2-diphenyl -1-picrylhydrazyl) 
The radical scavenging activity of different extracts was determined by using 
DPPH assay according to Chang et al [2001]. The decrease in the absorption of the 
DPPH solution after the addition of an antioxidant was measured at 517 nm. Ascorbic 
acid (10mg/ml DMSO) was used as reference. 
Principle 
            1, 1-diphenyl-2-picryl hydrazyl is a stable free radical with pink colour which 
turns yellow when scavenged. The DPPH assay uses this character to show free radical 
scavenging activity. The scavenging reaction between (DPPH) and an antioxidant (H-
A) can be written as,  
                                     DPPH + [H-A] →DPPH-H + (A) 
Antioxidants react with DPPH and reduce it to DPPH-H and as consequence the 
absorbance decreases. The degree of discoloration indicates the scavenging potential 
of the antioxidant compounds or extracts in terms of hydrogen donating ability. 
Reagent preparation 
0.1mM DPPH solution was prepared by dissolving 4mg of DPPH in 100ml of 
methanol.  
Procedure 
Different concentrations of sample such as 12.5µg/mL- 200µg/mL from a stock 
concentration of 10mg/mL were made up to a final volume of 20µl with DMSO and 
1.48ml DPPH (0.1mM) solution was added. A control without the test compound, but 
an equivalent amount of distilled water was taken. The reaction mixture incubated in 
dark condition at room temperature for 20 minutes. After 20 minutes, the absorbance 
of the mixture was read at 517nm. 3ml of DPPH was taken as control 
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Calculation 
         Percentage of inhibition =  
 
Reults were noted and tabulated in Table No.35 and Graph 8. 
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5. RESULTS AND DISCUSSION 
 The well-known Traditional medicine NANNARI MATHIRAI had been 
subjected to various studies and standardization to establish the works of Siddhars to 
be true. The study includes  
▪ Literary collections,  
▪ Organoleptic character,  
▪ Physicochemical analysis, 
▪ Phytochemical analysis, 
▪ Instrumental analysis, 
▪ Toxicological study and  
▪ Pharmacological study.  
The drug “NANNARI MATHIRAI” has been selected for the treatment of 
KAAMAALAI (JAUNDICE) in reference with the text “KANNUSWMY 
PRAMBARAI VAITHIYAM”.  
Discussion on review of literature: 
                   Literary collections about the drug from various text books were done. 
Siddha literatures related to the drug bring the evidence and importance of its utility in 
treating Kaamaalai ( Jaundice). 
        Botanical aspect explains the identification, description, active principle 
and medicinal uses of the plants. 
 Gunapadam review brings the effectiveness of the drug in treating 
Kaamaalai ( Jaundice). 
 Pharmaceutical review describes about the Mathirai and its properties. 
 The pharmacological review explains about the methodology of 
Hepatoprotective Activity and the drugs used for this study. 
                    Modern and Siddha aspect of the disease was also reviewed. 
Standardization of the test drug: 
 Standardisation of the drug is more essential to derive the efficacy and the 
potency of the drug by analysing it by various studies. Following are the results of 
physicochemical and phytochemical analysis. Physical characterisation and estimation 
of basic and acidic radicals have been done and tabulated. 
 Toxicological results of the drug and pharmacological activity of the drug was 
derived. Its result has been tabulated and the interpretation was made below. Thus, it 
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gives a complete justification to bring the effectiveness of the trial drug Nannari 
Mathirai. 
  The extensive review on botanical aspect gave information about the 
microscopical characters, macroscopical characters, medicinal uses, constituents and 
the importance of the herbs in detail. Most of the herbs included in the formulation are 
hepatoprotective in activity. The studies strongly supported the fact through these 
results. They are discussed below 
Nannari is indicated for curing Jaundice (Kaamaalai). 
 Elam is used in the treatment of biliousness. 
 Seeragam is indicated for the treatment of Liver diseases. It also known to 
improving the fuctions of liver. 
 Perunjeragam is indicated for curing Jaundice (Kaamaalai). 
       Sevvagathi flower has an action of tonic to Liver.  
Discussion on pharmacological aspect: 
The pharmacological aspect of the drug says about their mode of action and the 
side effects which were used worldwide since ancient times.The current 
pharmacological methods available for carrying out the Hepatoprotective studies were 
explained clearly and the suitable In-vivo models carry out the activities were 
discussed. 
Result from the pharmacological study denotes the effects of Nannari ,Mathirai 
showed the promising effects in treating liver damage. Moreover, the increased levels 
of the serum enzymes were significantly decreased by the treatment with Nannari 
Mathirai   implying that the drug prevents the liver damage. 
Discussion on Pharmaceutical review: 
 This review explained the preparation of Mathirai in detail including the 
purification of raw drugs, methods of manufacturing of Mathirai and the Siddha 
parameters for the standardization of analyzing Mathirai. 
The powdered drugs were filtered through the white cloth so as to reduce the   
size of the particle in turn which enhances the bio-availability.The shelf life of the drug 
is improved by proper purification methods and preservation. 
Discussion on Materials and Methods: 
 The preparation of the drug was done carefully so as to achieve the highest 
potency. Mathirai are fine, dry powders of drugs. The term Mathirai may be applied to 
the powder of single drug or a mixture of two or more drugs. 
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On purification, the weight of the Mathirai is different from the exact value but 
not from the mean value when calculated. 
            The Mathirai were also subjected to Siddha parameters of the testing like,  
➢ Mathirai tends to be amorphous, 
➢ It should be never damp, 
➢ The fineness of the sieve should be 100 mesh or still finer. 
 
 The standardization of the drugs was achieved through various procedures like 
analyzing the organoleptic characters, physico-chemical characters, elements present 
in the drug and the results and discussion of standardization parameters is described 
below.  
Organoleptic characters: 
Table: 9. Organoleptic characters of Nannari mathirai: 
Colour Dark brown 
Odour Pleasant 
Taste Sweet 
Texture Powder in integrated form 
Particle size Completely pass through sieve no 
88 when powdered 
 
Table 10. Physicochemical Analysis of NM: 
S.no Parameters Percentage 
1 PH 5.45% 
2 Loss on drying 2.88% 
3 Total ash value 9.5% 
4 Acid insoluble ash 6% 
5 Water soluble ash 3% 
6 Water soluble extraction 16% 
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 The physicochemical analysis of the drug (NM) result reveals pH, Loss on 
drying, Total ash value, Acid insoluble ash and Water-soluble ash. The interpretation 
of the result was given below. 
Interpretation: 
1. pH: 
 It is a measure of hydrogen ion concentration. It is the measure of the acidic or 
alkaline nature. 7.0 is neutral, above 7.0 is alkaline and below is acidic. 
 The pH of the drug Nannari Mathirai is 5.45 which is acidic in nature. Acidic 
drug is essential for its bioavailability and effectiveness. Acidic drugs are better 
absorbed in stomach.
[92] 
2. Moisture (Loss on drying): 
 The total  amount of volatile content and moisture present in the drug was 
established in loss on drying. Moisture content of the drug reveals the stability and its 
shelf-life. 
 High moisture content can adversely affect the active ingredient of the drug. 
Thus, low moisture content could get maximum stability and better shelf life. Loss on 
drying of Nannari Mathirai is 2.88.
[93] 
3. Total Ash: 
 Ash constitutes are the inorganic residues obtained after complete combustion 
of a drug. Thus, Ash value is a validity parameter to describe and to assess the degree 
of purity of a given drug. Total ash value of plant material indicated the amount of 
minerals and earthy materials present in the drug. The total ash value of Nannari 
Mathirai is 9.5 % which determine the absence of inorganic content. 
 
7 Alcohol soluble extraction 8% 
8 Solubility  
Distilled water Soluble 
Chloroform Soluble 
Ethanol Soluble 
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5. Acid insoluble ash: 
 The acid insoluble ash value of the drug denotes the amount of siliceous matter 
present in the plant. The quality of the drug is better if the acid insoluble value is low. 
Acid insoluable ash value of Nannari Mathirai is 6 %. 
6. Water soluble ash: 
 Water-soluble ash is the part of the total ash content, which is soluble in water. 
Decreased water soluble ash value indicates easy facilitation of diffusion and osmosis 
mechanism. Water soluble ash value of Nannari Mathirai is 3%. 
7. Solubility: 
 Solubility is the major factor that controls the bioavailability of a drug 
substance. It is useful to determine the form of drug and processing of its dosage form. 
 The most frequent causes of low oral bioavailability are attributed to poor 
solubility and low permeability.
[94] 
NM is soluble in major solvents and sparingly soluble in some solvents proves 
that its efficiency of solubility in the stomach indirectly, increasing the bio availability.  
Weight variation test : 
Weight variation was carried out to ensure that, each of tablets contains the 
proper amount of drug. The test was carried out by weighing the 20 tablets individually 
using analytical balance, then calculating the average weight, and comparing the 
individual tablet weights to the average. The percentage of weight variation is 
calculated by using the following formula. The result of weight variation test was 
tabulated in Table No11.  
 
% of wt.variation = Individual wt-Average wt  x100 
                                    Average weight 
 
 
 
 
 
 
 
RESULTS AND DISCUSSION 
 
 
101 HEPATOPROTECTIVE ACTIVITY OF NANNARI MATHIRAI 
 
 
      Table No 11: Uniformity weight variation test result of Nannari Mathirai: 
 
 
S.NO Weight of 
each 
mathirai(mg) 
%of weight 
variation 
Maximum 
weight variation 
within ± 7.5% 
Maximum 
weight 
variation 
within ± 
15.0% 
1 129 5.444 %  Yes Yes 
2 137  4.666 % Yes Yes 
3 132 2.123 % Yes Yes 
4 131 -0.987 %  Yes Yes 
5 134 7.874 %  Yes Yes 
6 143 6.189 %  Yes Yes 
7 127 -5.690 %  Yes Yes 
8 122 1.900 %  Yes Yes 
9 134 -8.654 %  Yes Yes 
10 128 5.777 %  Yes Yes 
11 144 -2.763 %  Yes Yes 
12 138 0.076 %  Yes Yes 
13 130 3.132 %  Yes Yes 
14 126 -5.849 %  Yes Yes 
15 139 1.904 %  Yes Yes 
16 122 3.896 %  Yes Yes 
17 123 1.768 %  Yes Yes 
18 120 -3.765 %  Yes Yes 
19 143 -1.872 %  Yes Yes 
20 127 4.660 %  Yes Yes 
Average: 130.66 mg 
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Average weight of the Mathirai was noted as 129.855g. Out of 20 tablets tested, 
19 tablets of them lies within ±7.5% weight variation (1 tab above the limit) and all 20 
tab lies within ±15% weight variation.  
➢ According to the limits of weight test cited in the Indian pharmacopoeia, 
Nannari Mathirai passed the Uniformity weight test.  
➢ The uniformity test resembles unformal distribution of this tablet helps good 
absorption and distribution.  
➢ Hence all the tablets passed the weight variation test. 
 
                     Table no 12. Traditional test for pill: 
                                
SL.NO Character Inference 
1. Non sticky on rolling                  + 
2. No cracks over the surface after 
drying 
                 + 
3. Shall be rolled uniformly over the 
plane surface 
                 + 
4. Shining surface                   + 
 
 
   Phytochemical analysis: 
   Table no :13. The phytochemical Nannari Mathirai result were given below: 
 
S.No. Phytochemicals Test Name H2O 
Extract 
1 Alkaloids Mayer’s Test +ve 
2 Saponins Foam Test +ve 
3 Phenols Ferric Chloride Test +ve 
4 Flavonoids Alkaline Reagent Test +ve 
5 Proteins  Xanthoprotein Test +ve 
6 Amino acids Ninhydrin Test +ve 
7 Diterpenes Copper Acetate Test +ve 
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8 Gum & Mucilage Extract + Alcohol +ve 
9 Quinones NAOH + Extract +ve 
The above stated phytochemical properties for the given sample certified to be present. 
                                             
 
 
 
 
 
 
 
                       Fig 7: Phytochemical analysis of Nannari Mathirai 
The phytochemical analysis of the drug (NM) result reveals   Alkaloids, 
Saponins, Phenols, Flavanoids, Proteins, Amino acids, Diterpenes, Gum & Mucilage 
and Quinones. The interpretation of the result was given below. 
Interpretation: 
Alkaloids: 
➢ Alkaloids possess antispasmodic, analgesic, bactericidal effects. 
➢ Alkaloids are the active principles producing many essential effects in 
protecting the body [95]. 
Saponins: 
➢ Saponins include, supporting kuffer cells in the liver and encouraging normal 
detoxification. 
 
➢ In the digestive tract, saponins produce an emulsification of fat-soluble 
molecules. Saponins bind with bile acids and helps to eliminate them from the 
body, preventing cholesterol from being reabsorbed. 
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➢ Saponins can boost the immune system, have an antioxidant effect and may 
even support bone strength.
[96]
 
Phenols: 
➢ Phenols possess rich anti-oxidant property and protect the body from oxidative 
stress. 
 
➢ Phenols inhibit the LDL cholesterol levels. 
 
➢ Phenols reduces cell death and it regulate glucose metabolism. 
 
➢ Phenols increase the vasodilation of blood vessels to promote circulation. It is 
a Effective anti-hyperglycaemic agent. 
[97]
 
 
Flavanoides: 
 
➢ It is the most important group of polyphenolic compounds in plants. 
 
➢ Flavonoids can exert their anti-oxidant activity by scavenging the free radicals, 
by chelating metal ions or by inhibiting enzymatic systems responsible for free 
radical generation. 
 
➢ Flavanoids are immunomodulator. It also possesses anti-microbial activity 
which is confirmed by the various anti-microbial assays.
[98]
 
 
Protein and amino acids: 
➢ Proteins are very useful in the liver regeneration and energy production. 
➢ They boost glutathione production to protect the liver. 
➢ Protein is an amalgamation of amino acids. It is an important component of 
 every cell in the body. Body uses protein to build and repair tissues [99]. 
  
Diterpenes: 
➢ Diterpenes has an anti-oxidant effect. Diterpenes helps to cure hpertension. It 
also has tumour inhibitory properties as well as a stimulating effect on the 
immune system. 
➢ It is used widely as a stomachic.[100] 
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Gum & Mucilage:               
➢ It is used as a bulk laxative.Gum and mucilage are used for their demulcent 
properties for cough suppression.
[101]
 
High Performance Liquid Chromatography (HPLC): 
 
➢ HPLC analysis were done. HPLC analysis performed with Nannari           
Mathirai revealed the presence of following compounds: 
 
                             Table:14. HPLC analysis for Nannari mathirai: 
  
S.no PARAMETERS METHODS UNITS RESULTS 
1. Total polyphenol 
gallic acid equivalent 
Indian Pharmacopoeia 
2014 
Mg/10g 0.34 
2. Total flavonoids as 
quercetin equivalent 
TNTH/STP/FOOD/110 Mg/100g 17.20 
3. Total alkaloids  TNTH/STP/FOOD/426 Mg/100g 1.56 
4. Total tannin as tannic 
acid equivalent 
AOAC20thEdn.2012, 
955.35 
Mg/100g 0.89 
 
HPLC analysis reveals the presence of polyphenols, Flavanoids, Alkaloids and Tannins 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
      Graph 1 
Interpretation: 
 
❖ Polyphenols are the member of very large family of plant derived compounds 
which had the anti lipidogenic effect. This is mainly due to reduced fatty acid 
and triglycerol synthesis, increased in fatty acid oxidation and reduction of 
oxidative stress and inflammation. 
 
RESULTS AND DISCUSSION 
 
 
106 HEPATOPROTECTIVE ACTIVITY OF NANNARI MATHIRAI 
 
❖ Beneficial effects of polyphenols in the prevention and treatment of liver 
steatosis have been reported. 
 
❖ Polyphenols are biomolecules which produce hepatoprotective effects which 
reduce the liver fat accumulation, mainly by reducing lipogenesis and by 
increasing fatty acid oxidation and decrease oxidative stress and inflammation 
are the main factors responsible for liver damage
 [102]
. 
 
❖ Flavanoids a group of plant compounds which have the beneficial effects 
against Non-Alcoholic Fatty Liver Disease. 
 
❖ Flavanoids prevent Hepatosteatosis by increasing fatty acid oxidation in liver. 
They can also reduce caloric intake and decrease body weight and fat deposition 
in viseral tissues. 
 
❖ Flavanoids are the unique antioxidant. It also corrects dislipidemia and blood 
pressure
 [103]
. 
❖ Tannins and alkaloids contain anti-oxidant effect which produce many 
essential effects in protecting the body. 
 
BIOCHEMICAL ANALYSIS 
 
Table: 15. Results of basic radicals’ studies on Nannari Mathirai: 
 
S.no Parameter Observation Result 
1 Test for Potassium Yellow colour Precipitate Positive 
2 Test for Magnesium White colour precipitate Positive 
3  Test for Iron (Ferrous) Blood red colour Positive 
4 Test for Zinc Formation of white Precipitate Positive 
 
 The basic radical test reveals the presence of Potassium, Magnesium, Iron, 
Zinc. The interpretation of the result was given below. 
Interpretation: 
 
 Presence of these traces of minerals play an important role in the functioning 
of various enzymes in biological system and also have immunomodulatory function 
and hence the susceptibility to the course and the variety of viral infections. 
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Potassium: 
➢ Potassium levels may be an indicator of impending liver problems.  Potassium 
is absorbed through the small intestine. Severe lack of potassium can disturb 
the liver function and if potassium level falls below 30% to 40% causes Non-
Alcoholic Fatty Liver Diseases. 
➢ Potassium is important for maintaining the integrity of cell membranes and 
functions as a vital electrolyte.
[104] 
Magnesium: 
➢ Magnesium is essential for liver to prevent liver diseases. It enhances immune 
system. Depletion of magnesium levels leads to Cirrhosis and Fatty liver 
syndrome. 
➢ It also helps to regulate blood glucose levels and aid in the production of energy 
and protein
 [105]
. 
 
Iron: 
➢ Iron is an essential micronutrient that is a critical component of oxygen transport 
proteins (Haemoglobin & Myoglobin). Chronic iron deficiency results in 
decreased haemoglobin production and anaemia which may result chronic liver 
diseases. 
➢ Iron is essential for oxygen transport, energy production, other cellular growth 
and proliferation.Iron is an essential element for blood production and also 
needed for energy metabolism.
[106] 
 
Zinc: 
➢ The liver plays a central role in zinc homeostasis. Zinc is a trace mineral that is 
essential to the normal functioning of the immune system. 
 
➢ Zinc is essential for many metabolic and enzymatic functions. In Liver it act as 
powerful antioxidant.Deficiency of zinc leads to malabsorption syndrome and 
Cirrhosis of liver
[107]
. 
 
Table: 16. Test for acid radical studies on Nannari Mathirai: 
 
S.no Parameter Observation Result 
1 Test for Sulphate Formation of white precipitate Positive 
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Interpretation: 
 The acidic radicals test reveals the presence of Sulphate. Presence of Sulphate 
is essential for liver protection by reducing increased serum enzymes of liver. 
 MICROBIAL LOAD:                                   
 Principle: 
The antimicrobials present in the samples are allowed to diffuse out into the 
medium and interact in a plate freshly seeded with the test organisms. The resulting 
zones of inhibition will be uniformly circular as there will be a confluent lawn of 
growth. The diameter of zone of inhibition can be measured in millimeters. 
 
GRAM NEGATIVE 
Tab no 17.1    Organism: E. coli 
   
            14mm-Low sensitive,15mm- Moderate,16mm-Highly sensitive. 
 
   
Tab no 17.2    Organism: Klebsiella pneumoniae 
               
14mm-Low sensitive,15mm- Moderate,16mm-Highly sensitive. 
  
                         
Sample Concentration 
(μg/mL) 
Zone of inhibition      (mm) 
Nannari 
Mathirai 
(NM) 
Streptomycin (100µg) 26 
250 14 
500 16 
1000 16 
Sample Concentration 
(μg/mL) 
Zone of inhibition       (mm) 
Nannari 
Mathirai 
(NM) 
Streptomycin (100µg) 25 
250 16 
500 17 
1000 19 
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  Tab no: 17.3   Organism: Pseudomonas aeruginosa 
           14mm-Low sensitive,15mm- Moderate,16mm-Highly sensitive. 
GRAM POSITIVE 
Tab no 17.4    Organism: Staphylococcus aureus 
                 Note: Concentration of stock 10mg/mL DMSO 
14mm-Low sensitive,15mm- Moderate,16mm-Highly sensitive.                                                              
ANTIFUNGAL ACTIVITY 
 Tab no 17.5    Organism: Aspergillus niger 
14mm-Low sensitive, 15mm- Moderate,16mm-Highly sensitive. 
                              
 
 
 
 
 
 
Sample Concentration 
(μg/mL) 
Zone of inhibition       (mm) 
Nannari 
Mathirai 
(NM) 
Streptomycin (100µg) 30 
250 15 
500 16 
1000 17 
Sample Concentration 
(μg/mL) 
Zone of inhibition       (mm) 
Nannari 
Mathirai 
(NM) 
Streptomycin (100µg) 26 
250 16 
500 19 
1000 20 
Sample Concentration 
(μg/mL) 
Zone of inhibition      (mm) 
Nannari 
Mathirai 
(NM) 
Clotrimazole(100µg)  37 
250 18 
500 20 
1000 24 
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INTERPRETATION: 
Tab no 17.6   Microbial activity Results: 
 
 
 
 
 
 
 
                        
Discussion: 
The development of resistance against the presently available antibiotics arises 
the necessity of rediscovery of new anti-bacterial and anti-fungal agents in traditional 
systems of medicine. Different dosages of test drug against the microbes in 
antimicrobial activity of NM was compared with Standard drug Streptomycin and 
Clotrimazole (100μg)/ml disc for the following pathogens, they are Escherchia coli, 
Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus, Aspergillus 
niger. The results represent NM potentially inhibit the growth of all above organism in 
250μl, 500μl and 1000μl / disc. 14 mm – Low sensitive, 15 mm – Moderate, above 16 
mm – Highly sensitive. The findings reveal that the Siddha drug NM have anti-
microbial potency against bacterial and fungal pathogens which is used in the treatment 
of diseases. 
INSTRUMENTAL ANALYSIS: 
 
FTIR (Fourier Transform Infrared) Spectrum Analysis: FT-IR is an 
effective analytical tool for identification of an unknown sample screening and profiling 
samples. The sample is irradiated by a broad spectrum of infrared light and after Fourier 
transformation the level of absorbance at a particular frequency is plotted. The resulting 
spectrum is characteristic of the organic molecules present in the sample.  
  
 
 
 
 
S.no       Name of the Microbes Zone of 
Inhibition 
1. Escherchia coli (Highly sensitive) 500(µg/ml) 
2. Klebsiella pneumoniae (Highly sensitive) 250(µg/ml) 
3. Pseudomonas aeruginosa (Highly sensitive) 500(µg/ml) 
4. Staphylococcus aureus (Highly sensitive) 250(µg/ml) 
5. Aspergillus niger (Highly sensitive) 250(µg/ml) 
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Graph:2 FT-IR analysis for Nannari Mathirai 
 
                                              Table 18: FT-IR INTERPRETATION: 
 
Absorption 
peak cm-1 
Stretch Functional group 
3399 N–H stretch 1°, 2° amines, amides 
2925 C–H stretch Alkanes 
2091 -C=N Stretch Alkanes 
1620 –C=C– stretch Alkanes 
1515 N–O asymmetric stretch nitro compounds 
1447 C–H bond Alkanes 
1328 N–O symmetric stretch nitro compounds 
1232 C–N stretch aliphatic amines 
1160 C–N stretch aliphatic amines 
1036 C–N stretch aliphatic amines 
765 C–H “oop” Aromatics 
591 C–Br stretch alkyl halides 
523 C–Br stretch alkyl halides 
 
 
The above table shows the presence of alkanes, amide, alkyl halides, nitro 
compounds, aromatics, aliphatic amines which represents the peak value. The 
interpretation of the result was given below. 
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Interpretation: 
 
FTIR instrumental analysis was done. The test drug (NM) was identified to have 
13 peaks. They are the functional groups present in the trial drug Nannari Mathirai. 
Aromatic amines have anti-oxidant property. In liver aromatic amines involves 
metabolic activation and also involved in detoxification. 
[108] 
 
Nitro compounds has higher potential towards inhibitory activity against 
microorganisms. 
Amides enhance the drug effect against the hepatic disease. It also acts on the 
neurotransmitters; it is involved in the protein synthesis.
[109] 
  
Alkanes have little biological activity; it protects against Microorganism. 
 
Alkyl halides involved in free radical scavenging activity and also used in the treatment 
of cancer. 
Aliphatic compounds possess diverse biological activities, for example, 
hepatoprotective activity, antioxidant and antidepressant activities
 [110]
. 
SEM (SCANNING ELECTRON MICROSCOPE): 
The Scanning Electron Microscope uses a focused beam of high energy 
electrons to generate a variety of signals at the surface of solid specimens. The signals 
that derive from electron-sample interactions reveal information about the sample 
including external morphology, chemical composition, crystalline structure and 
orientation of materials making up the sample. 
 
                   Fig 8 SEM 5µm (SCANNING ELECTRON MICROSCOPE) 
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                 Fig 8.1 SEM 10µm  (SCANNING ELECTRON MICROSCOPE) 
 
 
 
 
 
 
 
                               
 
 
 
 
 
 
 
     
The SEM image is done by 500X magnification via 10µm aperture shows maximum 
depth focused. 
Interpretation: 
 
➢ Biodegradable microparticles have been used frequently as drug delivery 
vehicles due to its grand bioavailability, better encapsulation, control release 
and less toxic properties. The advantages of microparticles are 
➢ The test drug Nannari Mathirai contains micro particles. Micro particles present 
in the drug results in a better bioavailability and facilitates absorption. 
➢ The particles of micro size show that the drug may easily enter the cells at the 
molecular level to treat the disease rapidly and increase the therapeutic effect.      
➢ Micro particles are defined as particulate dispersion or solid particles with a                      
size in the range of 100-1000nm in diameter. 
➢ The above SEM studies of microscopic resolution showed objects of sizes                      
ranging from 1-3 microns. 
➢ Size and surface of micro particles can be easily manipulated to achieve both                    
passive and active drug targeting. 
➢ They control and sustain, the release of drug during the transportation and at                   
the site of localization, alters drug distribution in the body and subsequent                   
clearance of the drug so as to achieve increased drug therapeutic efficacy                   
thereby bio-availability and reduced side effects [111] 
➢ Hence Nannari Mathirai which is prepared biologically contains nanoparticles 
to enhance the pharmacological action in the target site. 
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XRD (X-Ray Diffraction studies) : 
X-Ray Diffraction allows one to asceertain the molecular structure of a 
crystalline material by diffracting X-rays through the sample. 
 
 
                                                                GRAPH:3 XRD for NM 
 
Interpretation : 
 
 The crystalline structure, the size and shape of the particles are highly dependent 
on the route of synthesis and highlight the efficacy of the drug. The nano particles may 
enhance bio absorption of the drug. 
 
XRD pattern of Nannari Mathirai shows the good crystallinity after calcinations 
process. The major diffraction peaks range from (21.84 to 63.26) are identified after 
XRD analysis NM concluded that Nano crystalline range (21-46nm) is association with 
organic molecules probably plays an important role in making it biocompatible and 
nontoxic at therapeutic doses. Other elements present in NM act as additional 
supplement and possibly helps in increase the efficacy of the formulation [112]. 
ICPOES (Inductively Coupled Plasma Optical Emission Spectrometry): 
ICPOES is a technique in which the composition of elements in samples can be 
determined using plasma and a spectrometer. 
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Table 19: ICP-OES (Inductively Coupled Plasma Optical Emission Spectrometry) 
results of Nannari Mathirai : 
 
S.NO Elements Wavelength Detected levels 
1 Aluminium (Al)   396.152                  BDL 
2 Arsenic (As) 188.979 BDL 
-3 Calcium (Ca) 31.150 31.150 mg/L 
4 Cadmium (Cd) 228.802 BDL 
5 Copper (Cu) 327.393 BDL 
6 Iron (Fe) 238.204 01.554mg/L 
7 Mercury (Hg) 253.652 BDL 
8 Pottasium (K) 766.491 03.171 mg/L 
9 Magnesium (Mg) 285.213 01.804 mg/L 
10 Sodium (Na) 589.592 24.150mg/L 
11 Nickle (Ni) 231.604 BDL 
12 Lead (Pb) 220.353 BDL 
13 Phosporous (P) 213.617 99.307 mg/L 
14                       Zinc (Zn) 206.200 01.206 mg/L 
 
Interpretation: 
The above results indicate that the trial drug is extremely safe as it contains 
heavy metals within specified limits. The presence of Ca (31.150 mg/l), Fe (01.554 
mg/l), K (03.171 mg/dl), Na(24.150mg/l), P(99.307 mg/dl) and Zn(01.206mg/l) has 
physiologically important. In Nannari Mathirai, the heavy metals like Al, As, Cd, Cu, 
Hg, Pb, and Ni were below detectable level. This reveals the safety of the drug. From 
the above results the heavy metals are observed with in permissible limits. Hence the 
safety of the drug is ensured. 
 
TOXICITY STUDY RESULTS: 
 
Wistar albino rat was treated with the test drug Nannari Mathirai of single dose 
of 200mg/kg. This study was conducted as per the OECD guidelines. The result of acute 
toxicity of Nannari Mathirai has been tabulated below. 
Acute oral toxicity study of Nannari Mathirai – OECD 423 Dose finding experiment 
and its behavioural Signs of acute oral Toxicity:  
Administration of doses 
“Nannari mathirai” prepared as per the classical Siddha literature 
was suspended in 2% CMC with uniform mixing and was administered to 
the groups of Wistar albino rats. 
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Table: 20. Observation done: 
 
Table: 21. (Observational study Results): 
 
 
1.Alertness 2. Aggressiveness 3. Pile erection 4. Grooming 5. Gripping 6. Touch  
Response 7. Decreased Motor Activity 8. Tremors 9 Convulsions 10. Muscle Spasm  
11. Catatonia 12. Musclerelaxant 13. Hypnosis 14. Analgesia15.Lacrimation  
16. Exophthalmos 17. Diarrhoea 18. Writhing 19 Respiration 20. Mortality.  
Group  Observation (control group) Observation (Test group) 
Body weight                                 Normal  Normally Increased 
Assessments of posture  Normal  Normal 
Signs of Convulsion  
Limb paralysis  
Normal Absence (-) 
Body tone  Normal  Normal 
Lacrimation  Normal Absence 
Salivation  Normal Absence 
Change in skin color  Normal No significant colour change 
Piloerection  Normal  Normal 
Defecation  Normal  Normal 
Sensitivity response  Normal  Normal 
Locomotion  Normal  Normal 
Muscle gripness  Normal  Normal 
Rearing  Normal Mild 
Urination  Normal  Normal 
Dose  
mg/k
g  
1  2  3  4  5  6  7  8  9  1
0  
1
1  
1
2  
1
3  
1
4  
1
5  
1
6  
1
7  
1
8  
1
9  
20  
Cont
rol 
+ - - + - + - - - - - - - - - - - - + - 
2000 
mg  
+  -  -  + -  +  -  -  -  -  -  -  -  -  -  -  -  -  +  -  
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Table 22 Body weight of wistar albino rats group exposed to NANNARI 
MATHIRAI: 
 
 
 
 
 
 
N.S- Not Significant, **(p < 0.01), *(p <0.05), n = 10 values are mean 
± S.D (One-way ANOVA followed by Dunnett’s test 
Table 23 Water intake (ml/day) of Wistar albino rats group exposed to 
NANNARI MATHIRAI: 
DOSE 
(mg/kg/day) 
DAYS 
1 7 14 
Control 61 ± 1.12 62±2.22 63.9±1.14 
400(High dose) 58.2±1.1 58±1.14       59.20±24 
P value (p)* NS NS NS 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One way  ANOVA followed by Dunnett’s test) 
 
Table 24: Food intake (gm/day) of Wistar albino rats group exposed to NANNARI  
MATHIRAI :        
DOSE 
(mg/kg/day) 
DAYS 
1 7 14 
Control 56.24±2.22 56.2±7.42 58.4±3.46 
400(High dose) 59.6±1.63 59.6±2.62 60.1±5.38 
P value (p)* NS NS NS 
 
N.S- Not Significant, **(p < 0.01), *(p <0.05), n = 10 values are mean 
± S.D (One-way ANOVA followed by Dunnett’s test). 
 
 
 
DOSE 
(mg/kg/day) 
DAYS 
1 7 14 
Control 280.2±42.30  281.4 ± 64.12 282.6 ±26.18 
400(High dose) 270.4± 21.24 271 ± 3.64 271.4 ± 2 
P value (p)* NS NS NS 
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Interpretation of Acute toxicity studies:  
 
➢ The acute oral toxicity potentials of Nannari mathirai in female Wistar albino 
rats were studied effectively.In the sighting study, the test substance was 
administered in sequential manner to one animal each at 2000 mg kg-1 body 
weight followed by two animals at 2000 mg kg-1 body weight. 
➢ According to OECD guidelines, for acute oral toxicity LD50 dose of 2000mg/kg 
of the drug is found to be safe. 
➢ From the maximum tolerable dose 2000mg/kg of Nannari Mathirai 1/5th or 
1/10th of the dose was considered as therapeutic dose for further study. 
➢ The treated animals were observed for mortality, untoward clinical/toxic signs, 
and alterations in body weight gain and necropsy findings during the study. 
➢ The treated animals survived throughout the study period and did not reveal any 
treatment related major abnormal clinical signs at the test dose levels. 
➢ Morphological characters like changes in skin, eyes, fur, nose appeared normal. 
➢ The rats did not reveal any observable signs of central nervous system. 
➢ The rats showed signs of alertness, grooming and touch response at the dose 
level of 2000mg/kg of body weight. 
➢ The overall percentage of body weight gain in rats treated with the drug every 
weekly was found to be normal indicating that the test animals were in a healthy 
condition during the days of observation period. 
➢ The weight gain of the animal was showed in Table. The changes in water and 
food intake recorded and it did not show any distinct deviations. 
➢ On necropsy, no abnormalities were observed. In conclusion, acute oral toxicity 
testing of screened drug did not produce any treatment-related adverse effects. 
➢ This indicates that the dosages administered were below toxic level and proves 
the safety of the drug. 
➢ Hence the test drug Nannari Mathirai is a safe herbal drug and can be used for 
long time administration.  
Repeated dose 28-day oral toxicity of Nannari Mathirai OECD – 407 
The results of acute toxicity studies in Wistar albino rats indicated that 
Nannari Mathirai was non-toxic and no behavioural changes was observed up to the 
dose level of 2000 mg/kg body weight. On the basis of body surface area ratio between 
rat and human, the doses selected for the study were100mg/kg, 200 mg/kg and 400 
mg/kg body weight. The oral route was selected for use because oral route is 
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considered to be a proposed therapeutic route. Then Sub acute oral 28 days repeated 
dose toxicity study was done and the results were tabulated below. 
Table 25 : Body weight (g) changes of rats exposed to NANNARI MATHIRAI: 
Dose 
(mg/Kg/day) 
                                          Days 
1 7 14 21 28 
Control 220.37±3.21 240.14±4.09 281.21±2.17 272.21±5.11 331.32±1.89 
100 (low dose) 220.28±3.21 220.21±3.25 240.17±2.71 242.12±3.41 262.22±3.54 
200 (mid dose) 230.22±2.45 232.45 ±.65 253.25±3.42 263.25±2.14 292.25±2.34 
400 (high dose) 210.12 ±.45 232.65±1.75 248.48±3.25 253.45±2.34 283.45 ±.25 
P value (p͙͙͙͙ )*          Ns          Ns           Ns          Ns        Ns 
 
 
  NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D                
(One way ANOVA followed by Dunnett’s test) 
Table: 26. Water intake (ml/day) of Wistar albino rats group exposed to 
NANNARI MATHIRAI: 
Dose 
(mg/Kg/day) 
 
Days 
1 6 14 21 28 
Control 60.2 ± 1.21 60.6±6.12 62.2±4.10 62±4.12 64.6±1.32 
100 (low dose) 62.1±1.10 62.6±2.42 62.9±1.72 63.2±6.86 64.4±1.54 
200 (mid dose) 58.1±1.26 58.3±3.21 59.1±6.41 59.4±1.72 59.4±1.82 
400 (high dose) 54.1±1.41 54.2±1.42 54.4±1.44 54.6±1.52 55.8±2.82 
P value (p)* Ns Ns Ns Ns Ns 
 
N.S- Not Significant, **(p > 0.01),  *(p >0.05), n = 10 values are mean ± S.D 
(One way  ANOVA followed  by Dunnett’s test) 
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  Table: 27. Food intake (ml/day) of Wistar albino rats group exposed to      
NANNARI MATHIRAI: 
 
DOSE 
(mg/Kg/day) 
DAYS 
1 7 14 22 28 
CONTROL 36±4.12 36.2±3.12 37.3±2.84 37.2±1.41 38±2.43 
100(low dose) 38.2±1.41 38.3±1.13 38.1±1.21 39.5±1.23 39.5±1.26 
200 (mid dose) 35.1±3.32 35.2±3.04 35.2±2.42 36.2±2.61 37.2±1.42 
400 (high dose) 37.1±1.32 37.1±1.41 37.6±2.62 38.2±1.10 39.6±3.42 
P value (p)* NS NS NS NS NS 
 
 N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One 
way      ANOVA followed by Dunnett’s test. 
Interpretation of weight, water and food intake 
➢ The overall percent of body weight gain in rats treated with the drug was found 
to be normal and showing a steady increase in weight indicating that the test 
animals were in a healthy condition during the 28 days of observation period. 
➢ There is no significant change in water intake by the animals during the period 
of study. 
➢ The weight increase of the animals showed that the intake of food by the animals 
was good during the period of 28 days study. 
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Table 28: Effect of NANNARI MATHIRAI on Haematological parameters: 
 
Parameters Control 100 mg/kg 200 mg/kg 400 mg/kg P value 
Total 
cholesterol(mg/dl) 
111.53±13.17 110± 18.2 108.6±7.8 105.4± 22.8 NS 
Triglycerides 
(mg/dl) 
97.56± 14.5 94.3± 11.2 86.2± 15.4 85.6±9.8 NS 
Glucose (mg/dl) 113.4± 12.2 97.2± 9.6 83.4± 10.2 80.5± 13.4 NS 
LDL 78.6±2.13 78.7±2.05 78.10±1.03 77.40±01.32 NS 
VLDL 14.2±1.52 13.20±2.41 14.02±1.32 14.04±12.15 NS 
HDL 28.12±4.32 28.32±2.50 28.46±1.20 29.51±1.23 NS 
Albumin (g/dl) 6.21±0.22 6.22±0.52 6.4±7.20 6.55±6.48 NS 
           Values are expressed as mean S.E.M (Dunnett's test). *P<0.05, 
**P<0.01,***P<0.001 vs control; N=10. 
LDL-Low Density Lipoprotein, VLDL-Very Low Density Lipoprotein, HDL-High 
Density Lipoprotein. 
Interpretation 
The biochemical parameters are within the normal range. This shows that the 
trial drug shows safe and non toxic effects on general body metabolism. 
                        
 Table 29: Effect of NANNARI MATHIRAI in Liver Function test: 
 
Parameters Control 100 mg/kg 200 mg/kg 400 mg/kg 
Protein (mg/dl) 6.33 ± 0.3 6.72 ± 1.4 6.4±  2.4 6.6±  0.8 
Total Bilirubin 
(mg/dl) 
0.9 ± 0.08 0.62 ± 0.04 0.72±  0.08 0.83±  0.12 
SGOT (U/L) 86.5 ± 5.0 85.4 ± 8.2 83.2 ± 4.6 80.3±  13.3 
SGPT(U/L) 46.5 ± 6.2 43.4±  7.3 42.4±  5.8 40.4 ± 16.2 
Alkaline 
phosphatase(U/L) 
48.6  ±7.2 52.6 ± 13.4 42.8 ± 1.2 56.3±  3.6 
 
Values are expressed as mean S.E.M (Dunnett's test). *P<0.05, 
**P<0.01,***P<0.001 vs control; N=10.  
SGOT-Serum Glutamic-Oxaloacetic Transaminase,SGPT-Serum Glutamate-
Pyruvate Transminase,ALP-Alkaline phosphatase. 
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Interpretation 
➢ The total bilirubin, bilirubin direct and bilirubin indirect showed that normal 
range. 
➢ Thus the liver function test of NM shows normal in this 28 day repeated oral 
toxicity. 
 
Table 30: Effect of NANNARI MATHIRAI In Renal function test: 
 
Parameters Control 100 mg/kg 200mg/kg 400mg/kg 
BUN (mg/dl) 21.33±4.6 22.4±1.6 22.3±1.2 24.2±2.4 
Urea (mg/dl) 63± 4.3 63±2.2 62±5.2 61.4±3.8 
Creatinine(mg/dl) 0.53±0.03 0.62±0.04 0.55±0.007 0.63±0.04 
Uric acid (mg/dl) 4.02±0..04 4.06±0.21 4.4±0.13 4.20±0.10 
 
NS- Not Significant, **(p > 0.01), * (p >0.05) , n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) . 
BUN-Blood Urea Nitrogen. 
Interpretation: 
The renal function test of the animals shows the normal limits thus the trial drug 
was safe and not produce any nephro toxicity, thus it suggests that the trial drug Nannari        
mathirai was safe for long term administration.  
DISCUSSION: 
Observations: 
Overall observations were similar in both sex rats. 
Clinical signs of toxicity: 
No clinical signs of toxicity were observed 
No mortality was observed after 28 days repeated dose administration of 
Nannari mathirai. 
All animals survived to study termination period. 
Body weight: 
No significant alterations were observed in body weight. 
Food and water consumption: 
No significant alterations were observed. 
Physiological activities: 
No changes in the general behaviour. 
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Blood analysis: 
Hematology: 
No treatment related effects were observed.However there is a slight variations 
in the result but they were in the permissible limit. 
Biological parameters: 
There is a slight difference has been noted but it is normal within the normal 
limit.No treatment related effects were observed. 
Histological examination: 
Histological examination of organs did not show any pathological changes. 
Discussion: 
 The acute and repeated 28 days oral toxicity studies of Nannari mathirai 
did not produce any toxicity signs in wistar albino rats. Daily administration of Nannari 
mathirai at different doses 100mg/kg,200mg/kg, 400mg/kg for 28 days was tolerated 
by the rats without any mortality and morbidity, indicates the drug tolerance. Hence the 
polyherbal formulation of Nannari mathirai can be considered to be safe drug for 
prolonged duration use as revealed by toxicological studies.      
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HISTOPATHOLOGY OF REPEATED ORAL TOXICITY STUDIES: 
      Fig:9                                                                 
LIVER 
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Interpretation: 
From the histopathological examination, the slides of animal organs did not 
reveal abnormalities. 
From the acute and repeated oral toxicity studies the drug produced some 
significant changes. But the values were found within normal limits. So, the drug 
Nannari Mathirai was non-toxic and safe. 
 Thus, the safety of the drug is revealed so that it can be administered for long 
time without side effects. 
PHARMACOLOGICAL ACTIVITIES:  
              Tab 31. EFFECT OF NANNARI MATHIRAI ON LIVER INJURY 
INDUCED BY CCL4   IN WISTAR ALBINO RATS: 
 
Values are expressed as mean ± S.E.M followed by Dunnett test. *P < 0.05, 
**P < 0.01,   ***P < 0.001 vs control. (n - 6); 
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SGOT-Serum Glutamic-Oxaloacetic Transaminase,SGPT-Serum 
Glutamate-Pyruvate Transminase,ALP-Alkaline phosphatase. 
 
Group Treatment SGOT (IU/L) SGPT (IU/L) ALP (IU/L) 
    I Normal control 68.50±3.33 52.07±2.77 88.11±2.18 
    II Normal saline+CCL4 106.4± 2.26 98.64± 1.35 86.9±1.57 
    III Silymarin + CCL4 18.62± 0.45** 18.28± 0.87** 50.87±0.48** 
    IV NM 100mg + CCL4 35.36± 1.7** 34.45± 0.54** 55.18± 1.92** 
    V NM 200mg + CCL4 23± 0.07** 21.43± 1.10** 52± 0.08** 
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Table no 32: Effect of total Protein and Bilirubin with CCL4 IN RAT 
 
Group Treatment TB (mg/100ml) TP (mg/dl) TA (mg/dl) 
    I Control 0.98± 0.54 4.96±1.02 2.11±0.22 
    II CCL4 2.94 ± 0.02 7.45 ± 0.07** 1.05±  0.02 
    III Silymarin 1.15 ± 0.07** 6.25 ± 0.04** 2.84±  0.05** 
    IV NM100mg 2.16 ± 0.05** 5.01 ± 0.02** 1.63 ± 0.01** 
     V NM200mg 1.59 ± 0.09** 5.96±  0.06** 2.40 ± 0.03** 
 
Values are expressed as mean ± S.E.M followed by Dunnett test. *P < 0.05,  
 
 
 
 
 
 
 
GRAPH 5: 
Total Bilurubin, TP-Total Protein, TA-Total Albumin 
 
HISTOPATHOLOGY SLIDES OF NM ON CCL4 INDUCED 
HEPATOTOXICITY: 
 
Group I: Control rat showing normal central vein and normal hepatocytes. 
Group II: Showing dilated central vein and hepatocytes with degeneration. 
Group III: Photo micrograph of liver tissue treated with silymarin 
showing normal hepatocytes, portal vein (V), portal Artery 
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Group IV: Liver tissue of rats treated with NM  100 mg /kg showing mild 
degree of necrosis (N) with normal cells (C). 
 
Group V: Liver tissue of rats treated with NM  200 mg /kg Central vein showing 
normal hepatocytes with regenerating hepatocytes and mild inflammation in the portal 
area. 
Fig 10 
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Interpretation 
➢ The serum marker enzymes SGOT, SGPT and Total Proteins were exceedingly 
susceptible to hepatotoxins. They assist as markers of inflammation of liver 
cells or death of some cells due to liver damage and oxidative stress, which 
stimulate the release of amino transferases from hepatocytes into the blood. 
➢ The changes associated with Carbon tetrachloride induced liver damage of the 
present study appeared similar to the acute viral hepatitis. 
➢ In CCl4 induced hepatotoxicity, the administration of the toxicant CCl4 showed 
a distinct rise in the levels of serum marker enzymes namely SGOT, SGPT and 
Total protein as shown in the Table. 29 
➢ The protective effects of Nannari Mathirai and silymarin on the effect of liver 
serum marker enzymes are exposed in Table 32. 
➢ The serum enzymes like SGOT, SGPT and Total Protein of treated animals were 
significantly reduced by seven days pre-treatment of Nannari Mathirai at three 
dose levels 100 mg/kg and 200mg/kg  when compared with CCl4 treated control. 
No significant clinical abnormalities in other groups. 
➢ This study reveals that increase in the activity of the serum enzymes SGPT, 
SGOT and Total Proteins were detected in wister Albino rats treated with 
normal saline and CCl4 (Group 1 and 2). However, the activities of these serum 
enzymes were significantly (P < 0.01) lower in rats treated with Nannari 
Mathirai (Group 3 and 4) than in Group 1 wister Albino rats. 
➢ Reduction in the levels of AST, ALT, ALP and Total protein toward the normal 
value is an indication of regeneration process. The protective effect exhibited 
by NM at dose level of 200 mg/kg was comparable with the standard drug. 
➢ These findings suggested that the administration of Nannari Mathirai has 
significantly neutralized the toxic effects of Carbon tetrachloride and helped in 
regeneration of hepatocytes. 
➢ This present study confirmed that CCl4 induced a marked rise in oxidative stress 
and cellular degeneration in wister Albino rat’s liver. Both the doses of Nannari 
Mathirai treatment (100 and 200 mg/kg body wt.) significantly improved the 
effect of CCl4 induced oxidative stress damage and reduced the expression of 
inflammatory and apoptotic proteins. As a result this protective effect of 
Nannari Mathirai could be correlated directly to its antioxidant property. 
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➢ Therefore the reduction in the activity of these enzymes may result in a number 
of deleteriousn effects by administration of Nannari Mathirai increased the 
activities against CCl4 induced liver damage in rats to prevent the accumulation 
of excessive fats and protected the Liver [113]. 
➢ This was further confirmed by histopathological injuries. 
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HEPATOPROTECTIVE ACTIVITY OF NANNARI MATHIRAI IN 
ETHANOL INDUCED HEPATOTOXICITY IN RATS: 
 
Table no: 33 Effect of NANNARI MATHIRAI on liver injury induced by ethanol 
in rats 
 
Group Treatment SGOT 
(IU/L) 
SGPT 
(IU/L) 
ALP 
(IU/L) 
I Saline 68.50±3.33 52.07±2.77 88.11±2.18 
II  Ethanol 110.15±2.36 97.2±1.14 84.48±1.43 
III Ethanol+Silymarin 16.25±1.04** 15.47±0.006** 47.38±0.25** 
IV Ethanol+NM100 32.38±1.11** 33.26±1.58** 52.43±1.33** 
V NM200 21±0.13** 20.0±0.62** 50.20±0.04** 
Values are expressed as mean ± S.E.M followed by Dunnett test. *P < 0.05, **P < 
0.01, ***P < 0.001 vs control. (n - 6); 
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SGOT-Serum Glutamic-Oxaloacetic Transaminase,SGPT-Serum Glutamate-
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 Table 34 Bio chemical parameters in ethanol induced hepatotoxicity in rats on 
NANNARI MATHIRAI: 
 
Group Treatment TB (mg/100ml) TP (mg/dl) TA (g%) 
I Control 0.98± 0.54 4.96±1.02 2.11±0.22 
II Ethanol 2.24  0.02 4.45  0.07 1.05  0.02 
III Silymarin 0.85  0.07** 6.05  0.04** 2.84  0.05** 
IV NM 100mg 1.86  0.05** 5.01  0.02** 1.63  0.01** 
V NM 200mg 0.97  0.09** 4.96  0.06** 1.50  0.03** 
 
Values are expressed as mean ± S.E.M followed by Dunnett test. *P < 0.05,  **P < 
0.01, ***P <0.001 vs control. (n - 6); 
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HISTOPATHOLOGY SLIDES OF NANNARI MATHIRAI ON ETHANOL 
INDUCED HEPATOTOXICITY: 
Group I: Control rat showing normal liver tissue. 
 
Group II: Liver tissue of rat administered alcohol showing periportal necrosis with the 
presence of multinucleated hepatocytes and dilated central vein. 
Group III: Photo micrograph of liver tissue treated with silymarin showing normal 
hepatocytes, portal vein (V), portal Artery 
 
Group IV: Liver tissue of rats treated with NM at 100 mg/kg showing apparently 
normal liver with few scattered hepatocytes. 
Group V: Liver tissue of rats treated with NM 200 mg/kg showing normal hepatocytes 
with regenerating hepatocytes and mild inflammation. 
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HISTOPATHOLOGY SLIDES OF NANNARI MATHIRAI ON ETHANOL 
INDUCED HEPATOTOXICITY: 
Fig 11 
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Interpretation: 
 
➢ In the present study ethanol was used to induce Hepatotoxicity. 
➢ Ethanol produces a constellation of dose related deleterious effects in the liver. 
Both acute and chronic ethanol administration cause enhanced formation of 
cytokines, especially TNF-alpha by hepatic Kupffer cells, which have a 
significant role in liver injury. 
➢ Elevated levels of SGOT, SGPT and ALP are indications of hepatocellular 
injury. 
➢ In Ethanol treated rats the levels of serum marker enzymes (SGOT, SGPTand 
Bilirubin) elevated significantly. Moreover, the increased levels of the serum 
enzymes were significantly decreased by the treatment with Nannari Mathirai 
at 100 mg/kg and 200 mg/kg implying that the drug prevent the liver damage. 
➢ The treatment Nannari Mathirai confirmed dose dependent activity, at dose 
level 200 mg/kg revealed good result than 100mg/kg. 
➢ This was further confirmed by histopathological slides in Fig 11. 
 
RESULTS OF ANTI-OXIDANT ACTIVITY OF NANNARI MATHIRAI: 
Due to various factors of the fast moving life style like fast foods, change in daily 
routines, the level of oxidants or reactive oxygen species are increased in the body. It has 
been established that oxidative stress is the major causative factor in the induction of 
many chronic and degenerative diseases including atherosclerosis, ischemic heart 
disease, ageing, diabetes mellitus, cancer, immune suppression, neurodegenerative 
diseases and others. The free radicals are scavenged from the body by various 
mechanisms to enable good functioning of the organs. 
The scavenging activity for free radicals, DPPH has widely used to evaluate the 
anti-oxidant activity of natural product from plant and natural sources. In this in vitro 
study of anti-oxidant activity of Nannari Mathirai DPPH was used as a free radical. 
The preliminary phytochemical screening of Nannari Mathirai shows 
flavonoids, phenols, quinones, glycosides, terpenoids, steroid, and alkaloids followed 
by other accessions. 
The presence of flavonoids, phenols, quinones were given a strong support to do 
the Qualitative analysis of antioxidant activity of Nannari Mathirai. 
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Qualitative analysis of antioxidant activity of NM extract: 
The antioxidant activity of Nannari Mathirai extracts was determined by 
standard method. 50 μl of Nannari Mathirai extracts was taken in the micro titer plate. 
100 μl of 0.1% methanolic 1,1-diphenyl- 2-picrylhydrazyl (DPPH) was added over the 
samples and incubated for 30minutes in dark condition. The samples were then 
observed for discolouration. The Nannari Mathirai extracts showed the colour changes 
from purple to yellow; it denotes the strong positive of the antioxidant activity. The 
antioxidant positive samples were subjected for further quantitative analysis. extracts 
showed the colour changes from purple to yellow; it denotes the strong positive of the 
antioxidant activity. The antioxidant positive samples were subjected for further 
quantitative analysis. extracts showed the colour changes from purple to yellow; it 
denotes the strong positive of the antioxidant activity. The antioxidant positive samples 
were subjected for further quantitative analysis. 
                                    Table: 35. DPPH Assay of Nannari Mathirai: 
 
Sample 
concentration(µg/ml) 
Absorbance 
 
Percentage of inhibition 
Drug Standard Drug Standard 
Control 1.3547 1.7983     - 0.00 
12.5 1.2774 1.4044 21.79 21.90 
25 0.9293 1.0782 35.35 40.04 
50 0.6672 0.7121 52.86 60.40 
100 0.1019 0.2921 71.27 83.75 
200 0.0621 0.0692 82.49 96.15 
DPPH ASSAY ON NM 
 
  
 
 
 
 
 
 
 
 
 
 
Graph 8 
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Graph 9: 
Interpretation: 
In the present study, the extract of Nananri Mathirai was found to possess 
concentration dependent scavenging activity on DPPH radicals. The values of DPPH 
free radical scavenging activity of the extract Nananri Mathirai was given.  
           The extract of Nananri Mathirai showed the highest DPPH scavenging activity 
(82.49%) at 200μg/ml and the lowest percentage of inhibition (21.79%) at 12.5μg/ml.            
            Ascorbic acid (Standard) showed highest percentage of inhibition (96.15%) at 
200μg/ml and the lowest percentage of inhibition (21.90%) at 12.5μg/ml. 
            This indicated that % of inhibition with increase with increase in concentration 
of both the standard and Nananri Mathirai extract. The Nananri Mathirai extract has 
more or less equal DPPH scavenging activity [114]. 
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6.CONCLUSION: 
Siddha system of medicine believes that herbal formulation is one of the effective 
medicines for chronic diseases as is have no side effects. Herbal formulations are gaining 
popularity worldwide due to its nanomedicine form, increased bioavailability, minimal side 
effect, longer shelf life period and need less dosage. 
The main obstacle in Siddha system of medicine in modern medical practice is the lack 
of scientific and clinical data and a better understanding of the efficacy and safety of herbal, 
metal and mineral drugs. 
Liver diseases are the one of the most common health problems in the world wide. The Liver 
is quantitatively important site for drug metabolism. However, many drugs are known to cause 
hepatic injury. Conventional and synthetic drugs are used in the treatment of liver diseases are 
sometimes inadequate and can have serious adverse effect. In the absence of a reliable liver 
protective drug in modern medicine there are a number of medicinal preparations from Siddha 
system of medicine recommended for the treatment of liver disorders. 
          In order to overcome this difficulty a novel attempt has been made to standardize the 
Siddha drug “NANNARI MATHIRAI” for its Hepatoprotective properties by using analytical, 
preclinical studies. 
         The drug “NANNARI MATHIRAI” was selected from the Siddha literature 
KANNUSWAMY PRAMBARAI VAITHIYAM to validate the safety and its efficacy of CCL4, 
Ethanol induced hepatotoxicity and Antioxidant activity in Wistar albino rats. 
         The Raw drugs was authenticated by the Botanist and by the Gunapadam experts, GSMC, 
Chennai. 
Actions of the drug profile: 
   Nannari is indicated for curing Jaundice (Kaamaalai). 
 Elam is used in the treatment of biliousness. 
 Seeragam is indicated for the treatment of Liver diseases. It also known to 
improving the fuctions of liver. 
 Perunjeragam is indicated for curing Jaundice (Kaamaalai). 
  Sevvagathi flower has an action of tonic to Liver.  
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          Various analysis such as physicochemical, phytochemical, biochemical analysis, 
instrumental analysis was made. From the above analysis we came to know the presence of 
active ingredients responsible for its activity. 
Physico-chemical analysis: 
               The pH of Nannari Mathirai was 5.45%. This is acidic in nature. Acidic drug is 
essential for its bioavailability and effectiveness. Acidic drugs are easily absorbed in upper 
part of stomach. Hence, the drug should not produce any harmful effect to the mucus 
membrane of the GI tract. 
Phytochemical analysis: 
                  Phytochemical analysis showed the presence of Carbohydrates, Glycosides, 
Saponins, Phenols, Flavanoides, Diterpenes, Gum & Mucilage. 
  Biochemical analysis: 
              Biochemical analysis showed the presence of Potassium, Magnesium, Iron, Zinc and 
Sulphate. Thus, from these results we come to know the effectiveness of the drug is due to the 
presence of these constituents and it has a synergistic effect in acting against the disease. 
               Phytochemicals are natural bioactive compound, found in plants and fibres, which 
act as a defense system against diseases and more accurately to protect against diseases. 
                HPLC analysis performed with Nannari Mathirai revealed the pressence of 
Polyphenols, Flavanoides, Alkaloides and Tannins. 
               Polyphenols are biomolecules which produce hepatoprotective effects. Mainly 
because of they reduce liver fat accumulation, mainly by reducing lipogenesis and by 
increasing fatty acid oxidation and decrease oxidative stress and inflammation, the main 
factors responsible for liver damage. Flavanoides are the unique antioxidant, which have the 
beneficial effects against Liver Disease. 
   Antimicrobial activity: 
               The showed a Nannari Mathirai broad-spectrum antimicrobial activity contrary to 
all the microorganisms. In the study reveals that the presence of bacterial and fungal load in 
the trial drug (NM). They present within the normal limits. 
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 Instrumental analysis: 
               Based on the results, Nannari Mathirai is preferably non-toxic to human in its 
therapeutic dose. The standardization of the drug was evaluated by chemical 
characterization with heavy metal analysis, functional group analysis, elemental analysis 
and determination of particle size by ICP-OES, FTIR, and SEM respectively. 
               ICP-OES reveals that in Nannari Mathirai, the heavy metals like Al, As, Cd, 
Cu, Hg, Pb, and Ni were below detectable level. This reveals the safety of the drug. 
               The major diffraction peaks are identified after XRD analysis. XRD pattern of 
the trail drug Nannari Mathirai shows some good crystanility. 
            The SEM picture shown the presence of microparticle of size 100-1000 nm in the 
drug Nannari Mathirai. Further, the study shows that is a kind of micromedicine which 
favours the advantages of bio availability, better absorption and non-toxic with minimal 
dose level. 
        Pharmacokinetic aspect: 
The acid medicines were absorbed in acid medium. That is the Nannari Mathirai     
       may be absorbed in the upper part of GI tract. 
Toxicity studies: 
From the acute toxicity study as per OECD guideline 423, it was concluded that 
the test drug Nannari Mathirai is a safest drug. No mortality was obtained. 
Toxicological study of both acute and sub-acute toxicity study was carried out in 
animal model Wistar albino rat according to the OECD guidelines. The test drug showed 
no acute toxicity as there was no mortality seen. The sub-acute toxicity after the repeated 
dose of 28 days was done. The mortality, functional observations, haematological and 
biochemical investigations were made. There was no significant change seen in the normal 
values. Thus, the toxicological study of the test drug greatly establishes the safety and gives 
the justification for long time administration. 
In Conclusion, no toxic effect was observed up to 200mg/kg of Nannari Mathirai 
treated over a period of 28 days (OECD 407).  
Pharmacological activities: 
The pharmacological study was carried out in the animal model Wistar albino rats. 
Three activities were seen in the drug Nannari Mathirai. The Activities were, 
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                      CCL4 induced Hepatotoxicity, 
                       Ethanol induced Hepatotoxicity and 
                      Anti-oxidant activity. 
Hepatoprotective activity against CCL4, Ethanol induced Hepatotoxicity 
and Antioxidant activity: 
The present study showed that Nannari Mathirai produce protective against the 
hepatotoxicity induced by CCL4 and Ethanol. The Hepatoprotective role of Nannari 
Mathirai might be due to its chemical constituent. Hence Nannari Mathirai may be act as 
prophylactic as well as curative drug in treating hepato toxic conditions. Further studies need 
to isolate the active constituents and mechanism of action. Thus, the author validates 
Nannari Mathirai as a new Hepato-protective drug which is cost effective and without any 
side effect.  
Thus, by scrutinizing all the above-mentioned factors it is concluded that the test drug 
NANNARI MATHIRAI is a new Hepato-protective (KAAMAALAI-JAUNDICE) drug 
which is cost effective and without any side effect as obtained. 
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                                                  7. SUMMARY 
The test drug Nannari mathirai was selected from the Siddha literature 
Kannuswamy prambarai vaithiyam written by Kannuswamy pillai for its 
hepatoprotective activity (Kaamaalai-Jaundice).The dissertation started with an 
introduction explaining about the Siddha concept, prevalence of jaundice and role of 
the test drug in treating hepatic diseases. 
            The review of literature strengthened the positive facts of possessing the             
Hepatoprotective activity by each of the single drug included in the formulation. 
 The pharmacological review possessed all the information regarding the 
exertion of action of the drugs, available drugs in the market, their adverse effects. 
 The test drug Nannari mathirai was prepared properly by the given procedure. 
All the ingredients were identified and authenticated by the experts. 
 Review of literature in various categories was carried out. Siddha aspect, 
botanical aspect and pharmaceutical review disclosed about the drug and the disease. 
  Pharmacological review was done to establish the methodologies. The drug was 
subjected to analysis such as physicochemical, phytochemical, biochemical and also, 
instrumental analysis which provided the key ingredients presenting the drug thus it 
accounts the efficacy of the drug. 
 Toxicological study was made according to OECD guidelines comprising both 
Acute and sub-acute toxicity study. It showed the safety of the drug which attributes its 
utility in long time administration. 
 Pharmacological study was done. It revealed the Hepatoprotective activity of 
Nannari mathirai in animal model Wistar albino rats. 
 Results and discussion give the necessary justifications to prove the 
potency of the drug. Conclusion gives a compiled form of the study and explains the 
synergistic effect of all the key ingredients and activities that supports the study.This 
current analysis authenticates that Nannari mathirai has impressive Hepatoprotective 
activity (Kaamaalai-Jaundice) which exemplifies the intelligence of the Siddha 
literature to reach globally for the welfare of mankind. Thus, the herbal formulation 
Nannari mathirai is validated for its safety and efficacy for treating jaundice and it 
would be a great drug of choice. 
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8. FUTURE SCOPE 
 
The Herbal formulation “Nannari mathirai” was taken as the compound drug 
preparation for Hepatoprotective activity (Kaamaalai-Jaundice) mentioned in the 
classical Siddha literature “Kannuswamy prambarai vaithiyam” written by 
Kannuswamy pillai . The mechanism of action by which Nannari mathirai produced 
its effect on hepatoprotective activity in experimental animals need to be validated in a 
scientific manner using specific experimental animal models and also multi-center 
clinical trials are required to understand the exact molecular mechanisms of action. So, 
it could be used worldwide for hepatoprotective action. 
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